<SEC-DOCUMENT>0001104659-25-122806.txt : 20251219
<SEC-HEADER>0001104659-25-122806.hdr.sgml : 20251219
<ACCEPTANCE-DATETIME>20251219090042
ACCESSION NUMBER:		0001104659-25-122806
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20251217
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251219
DATE AS OF CHANGE:		20251219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			XCel Brands, Inc.
		CENTRAL INDEX KEY:			0001083220
		STANDARD INDUSTRIAL CLASSIFICATION:	PATENT OWNERS & LESSORS [6794]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		EIN:				760307819
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37527
		FILM NUMBER:		251585274

	BUSINESS ADDRESS:	
		STREET 1:		1333 BROADWAY
		STREET 2:		10TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
		BUSINESS PHONE:		(347) 727-2474

	MAIL ADDRESS:	
		STREET 1:		1333 BROADWAY
		STREET 2:		10TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NETFABRIC HOLDINGS, INC
		DATE OF NAME CHANGE:	20050516

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HOUSTON OPERATING CO
		DATE OF NAME CHANGE:	19990402
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2533803d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:xelb="http://xcelbrands.com/20251217">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_xelb_xcelbrands.com_20251217 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20251217_20251217 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0001083220 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000004" name="dei:EntityCentralIndexKey">0001083220</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="xelb-20251217.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-12-17">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001083220</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-12-17</xbrli:startDate>
        <xbrli:endDate>2025-12-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, DC 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_904_edei--DocumentType_c20251217__20251217_z9ytgM5rsRo4"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15 (d)<br/>
of The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_90B_edei--DocumentPeriodEndDate_c20251217__20251217_zXhQAbmY8Qn5"><ix:nonNumeric contextRef="AsOf2025-12-17" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">December 17, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityRegistrantName_c20251217__20251217_zgzjjl0OwOvh"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000011" name="dei:EntityRegistrantName">XCEL BRANDS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its
charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center; width: 32%"><b><span id="xdx_90C_edei--EntityIncorporationStateCountryCode_c20251217__20251217_zBb6IyPrawMi"><ix:nonNumeric contextRef="AsOf2025-12-17" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="font-size: 10pt; text-align: center; width: 2%">&#160;</td>
    <td style="font-size: 10pt; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityFileNumber_c20251217__20251217_zF6BRcfAsOcl"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000013" name="dei:EntityFileNumber">001-37527</ix:nonNumeric></span></b></span></td>
    <td style="font-size: 10pt; text-align: center; width: 2%">&#160;</td>
    <td style="font-size: 10pt; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20251217__20251217_z3Qc0gjptohl"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000014" name="dei:EntityTaxIdentificationNumber">76-0307819</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center"><b>(State or Other Jurisdiction of <br/>
Incorporation)</b></td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>(Commission File<br/>
 Number)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b>(IRS Employer Identification<br/>
 No.)</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b><span id="xdx_90A_edei--EntityAddressAddressLine1_c20251217__20251217_zTW24UWa6Aa6"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000015" name="dei:EntityAddressAddressLine1">550 Seventh Avenue</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressAddressLine2_c20251217__20251217_z6SRz93NnDP9"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000016" name="dei:EntityAddressAddressLine2">11th Floor</ix:nonNumeric></span>,<br/>
<span id="xdx_904_edei--EntityAddressCityOrTown_c20251217__20251217_z01WlyUi9P5h"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000017" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20251217__20251217_zjBaichrS6zi"><ix:nonNumeric contextRef="AsOf2025-12-17" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></b></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressPostalZipCode_c20251217__20251217_zIWi4qFJEYr"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000019" name="dei:EntityAddressPostalZipCode">10018</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>(Address of Principal Executive
    Offices)</b></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="font-size: 10pt; text-align: center"><b>(Zip Code)</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s telephone number, including
area code (<span id="xdx_903_edei--CityAreaCode_c20251217__20251217_zp8VAghNz2ci"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000020" name="dei:CityAreaCode">347</ix:nonNumeric></span>) <span id="xdx_906_edei--LocalPhoneNumber_c20251217__20251217_z3cJEuziH2ol"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000021" name="dei:LocalPhoneNumber">727-2474</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former Name or Former Address, if Changed Since
Last Report)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i>
General Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 49px; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_908_edei--WrittenCommunications_c20251217__20251217_zEV3ZzXMu1Sb"><ix:nonNumeric contextRef="AsOf2025-12-17" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 5pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 49px; font-size: 10pt; text-align: justify"><span style="font-family: Wingdings"><span id="xdx_90C_edei--SolicitingMaterial_c20251217__20251217_zWsvL87I4byl"><ix:nonNumeric contextRef="AsOf2025-12-17" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 5pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 49px; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_901_edei--PreCommencementTenderOffer_c20251217__20251217_z7nMghjzlXIb"><ix:nonNumeric contextRef="AsOf2025-12-17" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 5pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 49px; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90A_edei--PreCommencementIssuerTenderOffer_c20251217__20251217_zLUs5fHLyMic"><ix:nonNumeric contextRef="AsOf2025-12-17" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_906_edei--EntityEmergingGrowthCompany_c20251217__20251217_zZTrBA9XTH76"><ix:nonNumeric contextRef="AsOf2025-12-17" format="ixt:booleanfalse" id="Fact000026" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; font-size: 10pt; text-align: center; width: 39%"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt; text-align: center; width: 23%"><span style="font-size: 10pt">Trading Symbol</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt; text-align: center; width: 38%"><span style="font-size: 10pt">Name of each exchange on which<br/>
 registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_902_edei--Security12bTitle_c20251217__20251217_zEfkAkQT94x1"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000027" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20251217__20251217_zk6dkrgAqy13"><ix:nonNumeric contextRef="AsOf2025-12-17" id="Fact000028" name="dei:TradingSymbol">XELB</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><span style="font-size: 10pt"><span id="xdx_90B_edei--SecurityExchangeName_c20251217__20251217_zY57R9gyqIwf"><ix:nonNumeric contextRef="AsOf2025-12-17" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> </span>Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 1.01.</b></span></td>
    <td style="font-size: 10pt; text-align: justify; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entry into a Material Definitive Agreement.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">On
December 17, 2025, Xcel Brands, Inc. (the &#8220;Company&#8221; or &#8220;Xcel&#8221;) entered into a Securities Purchase Agreement (the
&#8220;Purchase Agreement&#8221;) with several institutional and accredited investors (the &#8220;Purchasers&#8221;) for the issuance
and sale in a private placement (the &#8220;Private Placement&#8221;) of securities for gross proceeds at the Closing Date (as defined
below) of $2.05 million. The Purchase Agreement provides for the issuance and sale of (i)&#160;977,592 shares (the &#8220;Shares&#8221;)
of the Company&#8217;s common stock, par value of $0.001 per share (the &#8220;Common Stock&#8221;), (ii) pre-funded warrants (the &#8220;Pre-Funded
Warrants&#8221;) to purchase from the Company a total of 692,463 shares of Common Stock (the &#8220;Pre-Funded Warrant Shares&#8221;),
at an exercise price per share equal to $0.001, and (iii) warrants (the &#8220;Warrants&#8221;) to purchase from the Company a total of
835,023 shares of Common Stock (the &#8220;Warrant Shares&#8221;), at an exercise price per share equal to $3.00.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The closing of the Private
Placement occurred on December 18, 2025 (the &#8220;Closing Date&#8221;). Robert W. D&#8217;Loren, Chairman and Chief Executive Officer
of the Company, agreed to purchase 81,466 Shares and 40,733 Warrants for a total purchase price of $100,000. The aggregate net proceeds
to the Company from the sale of the Shares and Pre-Funded Warrants, after deducting the placement agent fees and other estimated offering
expenses payable by the Company, are estimated to be approximately $1.75 million. The Company intends to use the net proceeds from the
Private Placement for working capital and general corporate purposes. The Company issued a press release announcing the pricing of the
Private Placement, which has been filed as Exhibit 99.1 to this report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Placement
Agency Agreement, dated December 17, 2025 (the &#8220;Placement Agency Agreement&#8221;), by and between the Company and Wellington Shields
&amp; Co. LLC (the &#8220;Placement Agent&#8221;), the Placement Agent served as the exclusive placement agent in connection with the
Private Placement and received (i)&#160;a fee equal to up to 8% of the gross proceeds from the Shares and Pre-Funded Warrants sold in
the Private Placement, (ii) placement agent warrants (the &#8220;Placement Agent Warrants&#8221;) to purchase 4% of the aggregate number
of Shares and Pre-Funded Warrants sold in the Private Placement, for an aggregate of up to 66,802 shares of Common Stock (the &#8220;Placement
Agent Warrant Shares&#8221;), at an exercise price per share equal to $1.165 per share, and (iii)&#160;$50,000 for expenses occurred in
the Private Placement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Placement Agency Agreement
contains customary representations, warranties and covenants made by the Company. It also provides for customary indemnification by each
of the Company and the Placement Agent, severally and not jointly, for losses or damages arising out of or in connection with the Private
Placement, including for liabilities under the&#160;Securities Act of 1933, as amended (the &#8220;Act&#8221;), other obligations of the
parties and termination provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing does not purport to be a complete
description of the Placement Agency Agreement and is qualified in its entirety by reference to the full text of the form of such document,
which is filed as Exhibit&#160;10.2 to this Form&#160;8-K and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The representations, warranties
and covenants contained in the Placement Agency Agreement were made only for purposes of such agreement and as of specific dates, were
solely for the benefit of the parties to the Placement Agency Agreement and may be subject to limitations agreed upon by the contracting
parties. Accordingly, the Placement Agency Agreement is incorporated herein by reference only to provide investors with information regarding
the terms of the Placement Agency Agreement, and not to provide investors with any other factual information regarding the Company or
its business, and should be read in conjunction with the disclosures in the Company&#8217;s periodic reports and other filings with the
SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Purchase Agreement,
the Company agreed to prepare and file a resale registration statement (the &#8220;Resale Registration Statement&#8221;) with the United
States Securities and Exchange Commission (the &#8220;Commission&#8221;) registering for resale the Shares, Pre-Funded Warrant Shares,
and Warrant Shares, no later than 30 calendar days after the Closing Date, to use its commercially reasonable efforts to have the Resale
Registration Statement declared effective as promptly as possible thereafter, and in any event not more than 60&#160;days following the
Closing Date (or, in the event of a review by the Commission, the later of (i) 90 days following the Closing Date and (ii) 20 days following
the date on which the Company files its Annual Report on Form 10-K for the year ending December 31, 2025). The Company will use its commercially
reasonable efforts to keep the Resale Registration Statement effective at all times until the earlier of (i) such time as no Purchaser
owns any Shares, Pre-Funded Warrant Shares, or Warrant Shares issuable upon exercise thereof and (ii) such time as all Purchasers are
eligible to resell all Shares, Pre-Funded Warrant Shares, and Warrant Shares pursuant to Rule 144 without compliance by the Company with
the current public information requirement of Rule 144.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchase Agreement contains
customary representations, warranties and covenants made by the Company. It also provides for customary indemnification by the Company
to each of the Purchasers, severally and not jointly, for losses or damages arising out of or in connection with the Private Placement,
including for liabilities under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), other obligations of the parties and termination
provisions. Further, pursuant to the terms of the Purchase Agreement, the Company has agreed for a period of 60 days from the Closing
Date, subject to certain exceptions, not to sell any shares of its Common Stock, or any securities convertible into or exercisable or
exchangeable into shares of its Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing does not purport
to be a complete description of the Purchase Agreement and is qualified in its entirety by reference to the full text of the form of such
document, which is filed as Exhibit&#160;10.1 to this Form&#160;8-K and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The representations, warranties
and covenants contained in the Purchase Agreement were made only for purposes of such agreement and as of specific dates, were solely
for the benefit of the parties to the Purchase Agreement and may be subject to limitations agreed upon by the contracting parties. Accordingly,
the Purchsae Agreement is incorporated herein by reference only to provide investors with information regarding the terms of the Purchase
Agreement, and not to provide investors with any other factual information regarding the Company or its business, and should be read in
conjunction with the disclosures in the Company&#8217;s periodic reports and other filings with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: justify; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 3.02.</b></span></td>
    <td style="font-size: 10pt; text-align: justify; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered Sales of Equity Securities.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The securities referenced
above were sold without registration under the Act, in reliance upon the exemptions from registration provided under Section 4(2) of the
Act in reliance upon the exemptions from registration provided under Section 4(2) of the Act and Regulation D promulgated under the Act
(&#8220;Regulation D&#8221;). The Purchasers represented in the Purchase Agreement, among other things, that such Purchaser was acquiring
the Securities for investment for the Purchaser&#8217;s account and that the Purchaser was an &#8220;accredited investor&#8221; within
the meaning of Regulation D.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01</b></span></td>
    <td style="font-size: 10pt; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits. </b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font-size: 10pt; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #0000ee">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2533803d1_ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2533803d1_ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2533803d1_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2533803d1_ex4-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2533803d1_ex4-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2533803d1_ex4-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Placement Agent
    Warrant</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2533803d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2533803d1_ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase
    Agreement.</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2533803d1_ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2533803d1_ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Placement Agency
    Agreement, by and between Xcel Brand, Inc. and Wellington Shields &amp; Co. LLC</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2533803d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: bottom"><a href="tm2533803d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release of Xcel
    Brands, Inc. dated December 17, 2025.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the
    inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">Date: December 18, 2025</span></td>
    <td colspan="2"><span style="font-size: 10pt"><b>XCEL BRANDS, INC.</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%"><span style="font-size: 10pt">/s/ James F. Haran</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Name:</span></td>
    <td><span style="font-size: 10pt">James F. Haran</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title:</span></td>
    <td>Chief Financial Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2WvIHjPAyMYksQiK6XXKMJd2R2c3skXrLNiUaBoaZc745QviioI1qkeGyrko4Yde30iJU2CCjvqJzZNtdCm5WeFPGstR2Wn9gRo5BxywXkXT3yTkog3UK4SoIkyBOIIrTZAnHvfC+eka6UTVqq2QLUtdwZOpZoZX8mj+c5EiauteUdEY2inQK0SKc5TfEYRTDgQb5JL4bKMtMeP5UniiYHr1z5aNF/SUhb7FzcWam/+19AM7hSmI= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>tm2533803d1_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 4.1</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>THIS WARRANT
AND THE SHARES OF COMMON STOCK ISSUABLE UPON THE EXERCISE OF THIS WARRANT (THE &ldquo;SECURITIES&rdquo;) HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES.
THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY&nbsp;NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS (I)&nbsp;SUCH SECURITIES HAVE
BEEN REGISTERED FOR SALE PURSUANT TO THE SECURITIES ACT, (II)&nbsp;SUCH SECURITIES MAY&nbsp;BE SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES
ACT, (III)&nbsp;THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSFER MAY&nbsp;LAWFULLY BE
MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT, OR (IV)&nbsp;THE SECURITIES ARE TRANSFERRED WITHOUT CONSIDERATION TO AN AFFILIATE
OF SUCH HOLDER OR A CUSTODIAL NOMINEE (WHICH FOR THE AVOIDANCE OF DOUBT SHALL REQUIRE NEITHER CONSENT NOR THE DELIVERY OF AN OPINION).</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
        of Shares: [</FONT><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">]</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">(subject to adjustment)</FONT></P></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant No.&nbsp;[</FONT><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">]</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original Issue Date:
    December 18, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xcel
Brands,&nbsp;Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, [</FONT><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">]
or its registered assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set forth below, to purchase from the
Company up to a total of [</FONT><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">]
shares of common stock, $0.001 par value per share (the &ldquo;<B>Common Stock</B>&rdquo;), of the Company (each such share, a &ldquo;<B>Warrant
Share</B>&rdquo; and all such shares, the &ldquo;<B>Warrant Shares</B>&rdquo;) at an exercise price per share equal to $0.001 (the &ldquo;<B>Exercise
Price</B>&rdquo;), in each case as adjusted from time to time as provided in <U>Section&nbsp;9</U>, upon surrender of this Pre-Funded
Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof,
the &ldquo;<B>Warrant</B>&rdquo;) at any time and from time to time after the Original Issue Date (as defined below) (the &ldquo;<B>Initial
Exercise Date</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U></B>.
For purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediates, controls, is controlled
by or is under common control with such Person, as such terms are used in or construed under Rule&nbsp;405 promulgated under the Securities
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Attribution
Parties</B>&rdquo; means, collectively, the following Persons and entities: (i)&nbsp;any direct or indirect Affiliates of the Holder,
(ii)&nbsp;any Person acting or who could be deemed to be acting as a Group together with the Holder or any Attribution Parties and (iii)&nbsp;any
other Persons whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated with the Holder&rsquo;s and/or
any other Attribution Parties for purposes of Section&nbsp;13(d)&nbsp;or Section&nbsp;16 of the Exchange Act. For clarity, the purpose
of the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Bid
Price</B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common
Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day
from 9:30 a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c)&nbsp;if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per
share of Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by
an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Closing
Sale Price</B>&rdquo; means, for any security as of any date, the last trade price for such security on the Principal Trading Market
for such security, as reported by Bloomberg Financial Markets, or, if such Principal Trading Market begins to operate on an extended
hours basis and does not designate the last trade price, then the last trade price of such security prior to 4:00 P.M., New York City
time, as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last trade price of such security in the over-the-counter
market on the electronic bulletin board for such security as reported by Bloomberg Financial Markets. If the Closing Sale Price cannot
be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date
shall be the fair market value as mutually determined by the Company and the Holder. All such determinations shall be appropriately adjusted
for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Commission</B>&rdquo;
means the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and all of the rules&nbsp;and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Group</B>&rdquo;
shall have the meaning ascribed to it in Section&nbsp;13(d)&nbsp;of the Exchange Act, and all related rules, regulations and jurisprudence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Principal
Trading Market</B>&rdquo; means the national securities exchange or other trading market on which the Common Stock is primarily listed
on and quoted for trading, which, as of the Original Issue Date, shall be the Nasdaq Global Select Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Securities
Act</B>&rdquo; means the U.S. Securities Act of 1933, as amended, and all of the rules&nbsp;and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Securities
Purchase Agreement</B>&rdquo; means that certain Securities Purchase Agreement dated as of December&nbsp;17, 2025 by and among the Company
and the investors signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Standard
Settlement Period</B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, for the Principal Trading Market
with respect to the Common Stock that is in effect on the date of delivery of an applicable Exercise Notice, which as of the Original
Issue Date was &ldquo;T+1.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Trading
Day</B>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange , the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Transfer
Agent</B>&rdquo; means Continental Stock Transfer&nbsp;&amp; Trust Company, the current transfer agent of the Company, with an address
at 1 State Street, 30th Floor, New York, New York 10004 and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.&nbsp;(New
York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Issuance
of Securities; Registration of Warrants</U></B>. The Company shall register ownership of this Warrant, upon records to be maintained
by the Company for that purpose (the &ldquo;<B>Warrant Register</B>&rdquo;), in the name of the record Holder (which shall include the
initial Holder or, as the case may be, any assignee to which this Warrant is permissibly assigned hereunder) from time to time. The Company
may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
of Transfers</U></B>. Subject to compliance with all applicable securities laws, the Company shall, or will cause its Transfer Agent
to, register the transfer of all or any portion of this Warrant in the Warrant Register, upon (i)&nbsp;surrender of this Warrant, (ii)&nbsp;accompanied
by the Assignment Form&nbsp;attached hereto as Schedule 1 duly executed by the Holder, and (iii)&nbsp;and payment for all applicable
transfer taxes (if any) by the registered Holder. Upon any such registration or transfer, a new warrant to purchase Common Stock in substantially
the form of this Warrant (any such new warrant, a &ldquo;<B>New Warrant</B>&rdquo;) evidencing the portion of this Warrant so transferred
shall be issued to the transferee, and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall
be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such
transferee of all of the rights and obligations in respect of the New Warrant that the Holder has in respect of this Warrant. The Company
shall, or will cause its Transfer Agent to, prepare, issue and deliver at the Company&rsquo;s own expense any New Warrant under this
<U>Section&nbsp;3</U>. Until due presentment for registration of transfer, the Company may treat the registered Holder hereof as the
owner and holder for all purposes, and the Company shall not be affected by any notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
of Warrants</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">All or any part
of this Warrant shall be exercisable by the registered Holder in any manner permitted by this Warrant at any time and from time to time
on or after the Initial Exercise Date, and such rights shall not expire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Holder may exercise this Warrant by delivering to the Company (i)&nbsp;an exercise notice, in the form attached as <U>Schedule 2</U>
(the &ldquo;<B>Exercise Notice</B>&rdquo;), completed and duly signed, and (ii)&nbsp;payment of the Exercise Price for the number of
Warrant Shares as to which this Warrant is being exercised (which may take the form of a &ldquo;cashless exercise&rdquo; if so indicated
in the Exercise Notice pursuant to <U>Section&nbsp;10</U> below), and the date on which the last of such items is delivered to the Company
(as determined in accordance with the notice provisions hereof) is an <B>&ldquo;Exercise Date</B>.&rdquo; The Holder shall not be required
to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall have the
same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number
of Warrant Shares, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this section, following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given
time may be less than the amount stated on the face hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of Warrant Shares</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
exercise of this Warrant, the Company shall promptly (but in no event later than the number of Trading Days comprising the Standard Settlement
Period following the Exercise Date) (such date, the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;), upon the request of the Holder,
cause the Transfer Agent to credit such aggregate number of shares of Common Stock specified by the Holder in the Exercise Notice and
to which the Holder is entitled pursuant to such exercise (the &ldquo;<B>Exercise Shares</B>&rdquo;) to (i)&nbsp;the Holder&rsquo;s or
its designee&rsquo;s balance account with The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) through its Deposit Withdrawal At Custodian
system or (ii)&nbsp;in book-entry form via a direct registration system (&ldquo;<B>DRS</B>&rdquo;) maintained by or on behalf of the
Transfer Agent, in each case, (i)&nbsp;following any sale of such Securities pursuant to a registration statement (including the Registration
Statement) covering the resale of such security that is effective and usable under the Securities Act, (ii)&nbsp;following any sale of
such Securities pursuant to Rule&nbsp;144, or (iii)&nbsp;if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission). If the conditions set forth in clauses
(i), (ii), or (iii)&nbsp;above are not met, then the Company shall cause the Transfer Agent to either (i)&nbsp;record the Exercise Shares
in the name of the Holder or its designee on the certificates reflecting the Exercise Shares with an appropriate legend regarding restriction
on transferability, which shall be issued and dispatched by overnight courier to the address as specified in the Exercise Notice, and
on the Company&rsquo;s share register or (ii)&nbsp;issue such Exercise Shares in the name of the Holder or its designee in restricted
book-entry form in the Company&rsquo;s share register. The Holder, or any Person so designated by the Holder to receive Warrant Shares,
shall be deemed to have become the holder of record of such Warrant Shares as of the Exercise Date, irrespective of the date such Warrant
Shares are credited to the Holder&rsquo;s DTC account, the date of the book entry positions or the date of delivery of the certificates
evidencing such Exercise Shares, as the case may be. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to deliver to the Holder or its
designee Exercise Shares in the manner required pursuant to <U>Section&nbsp;5(a)</U>&nbsp;within the Standard Settlement Period following
the Exercise Date (other than a failure caused by incorrect or incomplete information provided by Holder to the Company) and the Holder
or the Holder&rsquo;s broker on its behalf purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in
satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;)
but did not receive within the Standard Settlement Period, then the Company shall, within two Trading Days after the Holder&rsquo;s request
and in the Holder&rsquo;s sole discretion, promptly honor its obligation to deliver to the Holder or its designee the Exercise Shares
pursuant to <U>Section&nbsp;5(a)</U>&nbsp;and pay cash to the Holder in an amount equal to the excess (if any) of the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased in the Buy-In, less the product
of (A)&nbsp;the number of shares of Common Stock purchased in the Buy-In, times (B)&nbsp;the Closing Sale Price of a share of Common
Stock on the Exercise Date. The Holder shall provide the Company written notice within three (3)&nbsp;Trading Days after the occurrence
of a Buy-In, indicating the amounts payable to the Holder in respect of the Buy-In together with applicable confirmations and other evidence
reasonably requested by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
the extent permitted by law and subject to <U>Section&nbsp;5(b),</U> the Company&rsquo;s obligations to issue and deliver Warrant Shares
in accordance with and subject to the terms hereof (including the limitations set forth in <U>Section&nbsp;11</U> below) are absolute
and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any
provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment,
limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any
violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance that might otherwise
limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Subject to <U>Section&nbsp;5(b)</U>,
nothing herein shall limit the Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including,
without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver
Exercise Shares; provided, however, that the Holder shall not be entitled to both (i)&nbsp;require the Company to reinstate the portion
of the Warrant and equivalent number of Warrant Shares for which such exercise was not timely honored and (ii)&nbsp;receive the number
of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements under <U>Section&nbsp;5(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section&nbsp;5(a)</U>&nbsp;by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written notice to the Company
at any time prior to the delivery of the applicable Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
this Warrant shall have been exercised in part, the Company shall, at the request of the Holder and upon surrender of this Warrant certificate,
at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the
unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical to this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Charges,
Taxes and Expenses</U></B><U>.</U> Issuance and delivery of Exercise Shares shall be made without charge to the Holder for any issue
or transfer tax, transfer agent fee or other incidental tax or expense (excluding any applicable stamp duties) in respect of the issuance
of such shares, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company shall not be required
to pay any tax that may be payable in respect of any transfer involved in the registration of any Warrant Shares or the Warrants in a
name other than that of the Holder or an Affiliate thereof. The Holder shall be responsible for all other tax liability that may arise
as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Replacement
of Warrant</U></B>. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt
of evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case) and, in each case, a customary and
reasonable contractual indemnity, if requested by the Company. If a New Warrant is requested as a result of a mutilation of this Warrant,
then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company&rsquo;s obligation to issue
the New Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reservation
of Warrant Shares</U></B>. The Company covenants that it will, at all times while this Warrant is outstanding, reserve and keep available
out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue
Warrant Shares upon exercise of this Warrant as herein provided, the number of Warrant Shares that are initially issuable and deliverable
upon the exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the
Holder (taking into account the adjustments and restrictions of <U>Section&nbsp;9</U>). The failure of the Company to reserve and keep
available out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock a sufficient number of shares of
Common Stock to enable it to issue Warrant Shares upon exercise of this Warrant as herein provided is referred to herein as an &ldquo;<B>Authorized
Share Failure</B>.&rdquo; The Company covenants that all Warrant Shares so issuable and deliverable shall, upon issuance and the payment
of the applicable Exercise Price in accordance with the terms hereof, be duly and validly authorized, issued and fully paid and non-assessable.
The Company will take all such action as may be reasonably necessary to assure that such shares of Common Stock may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of any securities exchange or automated quotation
system upon which the Common Stock may be listed. The Company further covenants that it will not, without the prior written consent of
the Holder, take any actions to increase the par value of the Common Stock at any time while this Warrant is outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Adjustments</U></B>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant (the &ldquo;<B>Number of
Warrant Shares</B>&rdquo;) are subject to adjustment from time to time as set forth in this <U>Section&nbsp;9</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding, (i)&nbsp;pays a stock dividend on its Common
Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii)&nbsp;subdivides
its outstanding shares of Common Stock into a larger number of shares of Common Stock, (iii)&nbsp;combines or reverse splits its outstanding
shares of Common Stock into a smaller number of shares of Common Stock or (iv)&nbsp;issues by reclassification of shares of capital stock
any additional shares of Common Stock of the Company, then in each such case the Number of Warrant Shares shall be multiplied by a fraction,
the numerator of which shall be the number of shares of Common Stock outstanding immediately after such event and the denominator of
which shall be the number of shares of Common Stock outstanding immediately before such event. Any adjustment made pursuant to clause
(i)&nbsp;of this paragraph shall become effective immediately after the record date for the determination of stockholders entitled to
receive such dividend or distribution, provided, however, that if such record date shall have been fixed and such dividend is not fully
paid on the date fixed therefor, the Number of Warrant Shares shall be recomputed accordingly as of the close of business on such record
date and thereafter the Number of Warrant Shares shall be adjusted pursuant to this paragraph as of the time of actual payment of such
dividends. Any adjustment pursuant to clause (ii), (iii)&nbsp;or (iv)&nbsp;of this paragraph shall become effective immediately after
the effective date of such subdivision, combination or issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Pro
Rata Distributions</U>. If, on or after the Original Issue Date, the Company shall declare or make any dividend or other pro rata distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property, options, evidence of indebtedness or any other assets
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction, but, for
the avoidance of doubt, excluding any distribution of shares of Common Stock subject to Section&nbsp;9(a),any distribution of Purchase
Rights (as defined below) subject to Section&nbsp;9(c)&nbsp;and any Fundamental Transaction (as defined below) subject to Section&nbsp;9(d))
(a &ldquo;<B>Distribution</B>&rdquo;) then, in each such case, the Holder shall be entitled to participate in such Distribution to the
same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon
complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without limitation,
the Maximum Percentage (as defined below)) immediately before the date on which a record is taken for such Distribution, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such
Distribution (provided, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the
Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such
Distribution to such extent (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution
(and beneficial ownership) to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder
until such time or times as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum
Percentage, at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial
Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Purchase
Rights</U>. If at any time on or after the Original Issue Date, the Company grants, issues or sells any Options, Convertible Securities
or rights to purchase stock, warrants, securities or other property, in each case pro rata to the record holders of any class of Common
Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase
Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock
acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including
without limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant, issuance or sale of
such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for
the grant, issuance or sale of such Purchase Rights (provided, that to the extent that the Holder&rsquo;s right to participate in any
such Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall
not be entitled to participate in such Purchase Right to such extent (and shall not be entitled to beneficial ownership of such Common
Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and at the Holder&rsquo;s election, in its sole discretion,
either (1)&nbsp;such Purchase Right to such extent shall be held in abeyance for the benefit of the Holder until such time or times as
its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or
times the Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any
subsequent Purchase Right to be held similarly in abeyance) to the same extent as if there had been no such limitation or (2)&nbsp;the
Company shall offer the Holder the right upon exercise of such Purchase Right to acquire a security (e.g. a pre-funded warrant) that
would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage but will otherwise to the extent possible
have economic and other rights, preferences and privileges substantially consistent and on par with the securities or other property
issuable upon exercise of the originally offered Purchase Rights). As used in this Section&nbsp;9(c), (i)&nbsp;&ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities and (ii)&nbsp;&ldquo;Convertible
Securities&rdquo; mean any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable
for shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Fundamental
Transactions</U>. If, at any time while this Warrant is outstanding (i)&nbsp;the Company, directly or indirectly in one or more related
transactions, effects any merger or consolidation of the Company with or into another Person, in which the Company is not the surviving
entity or in which the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly,
at least 50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii)&nbsp;the Company, directly
or indirectly in one or more related transactions, effects any sale, lease, license, assignment, transfer, conveyance or other disposition
to another Person of all or substantially all of its assets in one or a series of related transactions, (iii)&nbsp;pursuant to any tender
offer or exchange offer (whether by the Company or another Person), holders of capital stock tender shares representing more than 50%
of the voting power of the capital stock of the Company and the Company or such other Person, as applicable, accepts such tender for
payment, (iv)&nbsp;the Company, directly or indirectly in one or more related transactions, consummates a stock purchase agreement or
other business combination (including, without limitation, a reorganization, recapitalization, triangular merger, spin-off or scheme
of arrangement) with another Person whereby such other Person (directly or indirectly) acquires more than 50% of the capital stock of
the Company (either by voting power or economic interest) (except for any such transaction in which the stockholders of the Company immediately
prior to such transaction maintain, in substantially the same proportions, the voting power of such Person immediately after the transaction)
or (v)&nbsp;the Company, directly or indirectly in one or more related transactions, effects any reclassification of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of shares of Common Stock covered by Section&nbsp;9(a)&nbsp;above)
(in any such case, a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then following such Fundamental Transaction the Holder shall have
the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled
to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the
holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant (including any Distributions or Purchase Rights
then held in abeyance pursuant to Sections 9(b)&nbsp;or 9(c)&nbsp;above) without regard to any limitations on exercise contained herein
(the &ldquo;<B>Alternate Consideration</B>&rdquo;). If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it received
upon any exercise of this Warrant following such Fundamental Transaction. The Company shall not effect any Fundamental Transaction in
which the Company is not the surviving entity or the Alternate Consideration includes securities of another Person unless (i)&nbsp;the
Alternate Consideration is solely in the form of cash and the Company provides for the simultaneous &ldquo;cashless exercise&rdquo; of
this Warrant pursuant to Section&nbsp;10 below or (ii)&nbsp;prior to or simultaneously with the consummation thereof, any successor to
the Company, surviving entity or other Person (including any purchaser of assets of the Company) shall assume the obligation to deliver
to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and
the other obligations under this Warrant. The provisions of this paragraph (d)&nbsp;shall similarly apply to subsequent transactions
analogous to a Fundamental Transaction type. If the Company undertakes a Fundamental Transaction in which the Company is not the surviving
entity and the Alternate Consideration includes securities of another Person, then the Company shall provide that, prior to or simultaneously
with the consummation of such Fundamental Transaction, any successor to the Company, surviving entity or other Person (including any
purchaser of assets of the Company) shall assume the obligation to deliver to the Holder such Alternate Consideration as the Holder is
entitled to receive in accordance with the foregoing provisions, and to assume the other obligations under this Warrant. The provisions
of this paragraph (d)&nbsp;shall similarly apply to subsequent transactions analogous to a Fundamental Transaction type.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Number
of Warrant Shares</U>. Simultaneously with any adjustment to the Number of Warrant Shares pursuant to Section&nbsp;9, the Exercise Price
shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the
increased or decreased Number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such
adjustment. Notwithstanding the foregoing, in no event may the Exercise Price be adjusted below the par value of the Common Stock then
in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Calculations</U>.
All calculations under this Section&nbsp;9 shall be made to the nearest one-tenth of one cent or the nearest share, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
of Adjustments</U>. Upon the occurrence of each adjustment pursuant to this Section&nbsp;9, the Company at its expense will, promptly
compute such adjustment, in good faith, in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment,
including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon
exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts
upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder
and to the Transfer Agent, if applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
of Corporate Events</U>. If, while this Warrant is outstanding, the Company (i)&nbsp;declares a dividend or any other distribution of
cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants
to subscribe for or purchase any capital stock of the Company or any subsidiary, (ii)&nbsp;authorizes or approves, enters into any agreement
contemplating or solicits stockholder approval for any Fundamental Transaction or (iii)&nbsp;authorizes the voluntary dissolution, liquidation
or winding up of the affairs of the Company, then the Company shall deliver to the Holder a notice of such transaction at least ten days
prior to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in or vote
with respect to such transaction; provided, however, that the failure to deliver such notice or any defect therein shall not affect the
validity of the corporate action required to be described in such notice. In addition, if while this Warrant is outstanding, the Company
authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for any Fundamental Transaction contemplated
by <U>Section&nbsp;9(d)</U>, other than a Fundamental Transaction under clause (iii)&nbsp;of <U>Section&nbsp;9(d)</U>, the Company shall
deliver to the Holder a notice of such Fundamental Transaction at least 20 days prior to the date such Fundamental Transaction is consummated.
In the event that any such notice pursuant to this <U>Section&nbsp;9(i)</U>&nbsp;and the contents thereof shall be deemed to constitute
material, non-public information, the Company shall (on the applicable time frames set forth therein) offer the Holder the ability to
sign a confidentiality agreement related thereto in a form acceptable to the Holder sufficient to allow the Holder to receive such notice,
and the Company shall deliver such notice immediately upon execution of such confidentiality agreement. If the Holder does not sign such
confidentiality agreement, then the Holder shall not receive such notice and the Company&rsquo;s obligation to provide such notice shall
be deemed waived. Holder agrees to maintain any material, non-public information disclosed pursuant to this <U>Section&nbsp;9(h)</U>&nbsp;in
confidence until such information is publicly available or in accordance with the applicable confidentiality agreement, and shall comply
with applicable law with respect to trading in the Company&rsquo;s securities following receipt of any such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
of Exercise Price</U></B>. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy
its obligation to pay the Exercise Price through a &ldquo;cashless exercise&rdquo;, in which event the Company shall issue to the Holder
the number of Warrant Shares in an exchange of securities effected pursuant to Section&nbsp;3(a)(9)&nbsp;of the Securities Act, determined
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-size: 10pt">X = Y [(A-B)/A]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&ldquo;X&rdquo;
equals the number of Warrant Shares to be issued to the Holder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&ldquo;Y&rdquo;
equals the total number of Warrant Shares with respect to which this Warrant is then being exercised;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&ldquo;A&rdquo;
equals (i)&nbsp;the Closing Sale Price of the shares of Common Stock as of the Trading Day on the date immediately preceding the Exercise
Date if the Exercise Notice is (1)&nbsp;both executed and delivered pursuant to Section&nbsp;4(b)&nbsp;hereof on a day that is not a
Trading Date or (2)&nbsp;both executed and delivered pursuant to Section&nbsp;4(b)&nbsp;hereof on a Trading Day prior to the opening
of &ldquo;regular trading hours&rdquo; (as defined in Rule&nbsp;600(b)&nbsp;of Regulation NMS promulgated under the federal securities
laws) on such Trading Day or (ii)&nbsp;the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours after
the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section&nbsp;&lrm;4(b)&nbsp;hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&ldquo;B&rdquo;
equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">For purposes of
Rule&nbsp;144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a &ldquo;cashless
exercise&rdquo; transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall
be deemed to have commenced, on the Original Issue Date (provided<I>&nbsp;</I>that the Commission continues to take the position that
such treatment is proper at the time of such exercise). If the Warrant Shares are issued in such a cashless exercise, the Company acknowledges
and agrees that, in accordance with Section&nbsp;3(a)(9)&nbsp;of the Securities Act, the Exercise Shares issued in such exercise shall
take on the registered characteristics of the Warrants being exercised and may be tacked on to the holding period of the Warrants being
exercised. Except as set forth in <U>Section&nbsp;5(b)</U>&nbsp;(buy-in remedy), in no event will the exercise of this Warrant be settled
in cash in lieu of the delivery of shares by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitations
on Exercise</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
anything to the contrary contained herein, the Company shall not effect the exercise of any portion of this Warrant, and the Holder of
this Warrant shall not exercise any portion of the Warrant, and any such exercise shall be null and void ab initio and treated as if
the exercise had not been made, to the extent that immediately prior to or following such exercise, the Holder, together with the Attribution
Parties, beneficially owns or would beneficially own as determined in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and
the rules&nbsp;promulgated thereunder, in excess of [4.99][9.99]% (the &ldquo;<B>Maximum Percentage</B>&rdquo;) of the Common Stock that
would be issued and outstanding following such exercise. For purposes of calculating beneficial ownership for determining whether the
Maximum Percentage is or will be exceeded, the aggregate number of shares of Common Stock held and/or beneficially owned by the Holder
together with the Attribution Parties, shall include the number of shares of Common Stock held and/or beneficially owned by the Holder
together with the Attribution Parties plus the number of shares of Common Stock issuable upon exercise of the relevant Warrant with respect
to which the determination is being made but shall exclude the number of shares of Common Stock which would be issuable upon (i)&nbsp;exercise
of the remaining, unexercised Warrant held and/or beneficially owned by the Holder or the Attribution Parties and (ii)&nbsp;exercise
or conversion of the unexercised or unconverted portion of any other securities of the Company held and/or beneficially owned by such
Holder or any Attribution Party (including, without limitation, any convertible notes, convertible stock or warrants) that are subject
to a limitation on conversion or exercise analogous to the limitation contained herein. For purposes of this Paragraph 11(a), beneficial
ownership of the Holder or the Attribution Parties shall, except as set forth in the immediately preceding sentence, be calculated and
determined in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;promulgated thereunder. For purposes of
this Warrant, in determining the number of outstanding shares of Common Stock, a Holder of this Warrant may rely on the number of outstanding
shares of Common Stock as reflected in (1)&nbsp;the Company&rsquo;s most recent Form&nbsp;10-K, Form&nbsp;10-Q, Current Report on Form&nbsp;8-K
or other public filing with the Securities and Exchange Commission, as the case may be, (2)&nbsp;a more recent public announcement by
the Company or (3)&nbsp;any other notice by the Company or the Company&rsquo;s transfer agent setting forth the number of shares of Common
Stock outstanding (such issued and outstanding shares, the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). For any reason at
any time, upon the written or oral request of the Holder, the Company shall within one Trading Day confirm in writing or by electronic
mail to the Holder the number of shares of Common Stock then outstanding. The Holder shall disclose to the Company the number of outstanding
shares contemporaneously or immediately prior to submitting an Exercise Notice for the relevant Warrant. If the Company receives an Exercise
Notice from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share
Number, the Company shall (i)&nbsp;notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the
extent that such Exercise Notice would otherwise cause the Holder&rsquo;s, together with the Attribution Parties&rsquo;, beneficial ownership,
as determined pursuant to this Section&nbsp;11(a), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced
number of Warrant Shares to be purchased pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the
 &ldquo;Reduction Shares&rdquo;) and (ii)&nbsp;as soon as reasonably practicable, the Company shall return to the Holder any exercise
price paid by the Holder for the Reduction Shares. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and the Attribution
Parties since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of Common Stock
to the Holder upon exercise of this Warrant results in the Holder, together with the Attribution Parties, being deemed to beneficially
own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section&nbsp;13(d)&nbsp;of
the Exchange Act), the number of shares so issued by which the Holder&rsquo;s, together with the Attribution Parties&rsquo;, aggregate
beneficial ownership exceeds the Maximum Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall
be cancelled ab initio, and the Holder and/or the Attribution Parties shall not have the power to vote or to transfer the Excess Shares.
As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to
the Holder the exercise price paid by the Holder for the Excess Shares and reinstate the Warrant to the extent of such surrendered Excess
Shares. By written notice to the Company, a Holder of this Warrant may from time to time increase or decrease the Maximum Percentage
to any other percentage specified in such notice, provided however, in no case shall the percentage specified be in excess of 19.99%.
Any increase in the Maximum Percentage will not be effective until the 61st day after such notice is delivered to the Company and shall
not negatively affect any partial exercise effected prior to such change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Section&nbsp;11 shall not restrict the number of shares of Common Stock which a Holder or the Attribution Parties may receive or beneficially
own in order to determine the amount of securities or other consideration that such Holder or the Attribution Parties may receive in
the event of a Fundamental Transaction as contemplated in Section&nbsp;9(c)&nbsp;of this Warrant. For purposes of clarity, the shares
of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially
owned by the Holder or the Attribution Parties for any purpose including for purposes of Section&nbsp;13(d)&nbsp;of the Exchange Act
and the rules&nbsp;promulgated thereunder or Section&nbsp;16 of the Exchange Act and the rules&nbsp;promulgated thereunder, including
Rule&nbsp;16a-1(a)(1). No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability
of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;11 to the extent
necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial
ownership limitation contained in this Section&nbsp;11 or to make changes or supplements necessary or desirable to properly give effect
to such limitation. The limitation contained in this Section&nbsp;11 may not be waived and shall apply to a successor holder of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Fractional Shares</U></B>. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any
fractional shares that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded up to the next whole number
and the Company shall not be required to pay the Holder in cash the fair market value (based on the Closing Sale Price) for any such
fractional shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U></B>.
Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in
writing and shall be deemed given and effective on the earliest of (i)&nbsp;the date of transmission, if such notice or communication
is delivered confirmed e-mail at the e-mail address specified by the Company prior to 5:30 P.M., New York City time, on a Trading Day,
(ii)&nbsp;the next Trading Day after the date of transmission, if such notice or communication is delivered via confirmed e-mail at the
e-mail address specified by the Company on a day that is not a Trading Day or later than 5:30 P.M., New York City time, on any Trading
Day, (iii)&nbsp;the Trading Day following the date of mailing, if sent by nationally recognized overnight courier service specifying
next business day delivery, or (iv)&nbsp;upon actual receipt by the Person to whom such notice is required to be given, if by hand delivery.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Agent</U></B>. The Company shall initially serve as warrant agent under this Warrant. Upon ten (10)&nbsp;days&rsquo; notice to the Holder,
the Company may appoint a new warrant agent. Any entity into which the Company or any new warrant agent may be merged or any entity resulting
from any consolidation to which the Company or any new warrant agent shall be a party or any entity to which the Company or any new warrant
agent transfers substantially all of its corporate trust or stockholders services business shall be a successor warrant agent under this
Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be
mailed (by first class mail, postage prepaid) to the Holder at the Holder&rsquo;s last address as shown on the Warrant Register. The
Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof
or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Rights as a Stockholder</U>. Except as otherwise set forth in this Warrant, the Holder, solely in such Person&rsquo;s capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person&rsquo;s capacity as the Holder
of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action
(whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, amalgamation, conveyance or otherwise),
receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant
Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant
shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise)
or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Further
Assurances</U>. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without
limitation, amending its certificate or articles of incorporation or through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of
the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all
such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without
limiting the generality of the foregoing, the Company will (a)&nbsp;not increase the par value of any Warrant Shares above the amount
payable therefor upon such exercise immediately prior to such increase in par value, (b)&nbsp;take all such action as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise
of this Warrant, and (c)&nbsp;use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any
public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant.
Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. Subject to compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may
not be assigned by the Company without the written consent of the Holder, except to a successor in the event of a Fundamental Transaction.
This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors and assigns.
Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the Company and the Holder
any legal or equitable right, remedy or cause of action under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment
and Waiver</U>. This Warrant may be amended only in writing signed by the Company and the Holder, or their successors and assigns. Except
as otherwise provided herein, the Company may take any action herein prohibited, or omit to perform any act herein required to be performed
by it, only if the Company has obtained the written consent of the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Acceptance</U>.
Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law; Jurisdiction</U>. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS WARRANT SHALL BE GOVERNED
BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW
THEREOF. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS
SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH
ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS),
AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT
TO THE JURISDICTION OF ANY SUCH COURT. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS
TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT
DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PERSON AT THE ADDRESS IN EFFECT FOR NOTICES TO IT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE
GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO
SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any
of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
If any part or provision of this Warrant is held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction,
the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original
business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Warrant shall remain binding
upon the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>[REMAINDER OF
PAGE INTENTIONALLY LEFT BLANK]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>XCEL BRANDS,&nbsp;INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>SCHEDULE 1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>ASSIGNMENT
FORM</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">(<I>To assign the
foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares</I>.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">FOR VALUE RECEIVED,
the foregoing Warrant and all rights evidenced thereby are hereby assigned to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 35%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:
    <U>&nbsp;</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:
    <U>&nbsp;</U></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>SCHEDULE 2</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>FORM&nbsp;OF
EXERCISE NOTICE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">[To be executed
by the Holder to purchase shares of Common Stock under the Warrant]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Ladies and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The undersigned
                                            is the Holder of Warrant No.&nbsp;__ (the &ldquo;Warrant&rdquo;) issued by Xcel Brands,&nbsp;Inc.,
                                            a Delaware corporation (the &ldquo;Company&rdquo;). Capitalized terms used herein and not
                                            otherwise defined herein have the respective meanings set forth in the Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The undersigned
                                            hereby exercises its right to purchase _____ Warrant Shares pursuant to the Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Holder
                                            intends that payment of the Exercise Price shall be made as (check one):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash Exercise</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Cashless Exercise&rdquo;
    under <U>Section&nbsp;10</U> of the Warrant </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If the Holder
                                            has elected a Cash Exercise, the Holder shall pay the sum of $ _____ in immediately available
                                            funds to the Company in accordance with the terms of the Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(5)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pursuant to
                                            this Exercise Notice, the Company shall deliver to the Holder Warrant Shares determined in
                                            accordance with the terms of the Warrant. The Warrant Shares shall be delivered (check one):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the following DWAC Account
    Number: _______________________________</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in book-entry form via
    a direct registration system</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">by
                                    physical delivery of a certificate to: ______________________________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">_______________________________________________________</FONT></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in restricted book-entry
    form in the Company&rsquo;s share register</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(6)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By its delivery
                                            of this Exercise Notice, the undersigned represents and warrants to the Company that in giving
                                            effect to the exercise evidenced hereby the Holder (i)&nbsp;the Holder is an &ldquo;accredited
                                            investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933,
                                            as amended and (ii)&nbsp;will not beneficially own in excess of the number of shares of Common
                                            Stock (as determined in accordance with Section&nbsp;13(d)&nbsp;of the Securities Exchange
                                            Act of 1934, as amended) permitted to be owned under <U>Section&nbsp;11(a)</U>&nbsp;of the
                                            Warrant to which this notice relates.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(7)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The number
                                            of shares of Common Stock that the undersigned, together with its Attribution Parties holds
                                            and/or beneficially owns and has the right to acquire through the exercise of derivative
                                            securities (and any limitations thereon on exercise or conversion) contemporaneously or immediately
                                            prior to submitting an Exercise Notice:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 35%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Holder:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">(Signature must
conform in all respects to name of Holder as specified on the face of the Warrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>tm2533803d1_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 4.2</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>THIS WARRANT
AND THE SHARES OF COMMON STOCK ISSUABLE UPON THE EXERCISE OF THIS WARRANT (THE &ldquo;SECURITIES&rdquo;) HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES.
THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY&nbsp;NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS (I)&nbsp;SUCH SECURITIES HAVE
BEEN REGISTERED FOR SALE PURSUANT TO THE SECURITIES ACT, (II)&nbsp;SUCH SECURITIES MAY&nbsp;BE SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES
ACT, (III)&nbsp;THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSFER MAY&nbsp;LAWFULLY BE
MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT, OR (IV)&nbsp;THE SECURITIES ARE TRANSFERRED WITHOUT CONSIDERATION TO AN AFFILIATE
OF SUCH HOLDER OR A CUSTODIAL NOMINEE (WHICH FOR THE AVOIDANCE OF DOUBT SHALL REQUIRE NEITHER CONSENT NOR THE DELIVERY OF AN OPINION).</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>WARRANT TO PURCHASE COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Shares: [</FONT><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">]</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">(subject to adjustment)</FONT></P></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant No.&nbsp;[</FONT><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">]</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original Issue Date:
    December 18, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Xcel
Brands,&nbsp;Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, [</FONT><FONT STYLE="font-family: Symbol">&middot;</FONT>] or its registered
assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set forth below, at any time on or after the date hereof
(the &ldquo;<B>Initial Exercise Date</B>&rdquo;) and on or prior to 5:00 p.m.&nbsp;(New York City time) on December 18, 2030 (the &ldquo;<B>Termination
Date</B>&rdquo;) but not thereafter, to purchase from the Company up to a total of [<FONT STYLE="font-family: Symbol">&middot;</FONT>]
shares of common stock, $0.001 par value per share (the &ldquo;<B>Common Stock</B>&rdquo;), of the Company (each such share, a &ldquo;<B>Warrant
Share</B>&rdquo; and all such shares, the &ldquo;<B>Warrant Shares</B>&rdquo;) at an exercise price per share equal to $3.00 (the &ldquo;<B>Exercise
Price</B>&rdquo;), in each case as adjusted from time to time as provided in <U>Section&nbsp;9</U>, upon surrender of this Warrant to
Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the &ldquo;<B>Warrant</B>&rdquo;)
at any time and from time to time after the Original Issue Date (as defined below) (the &ldquo;<B>Initial Exercise Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions</U></B>.
For purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediates, controls, is controlled
by or is under common control with such Person, as such terms are used in or construed under Rule&nbsp;405 promulgated under the Securities
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Attribution
Parties</B>&rdquo; means, collectively, the following Persons and entities: (i)&nbsp;any direct or indirect Affiliates of the Holder,
(ii)&nbsp;any Person acting or who could be deemed to be acting as a Group together with the Holder or any Attribution Parties and (iii)&nbsp;any
other Persons whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated with the Holder&rsquo;s and/or
any other Attribution Parties for purposes of Section&nbsp;13(d)&nbsp;or Section&nbsp;16 of the Exchange Act. For clarity, the purpose
of the foregoing is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Bid
Price</B>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common
Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day
from 9:30 a.m.&nbsp;(New York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market,
the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c)&nbsp;if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per
share of Common Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by
an independent appraiser selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Closing
Sale Price</B>&rdquo; means, for any security as of any date, the last trade price for such security on the Principal Trading Market
for such security, as reported by Bloomberg Financial Markets, or, if such Principal Trading Market begins to operate on an extended
hours basis and does not designate the last trade price, then the last trade price of such security prior to 4:00 P.M., New York City
time, as reported by Bloomberg Financial Markets, or if the foregoing do not apply, the last trade price of such security in the over-the-counter
market on the electronic bulletin board for such security as reported by Bloomberg Financial Markets. If the Closing Sale Price cannot
be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date
shall be the fair market value as mutually determined by the Company and the Holder. All such determinations shall be appropriately adjusted
for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Commission</B>&rdquo;
means the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and all of the rules&nbsp;and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Group</B>&rdquo;
shall have the meaning ascribed to it in Section&nbsp;13(d)&nbsp;of the Exchange Act, and all related rules, regulations and jurisprudence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Principal
Trading Market</B>&rdquo; means the national securities exchange or other trading market on which the Common Stock is primarily listed
on and quoted for trading, which, as of the Original Issue Date, shall be the Nasdaq Global Select Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Securities
Act</B>&rdquo; means the U.S. Securities Act of 1933, as amended, and all of the rules&nbsp;and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Securities
Purchase Agreement</B>&rdquo; means that certain Securities Purchase Agreement dated as of December&nbsp;17, 2025 by and among the Company
and the investors signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Standard
Settlement Period</B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, for the Principal Trading Market
with respect to the Common Stock that is in effect on the date of delivery of an applicable Exercise Notice, which as of the Original
Issue Date was &ldquo;T+1.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Trading
Day</B>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Trading
Market</B>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange , the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>Transfer
Agent</B>&rdquo; means Continental Stock Transfer&nbsp;&amp; Trust Company, the current transfer agent of the Company, with an address
at 1 State Street, 30th Floor, New York, New York 10004 and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">&ldquo;<B>VWAP</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.&nbsp;(New
York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Issuance
of Securities; Registration of Warrants</U></B>. The Company shall register ownership of this Warrant, upon records to be maintained
by the Company for that purpose (the &ldquo;<B>Warrant Register</B>&rdquo;), in the name of the record Holder (which shall include the
initial Holder or, as the case may be, any assignee to which this Warrant is permissibly assigned hereunder) from time to time. The Company
may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration
of Transfers</U></B>. Subject to compliance with all applicable securities laws, the Company shall, or will cause its Transfer Agent
to, register the transfer of all or any portion of this Warrant in the Warrant Register, upon (i)&nbsp;surrender of this Warrant, (ii)&nbsp;accompanied
by the Assignment Form&nbsp;attached hereto as Schedule 1 duly executed by the Holder, and (iii)&nbsp;and payment for all applicable
transfer taxes (if any) by the registered Holder. Upon any such registration or transfer, a new warrant to purchase Common Stock in substantially
the form of this Warrant (any such new warrant, a &ldquo;<B>New Warrant</B>&rdquo;) evidencing the portion of this Warrant so transferred
shall be issued to the transferee, and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall
be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such
transferee of all of the rights and obligations in respect of the New Warrant that the Holder has in respect of this Warrant. The Company
shall, or will cause its Transfer Agent to, prepare, issue and deliver at the Company&rsquo;s own expense any New Warrant under this
<U>Section&nbsp;3</U>. Until due presentment for registration of transfer, the Company may treat the registered Holder hereof as the
owner and holder for all purposes, and the Company shall not be affected by any notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Exercise
of Warrants</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">All or any part
of this Warrant shall be exercisable by the registered Holder in any manner permitted by this Warrant at any time or times on or after
the Initial Exercise Date and on or before the Termination Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Holder may exercise this Warrant by delivering to the Company (i)&nbsp;an exercise notice, in the form attached as <U>Schedule 2</U>
(the &ldquo;<B>Exercise Notice</B>&rdquo;), completed and duly signed, and (ii)&nbsp;payment of the Exercise Price for the number of
Warrant Shares as to which this Warrant is being exercised (which may take the form of a &ldquo;cashless exercise&rdquo; if so indicated
in the Exercise Notice pursuant to <U>Section&nbsp;10</U> below), and the date on which the last of such items is delivered to the Company
(as determined in accordance with the notice provisions hereof) is an <B>&ldquo;Exercise Date</B>.&rdquo; The Holder shall not be required
to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall have the
same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number
of Warrant Shares, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this section, following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given
time may be less than the amount stated on the face hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Delivery
of Warrant Shares</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
exercise of this Warrant, the Company shall promptly (but in no event later than the number of Trading Days comprising the Standard Settlement
Period following the Exercise Date) (such date, the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;), upon the request of the Holder,
cause the Transfer Agent to credit such aggregate number of shares of Common Stock specified by the Holder in the Exercise Notice and
to which the Holder is entitled pursuant to such exercise (the &ldquo;<B>Exercise Shares</B>&rdquo;) to (i)&nbsp;the Holder&rsquo;s or
its designee&rsquo;s balance account with The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) through its Deposit Withdrawal At Custodian
system or (ii)&nbsp;in book-entry form via a direct registration system (&ldquo;<B>DRS</B>&rdquo;) maintained by or on behalf of the
Transfer Agent, in each case, (i)&nbsp;following any sale of such Securities pursuant to a registration statement (including the Registration
Statement) covering the resale of such security that is effective and usable under the Securities Act, (ii)&nbsp;following any sale of
such Securities pursuant to Rule&nbsp;144, or (iii)&nbsp;if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission). If the conditions set forth in clauses
(i), (ii), or (iii)&nbsp;above are not met, then the Company shall cause the Transfer Agent to either (i)&nbsp;record the Exercise Shares
in the name of the Holder or its designee on the certificates reflecting the Exercise Shares with an appropriate legend regarding restriction
on transferability, which shall be issued and dispatched by overnight courier to the address as specified in the Exercise Notice, and
on the Company&rsquo;s share register or (ii)&nbsp;issue such Exercise Shares in the name of the Holder or its designee in restricted
book-entry form in the Company&rsquo;s share register. The Holder, or any Person so designated by the Holder to receive Warrant Shares,
shall be deemed to have become the holder of record of such Warrant Shares as of the Exercise Date, irrespective of the date such Warrant
Shares are credited to the Holder&rsquo;s DTC account, the date of the book entry positions or the date of delivery of the certificates
evidencing such Exercise Shares, as the case may be. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to deliver to the Holder or its
designee Exercise Shares in the manner required pursuant to <U>Section&nbsp;5(a)</U>&nbsp;within the Standard Settlement Period following
the Exercise Date (other than a failure caused by incorrect or incomplete information provided by Holder to the Company) and the Holder
or the Holder&rsquo;s broker on its behalf purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in
satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;)
but did not receive within the Standard Settlement Period, then the Company shall, within two Trading Days after the Holder&rsquo;s request
and in the Holder&rsquo;s sole discretion, promptly honor its obligation to deliver to the Holder or its designee the Exercise Shares
pursuant to <U>Section&nbsp;5(a)</U>&nbsp;and pay cash to the Holder in an amount equal to the excess (if any) of the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased in the Buy-In, less the product
of (A)&nbsp;the number of shares of Common Stock purchased in the Buy-In, times (B)&nbsp;the Closing Sale Price of a share of Common
Stock on the Exercise Date. The Holder shall provide the Company written notice within three (3)&nbsp;Trading Days after the occurrence
of a Buy-In, indicating the amounts payable to the Holder in respect of the Buy-In together with applicable confirmations and other evidence
reasonably requested by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
the extent permitted by law and subject to <U>Section&nbsp;5(b),</U> the Company&rsquo;s obligations to issue and deliver Warrant Shares
in accordance with and subject to the terms hereof (including the limitations set forth in <U>Section&nbsp;11</U> below) are absolute
and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any
provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment,
limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any
violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance that might otherwise
limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Subject to <U>Section&nbsp;5(b)</U>,
nothing herein shall limit the Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including,
without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver
Exercise Shares; provided, however, that the Holder shall not be entitled to both (i)&nbsp;require the Company to reinstate the portion
of the Warrant and equivalent number of Warrant Shares for which such exercise was not timely honored and (ii)&nbsp;receive the number
of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements under <U>Section&nbsp;5(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section&nbsp;5(a)</U>&nbsp;by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written notice to the Company
at any time prior to the delivery of the applicable Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
this Warrant shall have been exercised in part, the Company shall, at the request of the Holder and upon surrender of this Warrant certificate,
at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the
unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical to this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Charges,
Taxes and Expenses</U></B><U>.</U> Issuance and delivery of Exercise Shares shall be made without charge to the Holder for any issue
or transfer tax, transfer agent fee or other incidental tax or expense (excluding any applicable stamp duties) in respect of the issuance
of such shares, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company shall not be required
to pay any tax that may be payable in respect of any transfer involved in the registration of any Warrant Shares or the Warrants in a
name other than that of the Holder or an Affiliate thereof. The Holder shall be responsible for all other tax liability that may arise
as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Replacement
of Warrant</U></B>. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt
of evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case) and, in each case, a customary and
reasonable contractual indemnity, if requested by the Company. If a New Warrant is requested as a result of a mutilation of this Warrant,
then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company&rsquo;s obligation to issue
the New Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reservation
of Warrant Shares</U></B>. The Company covenants that it will, at all times while this Warrant is outstanding, reserve and keep available
out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue
Warrant Shares upon exercise of this Warrant as herein provided, the number of Warrant Shares that are initially issuable and deliverable
upon the exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the
Holder (taking into account the adjustments and restrictions of <U>Section&nbsp;9</U>). The failure of the Company to reserve and keep
available out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock a sufficient number of shares of
Common Stock to enable it to issue Warrant Shares upon exercise of this Warrant as herein provided is referred to herein as an &ldquo;<B>Authorized
Share Failure</B>.&rdquo; The Company covenants that all Warrant Shares so issuable and deliverable shall, upon issuance and the payment
of the applicable Exercise Price in accordance with the terms hereof, be duly and validly authorized, issued and fully paid and non-assessable.
The Company will take all such action as may be reasonably necessary to assure that such shares of Common Stock may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of any securities exchange or automated quotation
system upon which the Common Stock may be listed. The Company further covenants that it will not, without the prior written consent of
the Holder, take any actions to increase the par value of the Common Stock at any time while this Warrant is outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Certain
Adjustments</U></B>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant (the &ldquo;<B>Number of
Warrant Shares</B>&rdquo;) are subject to adjustment from time to time as set forth in this <U>Section&nbsp;9</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding, (i)&nbsp;pays a stock dividend on its Common
Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii)&nbsp;subdivides
its outstanding shares of Common Stock into a larger number of shares of Common Stock, (iii)&nbsp;combines or reverse splits its outstanding
shares of Common Stock into a smaller number of shares of Common Stock or (iv)&nbsp;issues by reclassification of shares of capital stock
any additional shares of Common Stock of the Company, then in each such case the Number of Warrant Shares shall be multiplied by a fraction,
the numerator of which shall be the number of shares of Common Stock outstanding immediately after such event and the denominator of
which shall be the number of shares of Common Stock outstanding immediately before such event. Any adjustment made pursuant to clause
(i)&nbsp;of this paragraph shall become effective immediately after the record date for the determination of stockholders entitled to
receive such dividend or distribution, provided, however, that if such record date shall have been fixed and such dividend is not fully
paid on the date fixed therefor, the Number of Warrant Shares shall be recomputed accordingly as of the close of business on such record
date and thereafter the Number of Warrant Shares shall be adjusted pursuant to this paragraph as of the time of actual payment of such
dividends. Any adjustment pursuant to clause (ii), (iii)&nbsp;or (iv)&nbsp;of this paragraph shall become effective immediately after
the effective date of such subdivision, combination or issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Pro
Rata Distributions</U>. If, on or after the Original Issue Date, the Company shall declare or make any dividend or other pro rata distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property, options, evidence of indebtedness or any other assets
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction, but, for
the avoidance of doubt, excluding any distribution of shares of Common Stock subject to Section&nbsp;9(a),any distribution of Purchase
Rights (as defined below) subject to Section&nbsp;9(c)&nbsp;and any Fundamental Transaction (as defined below) subject to Section&nbsp;9(d))
(a &ldquo;<B>Distribution</B>&rdquo;) then, in each such case, the Holder shall be entitled to participate in such Distribution to the
same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon
complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without limitation,
the Maximum Percentage (as defined below)) immediately before the date on which a record is taken for such Distribution, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such
Distribution (provided, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the
Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such
Distribution to such extent (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution
(and beneficial ownership) to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder
until such time or times as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum
Percentage, at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial
Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Purchase
Rights</U>. If at any time on or after the Original Issue Date, the Company grants, issues or sells any Options, Convertible Securities
or rights to purchase stock, warrants, securities or other property, in each case pro rata to the record holders of any class of Common
Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase
Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock
acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including
without limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant, issuance or sale of
such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for
the grant, issuance or sale of such Purchase Rights (provided, that to the extent that the Holder&rsquo;s right to participate in any
such Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall
not be entitled to participate in such Purchase Right to such extent (and shall not be entitled to beneficial ownership of such Common
Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and at the Holder&rsquo;s election, in its sole discretion,
either (1)&nbsp;such Purchase Right to such extent shall be held in abeyance for the benefit of the Holder until such time or times as
its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or
times the Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any
subsequent Purchase Right to be held similarly in abeyance) to the same extent as if there had been no such limitation or (2)&nbsp;the
Company shall offer the Holder the right upon exercise of such Purchase Right to acquire a security (e.g. a pre-funded warrant) that
would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage but will otherwise to the extent possible
have economic and other rights, preferences and privileges substantially consistent and on par with the securities or other property
issuable upon exercise of the originally offered Purchase Rights). As used in this Section&nbsp;9(c), (i)&nbsp;&ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities and (ii)&nbsp;&ldquo;Convertible
Securities&rdquo; mean any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable
for shares of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Fundamental
Transactions</U>. If, at any time while this Warrant is outstanding (i)&nbsp;the Company, directly or indirectly in one or more related
transactions, effects any merger or consolidation of the Company with or into another Person, in which the Company is not the surviving
entity or in which the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly,
at least 50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii)&nbsp;the Company, directly
or indirectly in one or more related transactions, effects any sale, lease, license, assignment, transfer, conveyance or other disposition
to another Person of all or substantially all of its assets in one or a series of related transactions, (iii)&nbsp;pursuant to any tender
offer or exchange offer (whether by the Company or another Person), holders of capital stock tender shares representing more than 50%
of the voting power of the capital stock of the Company and the Company or such other Person, as applicable, accepts such tender for
payment, (iv)&nbsp;the Company, directly or indirectly in one or more related transactions, consummates a stock purchase agreement or
other business combination (including, without limitation, a reorganization, recapitalization, triangular merger, spin-off or scheme
of arrangement) with another Person whereby such other Person (directly or indirectly) acquires more than 50% of the capital stock of
the Company (either by voting power or economic interest) (except for any such transaction in which the stockholders of the Company immediately
prior to such transaction maintain, in substantially the same proportions, the voting power of such Person immediately after the transaction)
or (v)&nbsp;the Company, directly or indirectly in one or more related transactions, effects any reclassification of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of shares of Common Stock covered by Section&nbsp;9(a)&nbsp;above)
(in any such case, a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then following such Fundamental Transaction the Holder shall have
the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled
to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the
holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant (including any Distributions or Purchase Rights
then held in abeyance pursuant to Sections 9(b)&nbsp;or 9(c)&nbsp;above) without regard to any limitations on exercise contained herein
(the &ldquo;<B>Alternate Consideration</B>&rdquo;). If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it received
upon any exercise of this Warrant following such Fundamental Transaction. The Company shall not effect any Fundamental Transaction in
which the Company is not the surviving entity or the Alternate Consideration includes securities of another Person unless (i)&nbsp;the
Alternate Consideration is solely in the form of cash and the Company provides for the simultaneous &ldquo;cashless exercise&rdquo; of
this Warrant pursuant to Section&nbsp;10 below or (ii)&nbsp;prior to or simultaneously with the consummation thereof, any successor to
the Company, surviving entity or other Person (including any purchaser of assets of the Company) shall assume the obligation to deliver
to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and
the other obligations under this Warrant. The provisions of this paragraph (d)&nbsp;shall similarly apply to subsequent transactions
analogous to a Fundamental Transaction type. If the Company undertakes a Fundamental Transaction in which the Company is not the surviving
entity and the Alternate Consideration includes securities of another Person, then the Company shall provide that, prior to or simultaneously
with the consummation of such Fundamental Transaction, any successor to the Company, surviving entity or other Person (including any
purchaser of assets of the Company) shall assume the obligation to deliver to the Holder such Alternate Consideration as the Holder is
entitled to receive in accordance with the foregoing provisions, and to assume the other obligations under this Warrant. The provisions
of this paragraph (d)&nbsp;shall similarly apply to subsequent transactions analogous to a Fundamental Transaction type.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Subsequent
Equity Sales</U>. If the Company or any subsidiary thereof, as applicable, at any time until the six (6)&nbsp;month anniversary of the
Original Issue Date, shall sell, enter into an agreement to sell, or grant any option to purchase, or sell or grant any right to reprice,
or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock
or Common Stock equivalents other than Exempt Issuances (as defined in the Securities Purchase Agreement), at an effective price per
share less than the Exercise Price then in effect (such lower price, the &ldquo;<B>Base Share Price</B>&rdquo; and such issuances collectively,
a &ldquo;<B>Dilutive Issuance</B>&rdquo;) (it being understood and agreed that if the holder of the Common Stock or Common Stock equivalents
so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange
prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to
receive shares of Common Stock at an effective price per share that is less than the Exercise Price, such issuance shall be deemed to
have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective price), then simultaneously with
the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Exercise Price shall be reduced and only reduced to
equal the Base Share Price, provided that the Base Share Price shall not be less than $1.165 (subject to adjustment for reverse and forward
stock splits, recapitalizations and similar transactions following the date of the Purchase Agreement). The Company shall notify the
Holder, in writing, no later than the Trading Day following the issuance or deemed issuance of any Common Stock or Common Stock equivalents
subject to this Section&nbsp;9(e), indicating therein the applicable issuance price, or applicable reset price, exchange price, conversion
price and other pricing terms (such notice, the &ldquo;<B>Dilutive Issuance Notice</B>&rdquo;). If the Company enters into a variable
rate transaction, the Company shall be deemed to have issued Common Stock or Common Stock equivalents at the lowest possible price, conversion
price or exercise price at which such securities may be issued, converted or exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Number
of Warrant Shares</U>. Simultaneously with any adjustment to the Number of Warrant Shares pursuant to Section&nbsp;9, the Exercise Price
shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the
increased or decreased Number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such
adjustment. Notwithstanding the foregoing, in no event may the Exercise Price be adjusted below the par value of the Common Stock then
in effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Calculations</U>.
All calculations under this Section&nbsp;9 shall be made to the nearest one-tenth of one cent or the nearest share, as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
of Adjustments</U>. Upon the occurrence of each adjustment pursuant to this Section&nbsp;9, the Company at its expense will, promptly
compute such adjustment, in good faith, in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment,
including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon
exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts
upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder
and to the Transfer Agent, if applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notice
of Corporate Events</U>. If, while this Warrant is outstanding, the Company (i)&nbsp;declares a dividend or any other distribution of
cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants
to subscribe for or purchase any capital stock of the Company or any subsidiary, (ii)&nbsp;authorizes or approves, enters into any agreement
contemplating or solicits stockholder approval for any Fundamental Transaction or (iii)&nbsp;authorizes the voluntary dissolution, liquidation
or winding up of the affairs of the Company, then the Company shall deliver to the Holder a notice of such transaction at least ten days
prior to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in or vote
with respect to such transaction; provided, however, that the failure to deliver such notice or any defect therein shall not affect the
validity of the corporate action required to be described in such notice. In addition, if while this Warrant is outstanding, the Company
authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for any Fundamental Transaction contemplated
by <U>Section&nbsp;9(d)</U>, other than a Fundamental Transaction under clause (iii)&nbsp;of <U>Section&nbsp;9(d)</U>, the Company shall
deliver to the Holder a notice of such Fundamental Transaction at least 20 days prior to the date such Fundamental Transaction is consummated.
In the event that any such notice pursuant to this <U>Section&nbsp;9(i)</U>&nbsp;and the contents thereof shall be deemed to constitute
material, non-public information, the Company shall (on the applicable time frames set forth therein) offer the Holder the ability to
sign a confidentiality agreement related thereto in a form acceptable to the Holder sufficient to allow the Holder to receive such notice,
and the Company shall deliver such notice immediately upon execution of such confidentiality agreement. If the Holder does not sign such
confidentiality agreement, then the Holder shall not receive such notice and the Company&rsquo;s obligation to provide such notice shall
be deemed waived. Holder agrees to maintain any material, non-public information disclosed pursuant to this <U>Section&nbsp;9(h)</U>&nbsp;in
confidence until such information is publicly available or in accordance with the applicable confidentiality agreement, and shall comply
with applicable law with respect to trading in the Company&rsquo;s securities following receipt of any such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Payment
of Exercise Price</U></B>. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy
its obligation to pay the Exercise Price through a &ldquo;cashless exercise&rdquo;, in which event the Company shall issue to the Holder
the number of Warrant Shares in an exchange of securities effected pursuant to Section&nbsp;3(a)(9)&nbsp;of the Securities Act, determined
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-size: 10pt">X = Y [(A-B)/A]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&ldquo;X&rdquo;
equals the number of Warrant Shares to be issued to the Holder;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&ldquo;Y&rdquo;
equals the total number of Warrant Shares with respect to which this Warrant is then being exercised;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&ldquo;A&rdquo;
equals (i)&nbsp;the Closing Sale Price of the shares of Common Stock as of the Trading Day on the date immediately preceding the Exercise
Date if the Exercise Notice is (1)&nbsp;both executed and delivered pursuant to Section&nbsp;4(b)&nbsp;hereof on a day that is not a
Trading Date or (2)&nbsp;both executed and delivered pursuant to Section&nbsp;4(b)&nbsp;hereof on a Trading Day prior to the opening
of &ldquo;regular trading hours&rdquo; (as defined in Rule&nbsp;600(b)&nbsp;of Regulation NMS promulgated under the federal securities
laws) on such Trading Day or (ii)&nbsp;the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours after
the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section&nbsp;&lrm;4(b)&nbsp;hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&ldquo;B&rdquo;
equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">For purposes of
Rule&nbsp;144 promulgated under the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a &ldquo;cashless
exercise&rdquo; transaction shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall
be deemed to have commenced, on the Original Issue Date (provided<I>&nbsp;</I>that the Commission continues to take the position that
such treatment is proper at the time of such exercise). If the Warrant Shares are issued in such a cashless exercise, the Company acknowledges
and agrees that, in accordance with Section&nbsp;3(a)(9)&nbsp;of the Securities Act, the Exercise Shares issued in such exercise shall
take on the registered characteristics of the Warrants being exercised and may be tacked on to the holding period of the Warrants being
exercised. Except as set forth in <U>Section&nbsp;5(b)</U>&nbsp;(buy-in remedy), in no event will the exercise of this Warrant be settled
in cash in lieu of the delivery of shares by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Limitations
on Exercise</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
anything to the contrary contained herein, the Company shall not effect the exercise of any portion of this Warrant, and the Holder of
this Warrant shall not exercise any portion of the Warrant, and any such exercise shall be null and void ab initio and treated as if
the exercise had not been made, to the extent that immediately prior to or following such exercise, the Holder, together with the Attribution
Parties, beneficially owns or would beneficially own as determined in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and
the rules&nbsp;promulgated thereunder, in excess of [4.99][9.99]% (the &ldquo;<B>Maximum Percentage</B>&rdquo;) of the Common Stock that
would be issued and outstanding following such exercise. For purposes of calculating beneficial ownership for determining whether the
Maximum Percentage is or will be exceeded, the aggregate number of shares of Common Stock held and/or beneficially owned by the Holder
together with the Attribution Parties, shall include the number of shares of Common Stock held and/or beneficially owned by the Holder
together with the Attribution Parties plus the number of shares of Common Stock issuable upon exercise of the relevant Warrant with respect
to which the determination is being made but shall exclude the number of shares of Common Stock which would be issuable upon (i)&nbsp;exercise
of the remaining, unexercised Warrant held and/or beneficially owned by the Holder or the Attribution Parties and (ii)&nbsp;exercise
or conversion of the unexercised or unconverted portion of any other securities of the Company held and/or beneficially owned by such
Holder or any Attribution Party (including, without limitation, any convertible notes, convertible stock or warrants) that are subject
to a limitation on conversion or exercise analogous to the limitation contained herein. For purposes of this Paragraph 11(a), beneficial
ownership of the Holder or the Attribution Parties shall, except as set forth in the immediately preceding sentence, be calculated and
determined in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;promulgated thereunder. For purposes of
this Warrant, in determining the number of outstanding shares of Common Stock, a Holder of this Warrant may rely on the number of outstanding
shares of Common Stock as reflected in (1)&nbsp;the Company&rsquo;s most recent Form&nbsp;10-K, Form&nbsp;10-Q, Current Report on Form&nbsp;8-K
or other public filing with the Securities and Exchange Commission, as the case may be, (2)&nbsp;a more recent public announcement by
the Company or (3)&nbsp;any other notice by the Company or the Company&rsquo;s transfer agent setting forth the number of shares of Common
Stock outstanding (such issued and outstanding shares, the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). For any reason at
any time, upon the written or oral request of the Holder, the Company shall within one Trading Day confirm in writing or by electronic
mail to the Holder the number of shares of Common Stock then outstanding. The Holder shall disclose to the Company the number of outstanding
shares contemporaneously or immediately prior to submitting an Exercise Notice for the relevant Warrant. If the Company receives an Exercise
Notice from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share
Number, the Company shall (i)&nbsp;notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the
extent that such Exercise Notice would otherwise cause the Holder&rsquo;s, together with the Attribution Parties&rsquo;, beneficial ownership,
as determined pursuant to this Section&nbsp;11(a), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced
number of Warrant Shares to be purchased pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the
 &ldquo;Reduction Shares&rdquo;) and (ii)&nbsp;as soon as reasonably practicable, the Company shall return to the Holder any exercise
price paid by the Holder for the Reduction Shares. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and the Attribution
Parties since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of Common Stock
to the Holder upon exercise of this Warrant results in the Holder, together with the Attribution Parties, being deemed to beneficially
own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section&nbsp;13(d)&nbsp;of
the Exchange Act), the number of shares so issued by which the Holder&rsquo;s, together with the Attribution Parties&rsquo;, aggregate
beneficial ownership exceeds the Maximum Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall
be cancelled ab initio, and the Holder and/or the Attribution Parties shall not have the power to vote or to transfer the Excess Shares.
As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to
the Holder the exercise price paid by the Holder for the Excess Shares and reinstate the Warrant to the extent of such surrendered Excess
Shares. By written notice to the Company, a Holder of this Warrant may from time to time increase or decrease the Maximum Percentage
to any other percentage specified in such notice, provided however, in no case shall the percentage specified be in excess of 19.99%.
Any increase in the Maximum Percentage will not be effective until the 61st day after such notice is delivered to the Company and shall
not negatively affect any partial exercise effected prior to such change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Section&nbsp;11 shall not restrict the number of shares of Common Stock which a Holder or the Attribution Parties may receive or beneficially
own in order to determine the amount of securities or other consideration that such Holder or the Attribution Parties may receive in
the event of a Fundamental Transaction as contemplated in Section&nbsp;9(c)&nbsp;of this Warrant. For purposes of clarity, the shares
of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially
owned by the Holder or the Attribution Parties for any purpose including for purposes of Section&nbsp;13(d)&nbsp;of the Exchange Act
and the rules&nbsp;promulgated thereunder or Section&nbsp;16 of the Exchange Act and the rules&nbsp;promulgated thereunder, including
Rule&nbsp;16a-1(a)(1). No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability
of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;11 to the extent
necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial
ownership limitation contained in this Section&nbsp;11 or to make changes or supplements necessary or desirable to properly give effect
to such limitation. The limitation contained in this Section&nbsp;11 may not be waived and shall apply to a successor holder of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Fractional Shares</U></B>. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any
fractional shares that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded up to the next whole number
and the Company shall not be required to pay the Holder in cash the fair market value (based on the Closing Sale Price) for any such
fractional shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Redemption
of Warrants</U>.</B> All, but not less than all, of the outstanding Warrants may be redeemed for cash, at the option of the Company,
at any time commencing January&nbsp;18, 2027 and; provided that the date on which the last reported sale price of the share of Common
Stock has been at least $8.00 per share (subject to adjustment in compliance with&nbsp;Section&nbsp;4&nbsp;hereof), on each of ten (10)&nbsp;trading
days within the twenty (20) trading day period ending on the third (3<SUP>rd</SUP>) trading day prior to the date on which notice of
the redemption is given, upon notice to the Registered Holders of the Warrants, as described in&nbsp;this Section&nbsp;13, at a Redemption
Price of $0.0625 per Warrant. In the event that the Company elects to redeem the Warrants pursuant to&nbsp;this Section&nbsp;13, the
Company shall fix a date for the redemption (the &ldquo;<B>Redemption Date</B>&rdquo;). Notice of redemption shall be mailed by first
class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (the &ldquo;<B>30-day Redemption
Period</B>&rdquo;) to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration
books. As used in this Agreement, &ldquo;Redemption Price&rdquo; shall mean the price per Warrant at which any Warrants are redeemed
pursuant to&nbsp;this Section&nbsp;13. The Warrants may be exercised, for cash (or on a &ldquo;cashless basis&rdquo; pursuant to&nbsp;Section&nbsp;10&nbsp;hereof,
if applicable) at any time after notice of redemption shall have been given by the Company pursuant to&nbsp;this Section&nbsp;13 and
prior to the Redemption Date. On and after the Redemption Date, the record holder of the Warrants shall have no further rights except
to receive, upon surrender of the Warrants, the Redemption Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Notices</U></B>.
Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in
writing and shall be deemed given and effective on the earliest of (i)&nbsp;the date of transmission, if such notice or communication
is delivered confirmed e-mail at the e-mail address specified by the Company prior to 5:30 P.M., New York City time, on a Trading Day,
(ii)&nbsp;the next Trading Day after the date of transmission, if such notice or communication is delivered via confirmed e-mail at the
e-mail address specified by the Company on a day that is not a Trading Day or later than 5:30 P.M., New York City time, on any Trading
Day, (iii)&nbsp;the Trading Day following the date of mailing, if sent by nationally recognized overnight courier service specifying
next business day delivery, or (iv)&nbsp;upon actual receipt by the Person to whom such notice is required to be given, if by hand delivery.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Warrant
Agent</U></B>. The Company shall initially serve as warrant agent under this Warrant. Upon ten (10)&nbsp;days&rsquo; notice to the Holder,
the Company may appoint a new warrant agent. Any entity into which the Company or any new warrant agent may be merged or any entity resulting
from any consolidation to which the Company or any new warrant agent shall be a party or any entity to which the Company or any new warrant
agent transfers substantially all of its corporate trust or stockholders services business shall be a successor warrant agent under this
Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be
mailed (by first class mail, postage prepaid) to the Holder at the Holder&rsquo;s last address as shown on the Warrant Register. The
Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof
or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Rights as a Stockholder</U>. Except as otherwise set forth in this Warrant, the Holder, solely in such Person&rsquo;s capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person&rsquo;s capacity as the Holder
of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action
(whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, amalgamation, conveyance or otherwise),
receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant
Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant
shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise)
or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Further
Assurances</U>. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without
limitation, amending its certificate or articles of incorporation or through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of
the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all
such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without
limiting the generality of the foregoing, the Company will (a)&nbsp;not increase the par value of any Warrant Shares above the amount
payable therefor upon such exercise immediately prior to such increase in par value, (b)&nbsp;take all such action as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise
of this Warrant, and (c)&nbsp;use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any
public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant.
Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Successors
and Assigns</U>. Subject to compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may
not be assigned by the Company without the written consent of the Holder, except to a successor in the event of a Fundamental Transaction.
This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors and assigns.
Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the Company and the Holder
any legal or equitable right, remedy or cause of action under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment
and Waiver</U>. This Warrant may be amended only in writing signed by the Company and the Holder, or their successors and assigns. Except
as otherwise provided herein, the Company may take any action herein prohibited, or omit to perform any act herein required to be performed
by it, only if the Company has obtained the written consent of the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Acceptance</U>.
Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Governing
Law; Jurisdiction</U>. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS WARRANT SHALL BE GOVERNED
BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW
THEREOF. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS
SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH
ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS),
AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT
TO THE JURISDICTION OF ANY SUCH COURT. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS
TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT
DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PERSON AT THE ADDRESS IN EFFECT FOR NOTICES TO IT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE
GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO
SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any
of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Severability</U>.
If any part or provision of this Warrant is held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction,
the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original
business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Warrant shall remain binding
upon the parties hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>[REMAINDER OF
PAGE INTENTIONALLY LEFT BLANK]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>XCEL BRANDS,&nbsp;INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>SCHEDULE 1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>ASSIGNMENT
FORM</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">(<I>To assign the
foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares</I>.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">FOR VALUE RECEIVED,
the foregoing Warrant and all rights evidenced thereby are hereby assigned to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 35%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:
    <U>&nbsp;</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:
    <U>&nbsp;</U></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>SCHEDULE 2</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>FORM&nbsp;OF
EXERCISE NOTICE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">[To be executed
by the Holder to purchase shares of Common Stock under the Warrant]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Ladies and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The undersigned
                                            is the Holder of Warrant No.&nbsp;__ (the &ldquo;Warrant&rdquo;) issued by Xcel Brands,&nbsp;Inc.,
                                            a Delaware corporation (the &ldquo;Company&rdquo;). Capitalized terms used herein and not
                                            otherwise defined herein have the respective meanings set forth in the Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The undersigned
                                            hereby exercises its right to purchase _____ Warrant Shares pursuant to the Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The Holder
                                            intends that payment of the Exercise Price shall be made as (check one):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash Exercise</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Cashless Exercise&rdquo;
    under <U>Section&nbsp;10</U> of the Warrant </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If the Holder
                                            has elected a Cash Exercise, the Holder shall pay the sum of $ _____ in immediately available
                                            funds to the Company in accordance with the terms of the Warrant.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(5)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pursuant to
                                            this Exercise Notice, the Company shall deliver to the Holder Warrant Shares determined in
                                            accordance with the terms of the Warrant. The Warrant Shares shall be delivered (check one):</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.2in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the following DWAC Account
    Number: _______________________________</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in book-entry form via
    a direct registration system</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">by physical delivery of a certificate
    to: ______________________________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 10pt">_______________________________________________________</FONT></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in restricted book-entry
    form in the Company&rsquo;s share register</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(6)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By its delivery
                                            of this Exercise Notice, the undersigned represents and warrants to the Company that in giving
                                            effect to the exercise evidenced hereby the Holder (i)&nbsp;the Holder is an &ldquo;accredited
                                            investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933,
                                            as amended and (ii)&nbsp;will not beneficially own in excess of the number of shares of Common
                                            Stock (as determined in accordance with Section&nbsp;13(d)&nbsp;of the Securities Exchange
                                            Act of 1934, as amended) permitted to be owned under <U>Section&nbsp;11(a)</U>&nbsp;of the
                                            Warrant to which this notice relates.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(7)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The number
                                            of shares of Common Stock that the undersigned, together with its Attribution Parties holds
                                            and/or beneficially owns and has the right to acquire through the exercise of derivative
                                            securities (and any limitations thereon on exercise or conversion) contemporaneously or immediately
                                            prior to submitting an Exercise Notice:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 35%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Holder:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">(Signature must
conform in all respects to name of Holder as specified on the face of the Warrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>tm2533803d1_ex4-3.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.3</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS WARRANT AND THE SHARES OF COMMON STOCK
ISSUABLE UPON THE EXERCISE OF THIS WARRANT (THE &ldquo;SECURITIES&rdquo;) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THE SECURITIES HAVE BEEN ACQUIRED
FOR INVESTMENT AND MAY&nbsp;NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS (I)&nbsp;SUCH SECURITIES HAVE BEEN REGISTERED FOR SALE PURSUANT
TO THE SECURITIES ACT, (II)&nbsp;SUCH SECURITIES MAY&nbsp;BE SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES ACT, (III)&nbsp;THE COMPANY
HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSFER MAY&nbsp;LAWFULLY BE MADE WITHOUT REGISTRATION UNDER
THE SECURITIES ACT, OR (IV)&nbsp;THE SECURITIES ARE TRANSFERRED WITHOUT CONSIDERATION TO AN AFFILIATE OF SUCH HOLDER OR A CUSTODIAL NOMINEE
(WHICH FOR THE AVOIDANCE OF DOUBT SHALL REQUIRE NEITHER CONSENT NOR THE DELIVERY OF AN OPINION).</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANT TO PURCHASE COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Shares: [</FONT><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">]</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">(subject to adjustment)</P></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant No.&nbsp;[</FONT><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">]</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original Issue Date:
    December 18</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xcel
Brands,&nbsp;Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, [</FONT><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">]
or its registered assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set forth below, at any time on or after
the date hereof (the &ldquo;<B>Initial Exercise Date</B>&rdquo;) and on or prior to 5:00 p.m.&nbsp;(New York City time) on December 18, 2030<FONT STYLE="font-size: 10pt"><SUP></SUP></FONT>
(the &ldquo;<B>Termination Date</B>&rdquo;) but not thereafter, to purchase from the Company up to a total of [</FONT><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">]
shares of common stock, $0.001 par value per share (the &ldquo;<B>Common Stock</B>&rdquo;), of the Company (each such share, a &ldquo;<B>Warrant
Share</B>&rdquo; and all such shares, the &ldquo;<B>Warrant Shares</B>&rdquo;) at an exercise price per share equal to $1.165  (the &ldquo;<B>Exercise
Price</B>&rdquo;), in each case as adjusted from time to time as provided in <U>Section&nbsp;9</U>, upon surrender of this Warrant to
Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the &ldquo;<B>Warrant</B>&rdquo;)
at any time and from time to time after the Original Issue Date (as defined below) (the &ldquo;<B>Initial Exercise Date</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Definitions</U></B>.
For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Affiliate</B>&rdquo;
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediates, controls, is controlled
by or is under common control with such Person, as such terms are used in or construed under Rule&nbsp;405 promulgated under the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Attribution Parties</B>&rdquo;
means, collectively, the following Persons and entities: (i)&nbsp;any direct or indirect Affiliates of the Holder, (ii)&nbsp;any Person
acting or who could be deemed to be acting as a Group together with the Holder or any Attribution Parties and (iii)&nbsp;any other Persons
whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated with the Holder&rsquo;s and/or any other
Attribution Parties for purposes of Section&nbsp;13(d)&nbsp;or Section&nbsp;16 of the Exchange Act. For clarity, the purpose of the foregoing
is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Bid Price</B>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed
or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m.&nbsp;(New
York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Market (or
a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Closing Sale Price</B>&rdquo;
means, for any security as of any date, the last trade price for such security on the Principal Trading Market for such security, as
reported by Bloomberg Financial Markets, or, if such Principal Trading Market begins to operate on an extended hours basis and does not
designate the last trade price, then the last trade price of such security prior to 4:00 P.M., New York City time, as reported by Bloomberg
Financial Markets, or if the foregoing do not apply, the last trade price of such security in the over-the-counter market on the electronic
bulletin board for such security as reported by Bloomberg Financial Markets. If the Closing Sale Price cannot be calculated for a security
on a particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value
as mutually determined by the Company and the Holder. All such determinations shall be appropriately adjusted for any stock dividend,
stock split, stock combination or other similar transaction during the applicable calculation period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Commission</B>&rdquo;
means the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Exchange Act</B>&rdquo;
means the Securities Exchange Act of 1934, as amended, and all of the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Group</B>&rdquo;
shall have the meaning ascribed to it in Section&nbsp;13(d)&nbsp;of the Exchange Act, and all related rules, regulations and jurisprudence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Person</B>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Principal Trading
Market</B>&rdquo; means the national securities exchange or other trading market on which the Common Stock is primarily listed on and
quoted for trading, which, as of the Original Issue Date, shall be the Nasdaq Global Select Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Securities Act</B>&rdquo;
means the U.S. Securities Act of 1933, as amended, and all of the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Securities Purchase
Agreement</B>&rdquo; means that certain Securities Purchase Agreement dated as of December&nbsp;17, 2025 by and among the Company and
the investors signatory thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Standard Settlement
Period</B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, for the Principal Trading Market with
respect to the Common Stock that is in effect on the date of delivery of an applicable Exercise Notice, which as of the Original Issue
Date was &ldquo;T+1.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Trading Day</B>&rdquo;
means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Trading Market</B>&rdquo;
means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange , the
Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Transfer Agent</B>&rdquo;
means Continental Stock Transfer&nbsp;&amp; Trust Company, the current transfer agent of the Company, with an address at 1 State Street,
30th Floor, New York, New York 10004 and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>VWAP</B>&rdquo; means,
for any date, the price determined by the first of the following clauses that applies: (a)&nbsp;if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.&nbsp;(New
York City time) to 4:02 p.m.&nbsp;(New York City time)), (b)&nbsp;if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c)&nbsp;if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Issuance
of Securities; Registration of Warrants</U></B>. The Company shall register ownership of this Warrant, upon records to be maintained
by the Company for that purpose (the &ldquo;<B>Warrant Register</B>&rdquo;), in the name of the record Holder (which shall include the
initial Holder or, as the case may be, any assignee to which this Warrant is permissibly assigned hereunder) from time to time. The Company
may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Registration
of Transfers</U></B>. Subject to compliance with all applicable securities laws, the Company shall, or will cause its Transfer Agent
to, register the transfer of all or any portion of this Warrant in the Warrant Register, upon (i)&nbsp;surrender of this Warrant, (ii)&nbsp;accompanied
by the Assignment Form&nbsp;attached hereto as Schedule 1 duly executed by the Holder, and (iii)&nbsp;and payment for all applicable
transfer taxes (if any) by the registered Holder. Upon any such registration or transfer, a new warrant to purchase Common Stock in substantially
the form of this Warrant (any such new warrant, a &ldquo;<B>New Warrant</B>&rdquo;) evidencing the portion of this Warrant so transferred
shall be issued to the transferee, and a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall
be issued to the transferring Holder. The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such
transferee of all of the rights and obligations in respect of the New Warrant that the Holder has in respect of this Warrant. The Company
shall, or will cause its Transfer Agent to, prepare, issue and deliver at the Company&rsquo;s own expense any New Warrant under this
<U>Section&nbsp;3</U>. Until due presentment for registration of transfer, the Company may treat the registered Holder hereof as the
owner and holder for all purposes, and the Company shall not be affected by any notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Exercise
of Warrants</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All or any part of this Warrant shall be exercisable
by the registered Holder in any manner permitted by this Warrant at any time or times on or after the Initial Exercise Date and on or
before the Termination Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Holder may exercise this Warrant by delivering to the Company (i)&nbsp;an exercise notice, in the form attached as <U>Schedule 2</U>
(the &ldquo;<B>Exercise Notice</B>&rdquo;), completed and duly signed, and (ii)&nbsp;payment of the Exercise Price for the number of
Warrant Shares as to which this Warrant is being exercised (which may take the form of a &ldquo;cashless exercise&rdquo; if so indicated
in the Exercise Notice pursuant to <U>Section&nbsp;10</U> below), and the date on which the last of such items is delivered to the Company
(as determined in accordance with the notice provisions hereof) is an <B>&ldquo;Exercise Date</B>.&rdquo; The Holder shall not be required
to deliver the original Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice shall have the
same effect as cancellation of the original Warrant and issuance of a New Warrant evidencing the right to purchase the remaining number
of Warrant Shares, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this section, following
the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given
time may be less than the amount stated on the face hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Delivery
of Warrant Shares</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Upon
exercise of this Warrant, the Company shall promptly (but in no event later than the number of Trading Days comprising the Standard Settlement
Period following the Exercise Date) (such date, the &ldquo;<B>Warrant Share Delivery Date</B>&rdquo;), upon the request of the Holder,
cause the Transfer Agent to credit such aggregate number of shares of Common Stock specified by the Holder in the Exercise Notice and
to which the Holder is entitled pursuant to such exercise (the &ldquo;<B>Exercise Shares</B>&rdquo;) to (i)&nbsp;the Holder&rsquo;s or
its designee&rsquo;s balance account with The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) through its Deposit Withdrawal At Custodian
system or (ii)&nbsp;in book-entry form via a direct registration system (&ldquo;<B>DRS</B>&rdquo;) maintained by or on behalf of the
Transfer Agent, in each case, (i)&nbsp;following any sale of such Securities pursuant to a registration statement (including the Registration
Statement) covering the resale of such security that is effective and usable under the Securities Act, (ii)&nbsp;following any sale of
such Securities pursuant to Rule&nbsp;144, or (iii)&nbsp;if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the Commission). If the conditions set forth in clauses
(i), (ii), or (iii)&nbsp;above are not met, then the Company shall cause the Transfer Agent to either (i)&nbsp;record the Exercise Shares
in the name of the Holder or its designee on the certificates reflecting the Exercise Shares with an appropriate legend regarding restriction
on transferability, which shall be issued and dispatched by overnight courier to the address as specified in the Exercise Notice, and
on the Company&rsquo;s share register or (ii)&nbsp;issue such Exercise Shares in the name of the Holder or its designee in restricted
book-entry form in the Company&rsquo;s share register. The Holder, or any Person so designated by the Holder to receive Warrant Shares,
shall be deemed to have become the holder of record of such Warrant Shares as of the Exercise Date, irrespective of the date such Warrant
Shares are credited to the Holder&rsquo;s DTC account, the date of the book entry positions or the date of delivery of the certificates
evidencing such Exercise Shares, as the case may be. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>In
addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to deliver to the Holder or its
designee Exercise Shares in the manner required pursuant to <U>Section&nbsp;5(a)</U>&nbsp;within the Standard Settlement Period following
the Exercise Date (other than a failure caused by incorrect or incomplete information provided by Holder to the Company) and the Holder
or the Holder&rsquo;s broker on its behalf purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in
satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &ldquo;<B>Buy-In</B>&rdquo;)
but did not receive within the Standard Settlement Period, then the Company shall, within two Trading Days after the Holder&rsquo;s request
and in the Holder&rsquo;s sole discretion, promptly honor its obligation to deliver to the Holder or its designee the Exercise Shares
pursuant to <U>Section&nbsp;5(a)</U>&nbsp;and pay cash to the Holder in an amount equal to the excess (if any) of the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased in the Buy-In, less the product
of (A)&nbsp;the number of shares of Common Stock purchased in the Buy-In, times (B)&nbsp;the Closing Sale Price of a share of Common
Stock on the Exercise Date. The Holder shall provide the Company written notice within three (3)&nbsp;Trading Days after the occurrence
of a Buy-In, indicating the amounts payable to the Holder in respect of the Buy-In together with applicable confirmations and other evidence
reasonably requested by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>To
the extent permitted by law and subject to <U>Section&nbsp;5(b),</U> the Company&rsquo;s obligations to issue and deliver Warrant Shares
in accordance with and subject to the terms hereof (including the limitations set forth in <U>Section&nbsp;11</U> below) are absolute
and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any
provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment,
limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any
violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance that might otherwise
limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares. Subject to <U>Section&nbsp;5(b)</U>,
nothing herein shall limit the Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including,
without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver
Exercise Shares; provided, however, that the Holder shall not be entitled to both (i)&nbsp;require the Company to reinstate the portion
of the Warrant and equivalent number of Warrant Shares for which such exercise was not timely honored and (ii)&nbsp;receive the number
of shares of Common Stock that would have been issued if the Company had timely complied with its delivery requirements under <U>Section&nbsp;5(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>If
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section&nbsp;5(a)</U>&nbsp;by
the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise by delivering written notice to the Company
at any time prior to the delivery of the applicable Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>If
this Warrant shall have been exercised in part, the Company shall, at the request of the Holder and upon surrender of this Warrant certificate,
at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the
unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical to this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Charges,
Taxes and Expenses</U></B><U>.</U> Issuance and delivery of Exercise Shares shall be made without charge to the Holder for any issue
or transfer tax, transfer agent fee or other incidental tax or expense (excluding any applicable stamp duties) in respect of the issuance
of such shares, all of which taxes and expenses shall be paid by the Company; provided, however, that the Company shall not be required
to pay any tax that may be payable in respect of any transfer involved in the registration of any Warrant Shares or the Warrants in a
name other than that of the Holder or an Affiliate thereof. The Holder shall be responsible for all other tax liability that may arise
as a result of holding or transferring this Warrant or receiving Warrant Shares upon exercise hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Replacement
of Warrant</U></B>. If this Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange
and substitution for and upon cancellation hereof, or in lieu of and substitution for this Warrant, a New Warrant, but only upon receipt
of evidence reasonably satisfactory to the Company of such loss, theft or destruction (in such case) and, in each case, a customary and
reasonable contractual indemnity, if requested by the Company. If a New Warrant is requested as a result of a mutilation of this Warrant,
then the Holder shall deliver such mutilated Warrant to the Company as a condition precedent to the Company&rsquo;s obligation to issue
the New Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Reservation
of Warrant Shares</U></B>. The Company covenants that it will, at all times while this Warrant is outstanding, reserve and keep available
out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock, solely for the purpose of enabling it to issue
Warrant Shares upon exercise of this Warrant as herein provided, the number of Warrant Shares that are initially issuable and deliverable
upon the exercise of this entire Warrant, free from preemptive rights or any other contingent purchase rights of persons other than the
Holder (taking into account the adjustments and restrictions of <U>Section&nbsp;9</U>). The failure of the Company to reserve and keep
available out of the aggregate of its authorized but unissued and otherwise unreserved Common Stock a sufficient number of shares of
Common Stock to enable it to issue Warrant Shares upon exercise of this Warrant as herein provided is referred to herein as an &ldquo;<B>Authorized
Share Failure</B>.&rdquo; The Company covenants that all Warrant Shares so issuable and deliverable shall, upon issuance and the payment
of the applicable Exercise Price in accordance with the terms hereof, be duly and validly authorized, issued and fully paid and non-assessable.
The Company will take all such action as may be reasonably necessary to assure that such shares of Common Stock may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of any securities exchange or automated quotation
system upon which the Common Stock may be listed. The Company further covenants that it will not, without the prior written consent of
the Holder, take any actions to increase the par value of the Common Stock at any time while this Warrant is outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Certain
Adjustments</U></B>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant (the &ldquo;<B>Number of
Warrant Shares</B>&rdquo;) are subject to adjustment from time to time as set forth in this <U>Section&nbsp;9</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding, (i)&nbsp;pays a stock dividend on its Common
Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common Stock, (ii)&nbsp;subdivides
its outstanding shares of Common Stock into a larger number of shares of Common Stock, (iii)&nbsp;combines or reverse splits its outstanding
shares of Common Stock into a smaller number of shares of Common Stock or (iv)&nbsp;issues by reclassification of shares of capital stock
any additional shares of Common Stock of the Company, then in each such case the Number of Warrant Shares shall be multiplied by a fraction,
the numerator of which shall be the number of shares of Common Stock outstanding immediately after such event and the denominator of
which shall be the number of shares of Common Stock outstanding immediately before such event. Any adjustment made pursuant to clause
(i)&nbsp;of this paragraph shall become effective immediately after the record date for the determination of stockholders entitled to
receive such dividend or distribution, provided, however, that if such record date shall have been fixed and such dividend is not fully
paid on the date fixed therefor, the Number of Warrant Shares shall be recomputed accordingly as of the close of business on such record
date and thereafter the Number of Warrant Shares shall be adjusted pursuant to this paragraph as of the time of actual payment of such
dividends. Any adjustment pursuant to clause (ii), (iii)&nbsp;or (iv)&nbsp;of this paragraph shall become effective immediately after
the effective date of such subdivision, combination or issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Pro
Rata Distributions</U>. If, on or after the Original Issue Date, the Company shall declare or make any dividend or other pro rata distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property, options, evidence of indebtedness or any other assets
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction, but, for
the avoidance of doubt, excluding any distribution of shares of Common Stock subject to Section&nbsp;9(a),any distribution of Purchase
Rights (as defined below) subject to Section&nbsp;9(c)&nbsp;and any Fundamental Transaction (as defined below) subject to Section&nbsp;9(d))
(a &ldquo;<B>Distribution</B>&rdquo;) then, in each such case, the Holder shall be entitled to participate in such Distribution to the
same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon
complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without limitation,
the Maximum Percentage (as defined below)) immediately before the date on which a record is taken for such Distribution, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such
Distribution (provided, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the
Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall not be entitled to participate in such
Distribution to such extent (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution
(and beneficial ownership) to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder
until such time or times as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum
Percentage, at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial
Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Purchase
Rights</U>. If at any time on or after the Original Issue Date, the Company grants, issues or sells any Options, Convertible Securities
or rights to purchase stock, warrants, securities or other property, in each case pro rata to the record holders of any class of Common
Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase
Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock
acquirable upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including
without limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant, issuance or sale of
such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for
the grant, issuance or sale of such Purchase Rights (provided, that to the extent that the Holder&rsquo;s right to participate in any
such Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, then the Holder shall
not be entitled to participate in such Purchase Right to such extent (and shall not be entitled to beneficial ownership of such Common
Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and at the Holder&rsquo;s election, in its sole discretion,
either (1)&nbsp;such Purchase Right to such extent shall be held in abeyance for the benefit of the Holder until such time or times as
its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or
times the Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any
subsequent Purchase Right to be held similarly in abeyance) to the same extent as if there had been no such limitation or (2)&nbsp;the
Company shall offer the Holder the right upon exercise of such Purchase Right to acquire a security (e.g. a pre-funded warrant) that
would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage but will otherwise to the extent possible
have economic and other rights, preferences and privileges substantially consistent and on par with the securities or other property
issuable upon exercise of the originally offered Purchase Rights). As used in this Section&nbsp;9(c), (i)&nbsp;&ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities and (ii)&nbsp;&ldquo;Convertible
Securities&rdquo; mean any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable
for shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Fundamental
Transactions</U>. If, at any time while this Warrant is outstanding (i)&nbsp;the Company, directly or indirectly in one or more related
transactions, effects any merger or consolidation of the Company with or into another Person, in which the Company is not the surviving
entity or in which the stockholders of the Company immediately prior to such merger or consolidation do not own, directly or indirectly,
at least 50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii)&nbsp;the Company, directly
or indirectly in one or more related transactions, effects any sale, lease, license, assignment, transfer, conveyance or other disposition
to another Person of all or substantially all of its assets in one or a series of related transactions, (iii)&nbsp;pursuant to any tender
offer or exchange offer (whether by the Company or another Person), holders of capital stock tender shares representing more than 50%
of the voting power of the capital stock of the Company and the Company or such other Person, as applicable, accepts such tender for
payment, (iv)&nbsp;the Company, directly or indirectly in one or more related transactions, consummates a stock purchase agreement or
other business combination (including, without limitation, a reorganization, recapitalization, triangular merger, spin-off or scheme
of arrangement) with another Person whereby such other Person (directly or indirectly) acquires more than 50% of the capital stock of
the Company (either by voting power or economic interest) (except for any such transaction in which the stockholders of the Company immediately
prior to such transaction maintain, in substantially the same proportions, the voting power of such Person immediately after the transaction)
or (v)&nbsp;the Company, directly or indirectly in one or more related transactions, effects any reclassification of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property (other than as a result of a subdivision or combination of shares of Common Stock covered by Section&nbsp;9(a)&nbsp;above)
(in any such case, a &ldquo;<B>Fundamental Transaction</B>&rdquo;), then following such Fundamental Transaction the Holder shall have
the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled
to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the
holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant (including any Distributions or Purchase Rights
then held in abeyance pursuant to Sections 9(b)&nbsp;or 9(c)&nbsp;above) without regard to any limitations on exercise contained herein
(the &ldquo;<B>Alternate Consideration</B>&rdquo;). If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it received
upon any exercise of this Warrant following such Fundamental Transaction. The Company shall not effect any Fundamental Transaction in
which the Company is not the surviving entity or the Alternate Consideration includes securities of another Person unless (i)&nbsp;the
Alternate Consideration is solely in the form of cash and the Company provides for the simultaneous &ldquo;cashless exercise&rdquo; of
this Warrant pursuant to Section&nbsp;10 below or (ii)&nbsp;prior to or simultaneously with the consummation thereof, any successor to
the Company, surviving entity or other Person (including any purchaser of assets of the Company) shall assume the obligation to deliver
to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder may be entitled to receive, and
the other obligations under this Warrant. The provisions of this paragraph (d)&nbsp;shall similarly apply to subsequent transactions
analogous to a Fundamental Transaction type. If the Company undertakes a Fundamental Transaction in which the Company is not the surviving
entity and the Alternate Consideration includes securities of another Person, then the Company shall provide that, prior to or simultaneously
with the consummation of such Fundamental Transaction, any successor to the Company, surviving entity or other Person (including any
purchaser of assets of the Company) shall assume the obligation to deliver to the Holder such Alternate Consideration as the Holder is
entitled to receive in accordance with the foregoing provisions, and to assume the other obligations under this Warrant. The provisions
of this paragraph (d)&nbsp;shall similarly apply to subsequent transactions analogous to a Fundamental Transaction type.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Subsequent
Equity Sales</U>. If the Company or any subsidiary thereof, as applicable, at any time until the six (6)&nbsp;month anniversary of the
Original Issue Date, shall sell, enter into an agreement to sell, or grant any option to purchase, or sell or grant any right to reprice,
or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock
or Common Stock equivalents other than Exempt Issuances (as defined in the Securities Purchase Agreement), at an effective price per
share less than the Exercise Price then in effect (such lower price, the &ldquo;<B>Base Share Price</B>&rdquo; and such issuances collectively,
a &ldquo;<B>Dilutive Issuance</B>&rdquo;) (it being understood and agreed that if the holder of the Common Stock or Common Stock equivalents
so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange
prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to
receive shares of Common Stock at an effective price per share that is less than the Exercise Price, such issuance shall be deemed to
have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective price), then simultaneously with
the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Exercise Price shall be reduced and only reduced to
equal the Base Share Price, provided that the Base Share Price shall not be less than $1.165 (subject to adjustment for reverse and forward
stock splits, recapitalizations and similar transactions following the date of the Purchase Agreement). The Company shall notify the
Holder, in writing, no later than the Trading Day following the issuance or deemed issuance of any Common Stock or Common Stock equivalents
subject to this Section&nbsp;9(e), indicating therein the applicable issuance price, or applicable reset price, exchange price, conversion
price and other pricing terms (such notice, the &ldquo;<B>Dilutive Issuance Notice</B>&rdquo;). If the Company enters into a variable
rate transaction, the Company shall be deemed to have issued Common Stock or Common Stock equivalents at the lowest possible price, conversion
price or exercise price at which such securities may be issued, converted or exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Number
of Warrant Shares</U>. Simultaneously with any adjustment to the Number of Warrant Shares pursuant to Section&nbsp;9, the Exercise Price
shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable hereunder for the
increased or decreased Number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such
adjustment. Notwithstanding the foregoing, in no event may the Exercise Price be adjusted below the par value of the Common Stock then
in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Calculations</U>.
All calculations under this Section&nbsp;9 shall be made to the nearest one-tenth of one cent or the nearest share, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notice
of Adjustments</U>. Upon the occurrence of each adjustment pursuant to this Section&nbsp;9, the Company at its expense will, promptly
compute such adjustment, in good faith, in accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment,
including a statement of the adjusted Exercise Price and adjusted number or type of Warrant Shares or other securities issuable upon
exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the facts
upon which such adjustment is based. Upon written request, the Company will promptly deliver a copy of each such certificate to the Holder
and to the Transfer Agent, if applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Notice
of Corporate Events</U>. If, while this Warrant is outstanding, the Company (i)&nbsp;declares a dividend or any other distribution of
cash, securities or other property in respect of its Common Stock, including, without limitation, any granting of rights or warrants
to subscribe for or purchase any capital stock of the Company or any subsidiary, (ii)&nbsp;authorizes or approves, enters into any agreement
contemplating or solicits stockholder approval for any Fundamental Transaction or (iii)&nbsp;authorizes the voluntary dissolution, liquidation
or winding up of the affairs of the Company, then the Company shall deliver to the Holder a notice of such transaction at least ten days
prior to the applicable record or effective date on which a Person would need to hold Common Stock in order to participate in or vote
with respect to such transaction; provided, however, that the failure to deliver such notice or any defect therein shall not affect the
validity of the corporate action required to be described in such notice. In addition, if while this Warrant is outstanding, the Company
authorizes or approves, enters into any agreement contemplating or solicits stockholder approval for any Fundamental Transaction contemplated
by <U>Section&nbsp;9(d)</U>, other than a Fundamental Transaction under clause (iii)&nbsp;of <U>Section&nbsp;9(d)</U>, the Company shall
deliver to the Holder a notice of such Fundamental Transaction at least 20 days prior to the date such Fundamental Transaction is consummated.
In the event that any such notice pursuant to this <U>Section&nbsp;9(i)</U>&nbsp;and the contents thereof shall be deemed to constitute
material, non-public information, the Company shall (on the applicable time frames set forth therein) offer the Holder the ability to
sign a confidentiality agreement related thereto in a form acceptable to the Holder sufficient to allow the Holder to receive such notice,
and the Company shall deliver such notice immediately upon execution of such confidentiality agreement. If the Holder does not sign such
confidentiality agreement, then the Holder shall not receive such notice and the Company&rsquo;s obligation to provide such notice shall
be deemed waived. Holder agrees to maintain any material, non-public information disclosed pursuant to this <U>Section&nbsp;9(h)</U>&nbsp;in
confidence until such information is publicly available or in accordance with the applicable confidentiality agreement, and shall comply
with applicable law with respect to trading in the Company&rsquo;s securities following receipt of any such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Payment
of Exercise Price</U></B>. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, satisfy
its obligation to pay the Exercise Price through a &ldquo;cashless exercise&rdquo;, in which event the Company shall issue to the Holder
the number of Warrant Shares in an exchange of securities effected pursuant to Section&nbsp;3(a)(9)&nbsp;of the Securities Act, determined
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">X = Y [(A-B)/A]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;X&rdquo;
equals the number of Warrant Shares to be issued to the Holder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;Y&rdquo;
equals the total number of Warrant Shares with respect to which this Warrant is then being exercised;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;A&rdquo;
equals (i)&nbsp;the Closing Sale Price of the shares of Common Stock as of the Trading Day on the date immediately preceding the Exercise
Date if the Exercise Notice is (1)&nbsp;both executed and delivered pursuant to Section&nbsp;4(b)&nbsp;hereof on a day that is not a
Trading Date or (2)&nbsp;both executed and delivered pursuant to Section&nbsp;4(b)&nbsp;hereof on a Trading Day prior to the opening
of &ldquo;regular trading hours&rdquo; (as defined in Rule&nbsp;600(b)&nbsp;of Regulation NMS promulgated under the federal securities
laws) on such Trading Day or (ii)&nbsp;the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2)&nbsp;hours thereafter (including until two (2)&nbsp;hours after
the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section&nbsp;&lrm;4(b)&nbsp;hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;B&rdquo;
equals the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of Rule&nbsp;144 promulgated under
the Securities Act, it is intended, understood and acknowledged that the Warrant Shares issued in a &ldquo;cashless exercise&rdquo; transaction
shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced,
on the Original Issue Date (provided<I>&nbsp;</I>that the Commission continues to take the position that such treatment is proper at
the time of such exercise). If the Warrant Shares are issued in such a cashless exercise, the Company acknowledges and agrees that, in
accordance with Section&nbsp;3(a)(9)&nbsp;of the Securities Act, the Exercise Shares issued in such exercise shall take on the registered
characteristics of the Warrants being exercised and may be tacked on to the holding period of the Warrants being exercised. Except as
set forth in <U>Section&nbsp;5(b)</U>&nbsp;(buy-in remedy), in no event will the exercise of this Warrant be settled in cash in lieu
of the delivery of shares by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Limitations
on Exercise</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notwithstanding
anything to the contrary contained herein, the Company shall not effect the exercise of any portion of this Warrant, and the Holder of
this Warrant shall not exercise any portion of the Warrant, and any such exercise shall be null and void ab initio and treated as if
the exercise had not been made, to the extent that immediately prior to or following such exercise, the Holder, together with the Attribution
Parties, beneficially owns or would beneficially own as determined in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and
the rules&nbsp;promulgated thereunder, in excess of [4.99][9.99]% (the &ldquo;<B>Maximum Percentage</B>&rdquo;) of the Common Stock that
would be issued and outstanding following such exercise. For purposes of calculating beneficial ownership for determining whether the
Maximum Percentage is or will be exceeded, the aggregate number of shares of Common Stock held and/or beneficially owned by the Holder
together with the Attribution Parties, shall include the number of shares of Common Stock held and/or beneficially owned by the Holder
together with the Attribution Parties plus the number of shares of Common Stock issuable upon exercise of the relevant Warrant with respect
to which the determination is being made but shall exclude the number of shares of Common Stock which would be issuable upon (i)&nbsp;exercise
of the remaining, unexercised Warrant held and/or beneficially owned by the Holder or the Attribution Parties and (ii)&nbsp;exercise
or conversion of the unexercised or unconverted portion of any other securities of the Company held and/or beneficially owned by such
Holder or any Attribution Party (including, without limitation, any convertible notes, convertible stock or warrants) that are subject
to a limitation on conversion or exercise analogous to the limitation contained herein. For purposes of this Paragraph 11(a), beneficial
ownership of the Holder or the Attribution Parties shall, except as set forth in the immediately preceding sentence, be calculated and
determined in accordance with Section&nbsp;13(d)&nbsp;of the Exchange Act and the rules&nbsp;promulgated thereunder. For purposes of
this Warrant, in determining the number of outstanding shares of Common Stock, a Holder of this Warrant may rely on the number of outstanding
shares of Common Stock as reflected in (1)&nbsp;the Company&rsquo;s most recent Form&nbsp;10-K, Form&nbsp;10-Q, Current Report on Form&nbsp;8-K
or other public filing with the Securities and Exchange Commission, as the case may be, (2)&nbsp;a more recent public announcement by
the Company or (3)&nbsp;any other notice by the Company or the Company&rsquo;s transfer agent setting forth the number of shares of Common
Stock outstanding (such issued and outstanding shares, the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). For any reason at
any time, upon the written or oral request of the Holder, the Company shall within one Trading Day confirm in writing or by electronic
mail to the Holder the number of shares of Common Stock then outstanding. The Holder shall disclose to the Company the number of outstanding
shares contemporaneously or immediately prior to submitting an Exercise Notice for the relevant Warrant. If the Company receives an Exercise
Notice from the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share
Number, the Company shall (i)&nbsp;notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the
extent that such Exercise Notice would otherwise cause the Holder&rsquo;s, together with the Attribution Parties&rsquo;, beneficial ownership,
as determined pursuant to this Section&nbsp;11(a), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced
number of Warrant Shares to be purchased pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the
 &ldquo;Reduction Shares&rdquo;) and (ii)&nbsp;as soon as reasonably practicable, the Company shall return to the Holder any exercise
price paid by the Holder for the Reduction Shares. In any case, the number of outstanding shares of Common Stock shall be determined
after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder and the Attribution
Parties since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of Common Stock
to the Holder upon exercise of this Warrant results in the Holder, together with the Attribution Parties, being deemed to beneficially
own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section&nbsp;13(d)&nbsp;of
the Exchange Act), the number of shares so issued by which the Holder&rsquo;s, together with the Attribution Parties&rsquo;, aggregate
beneficial ownership exceeds the Maximum Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall
be cancelled ab initio, and the Holder and/or the Attribution Parties shall not have the power to vote or to transfer the Excess Shares.
As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to
the Holder the exercise price paid by the Holder for the Excess Shares and reinstate the Warrant to the extent of such surrendered Excess
Shares. By written notice to the Company, a Holder of this Warrant may from time to time increase or decrease the Maximum Percentage
to any other percentage specified in such notice, provided however, in no case shall the percentage specified be in excess of 19.99%.
Any increase in the Maximum Percentage will not be effective until the 61st day after such notice is delivered to the Company and shall
not negatively affect any partial exercise effected prior to such change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>This
Section&nbsp;11 shall not restrict the number of shares of Common Stock which a Holder or the Attribution Parties may receive or beneficially
own in order to determine the amount of securities or other consideration that such Holder or the Attribution Parties may receive in
the event of a Fundamental Transaction as contemplated in Section&nbsp;9(c)&nbsp;of this Warrant. For purposes of clarity, the shares
of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially
owned by the Holder or the Attribution Parties for any purpose including for purposes of Section&nbsp;13(d)&nbsp;of the Exchange Act
and the rules&nbsp;promulgated thereunder or Section&nbsp;16 of the Exchange Act and the rules&nbsp;promulgated thereunder, including
Rule&nbsp;16a-1(a)(1). No prior inability to exercise this Warrant pursuant to this paragraph shall have any effect on the applicability
of the provisions of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph
shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;11 to the extent
necessary to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial
ownership limitation contained in this Section&nbsp;11 or to make changes or supplements necessary or desirable to properly give effect
to such limitation. The limitation contained in this Section&nbsp;11 may not be waived and shall apply to a successor holder of this
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>No
Fractional Shares</U></B>. No fractional Warrant Shares will be issued in connection with any exercise of this Warrant. In lieu of any
fractional shares that would otherwise be issuable, the number of Warrant Shares to be issued shall be rounded up to the next whole number
and the Company shall not be required to pay the Holder in cash the fair market value (based on the Closing Sale Price) for any such
fractional shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Redemption
of Warrants</U>.</B> All, but not less than all, of the outstanding Warrants may be redeemed for cash, at the option of the Company,
at any time commencing January&nbsp;18, 2027 and; provided that the date on which the last reported sale price of the share of Common
Stock has been at least $8.00 per share (subject to adjustment in compliance with&nbsp;Section&nbsp;4&nbsp;hereof), on each of ten (10)&nbsp;trading
days within the twenty (20) trading day period ending on the third (3<SUP>rd</SUP>) trading day prior to the date on which notice of
the redemption is given, upon notice to the Registered Holders of the Warrants, as described in&nbsp;this Section&nbsp;13, at a Redemption
Price of $0.0625 per Warrant. In the event that the Company elects to redeem the Warrants pursuant to&nbsp;this Section&nbsp;13, the
Company shall fix a date for the redemption (the &ldquo;<B>Redemption Date</B>&rdquo;). Notice of redemption shall be mailed by first
class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (the &ldquo;<B>30-day Redemption
Period</B>&rdquo;) to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration
books. As used in this Agreement, &ldquo;Redemption Price&rdquo; shall mean the price per Warrant at which any Warrants are redeemed
pursuant to&nbsp;this Section&nbsp;13. The Warrants may be exercised, for cash (or on a &ldquo;cashless basis&rdquo; pursuant to&nbsp;Section&nbsp;10&nbsp;hereof,
if applicable) at any time after notice of redemption shall have been given by the Company pursuant to&nbsp;this Section&nbsp;13 and
prior to the Redemption Date. On and after the Redemption Date, the record holder of the Warrants shall have no further rights except
to receive, upon surrender of the Warrants, the Redemption Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Notices</U></B>.
Any and all notices or other communications or deliveries hereunder (including, without limitation, any Exercise Notice) shall be in
writing and shall be deemed given and effective on the earliest of (i)&nbsp;the date of transmission, if such notice or communication
is delivered confirmed e-mail at the e-mail address specified by the Company prior to 5:30 P.M., New York City time, on a Trading Day,
(ii)&nbsp;the next Trading Day after the date of transmission, if such notice or communication is delivered via confirmed e-mail at the
e-mail address specified by the Company on a day that is not a Trading Day or later than 5:30 P.M., New York City time, on any Trading
Day, (iii)&nbsp;the Trading Day following the date of mailing, if sent by nationally recognized overnight courier service specifying
next business day delivery, or (iv)&nbsp;upon actual receipt by the Person to whom such notice is required to be given, if by hand delivery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Warrant
Agent</U></B>. The Company shall initially serve as warrant agent under this Warrant. Upon ten (10)&nbsp;days&rsquo; notice to the Holder,
the Company may appoint a new warrant agent. Any entity into which the Company or any new warrant agent may be merged or any entity resulting
from any consolidation to which the Company or any new warrant agent shall be a party or any entity to which the Company or any new warrant
agent transfers substantially all of its corporate trust or stockholders services business shall be a successor warrant agent under this
Warrant without any further act. Any such successor warrant agent shall promptly cause notice of its succession as warrant agent to be
mailed (by first class mail, postage prepaid) to the Holder at the Holder&rsquo;s last address as shown on the Warrant Register. The
Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof
or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B><U>Miscellaneous</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>No
Rights as a Stockholder</U>. Except as otherwise set forth in this Warrant, the Holder, solely in such Person&rsquo;s capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of share capital of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person&rsquo;s capacity as the Holder
of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action
(whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, amalgamation, conveyance or otherwise),
receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant
Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant
shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise)
or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Further
Assurances</U>. Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without
limitation, amending its certificate or articles of incorporation or through any reorganization, transfer of assets, consolidation, merger,
dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of
the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all
such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without
limiting the generality of the foregoing, the Company will (a)&nbsp;not increase the par value of any Warrant Shares above the amount
payable therefor upon such exercise immediately prior to such increase in par value, (b)&nbsp;take all such action as may be necessary
or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise
of this Warrant, and (c)&nbsp;use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any
public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations under this Warrant.
Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary
from any public regulatory body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Successors
and Assigns</U>. Subject to compliance with applicable securities laws, this Warrant may be assigned by the Holder. This Warrant may
not be assigned by the Company without the written consent of the Holder, except to a successor in the event of a Fundamental Transaction.
This Warrant shall be binding on and inure to the benefit of the Company and the Holder and their respective successors and assigns.
Subject to the preceding sentence, nothing in this Warrant shall be construed to give to any Person other than the Company and the Holder
any legal or equitable right, remedy or cause of action under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Amendment
and Waiver</U>. This Warrant may be amended only in writing signed by the Company and the Holder, or their successors and assigns. Except
as otherwise provided herein, the Company may take any action herein prohibited, or omit to perform any act herein required to be performed
by it, only if the Company has obtained the written consent of the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Acceptance</U>.
Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Governing
Law; Jurisdiction</U>. ALL QUESTIONS CONCERNING THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS WARRANT SHALL BE GOVERNED
BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW
THEREOF. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE AND FEDERAL COURTS
SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR WITH
ANY TRANSACTION CONTEMPLATED HEREBY OR DISCUSSED HEREIN (INCLUDING WITH RESPECT TO THE ENFORCEMENT OF ANY OF THE TRANSACTION DOCUMENTS),
AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT
TO THE JURISDICTION OF ANY SUCH COURT. EACH OF THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS
TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY THEREOF VIA REGISTERED OR CERTIFIED MAIL OR OVERNIGHT
DELIVERY (WITH EVIDENCE OF DELIVERY) TO SUCH PERSON AT THE ADDRESS IN EFFECT FOR NOTICES TO IT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE
GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF. NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO
SERVE PROCESS IN ANY MANNER PERMITTED BY LAW. EACH OF THE COMPANY AND THE HOLDER HEREBY WAIVES ALL RIGHTS TO A TRIAL BY JURY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Severability</U>.
If any part or provision of this Warrant is held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction,
the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original
business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Warrant shall remain binding
upon the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be duly executed by its authorized officer as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>XCEL BRANDS,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE 1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ASSIGNMENT FORM</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(<I>To assign the foregoing Warrant, execute
this form and supply required information. Do not use this form to purchase shares</I>.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please Print)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email Address:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Signature:
    <U>&nbsp;</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s Address:
    <U>&nbsp;</U></FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE 2</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>FORM&nbsp;OF EXERCISE NOTICE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[To be executed by the Holder to purchase shares
of Common Stock under the Warrant]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">The undersigned is the Holder of Warrant
                                            No.&nbsp;__ (the &ldquo;Warrant&rdquo;) issued by Xcel Brands,&nbsp;Inc., a Delaware corporation
                                            (the &ldquo;Company&rdquo;). Capitalized terms used herein and not otherwise defined herein
                                            have the respective meanings set forth in the Warrant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">The undersigned hereby exercises its right
                                            to purchase _____ Warrant Shares pursuant to the Warrant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">The Holder intends that payment of the Exercise
                                            Price shall be made as (check one):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.2in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash Exercise</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Cashless Exercise&rdquo;
    under <U>Section&nbsp;10</U> of the Warrant </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify">If the Holder has elected a Cash Exercise,
                                            the Holder shall pay the sum of $ _____ in immediately available funds to the Company in
                                            accordance with the terms of the Warrant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(5)</TD><TD STYLE="text-align: justify">Pursuant to this Exercise Notice, the Company
                                            shall deliver to the Holder Warrant Shares determined in accordance with the terms of the
                                            Warrant. The Warrant Shares shall be delivered (check one):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 0.2in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to the following DWAC Account
    Number: _______________________________</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in book-entry form via
    a direct registration system</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">by physical delivery of a certificate to: ______________________________________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">_______________________________________________________</P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in restricted book-entry
    form in the Company&rsquo;s share register</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(6)</TD><TD STYLE="text-align: justify">By its delivery of this Exercise Notice,
                                            the undersigned represents and warrants to the Company that in giving effect to the exercise
                                            evidenced hereby the Holder (i)&nbsp;the Holder is an &ldquo;accredited investor&rdquo; as
                                            defined in Regulation D promulgated under the Securities Act of 1933, as amended and (ii)&nbsp;will
                                            not beneficially own in excess of the number of shares of Common Stock (as determined in
                                            accordance with Section&nbsp;13(d)&nbsp;of the Securities Exchange Act of 1934, as amended)
                                            permitted to be owned under <U>Section&nbsp;11(a)</U>&nbsp;of the Warrant to which this notice
                                            relates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(7)</TD><TD STYLE="text-align: justify">The number of shares of Common Stock that
                                            the undersigned, together with its Attribution Parties holds and/or beneficially owns and
                                            has the right to acquire through the exercise of derivative securities (and any limitations
                                            thereon on exercise or conversion) contemporaneously or immediately prior to submitting an
                                            Exercise Notice:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 35%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Holder:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Signature must conform in all respects to name
of Holder as specified on the face of the Warrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>tm2533803d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: -0.5in"><FONT STYLE="text-transform: uppercase">&#8239;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of December 17, 2025 between Xcel Brands, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below) and Regulation D promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase
from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE I.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Definitions</U>. In
addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set
forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2</FONT><FONT STYLE="font-size: 10pt"><SUP>nd</SUP></FONT>)
Trading Day following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof
in the form of <U>Exhibit A</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof,
unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock, options or other equity awards to employees, officers, consultants
or directors of the Company pursuant to any incentive, stock or option plan duly adopted for such purpose, by a majority of the non-employee
members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for
services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder, and/or
other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this
Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities
or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or
combinations or otherwise pursuant to the terms in effect on the date hereof), (c) Securities issued to a lender in connection with the
incurrence of indebtedness and Securities issuable upon exercise, exchange or conversion thereof (d) the execution of an equity line of
credit or a similar arrangement for the issuance of securities of the Company from time to time, as long as no sales are made under such
agreement until the 30<SUP>th</SUP> day following the date of this Agreement and (e) securities issued pursuant to mergers, acquisitions,
business combinations, joint ventures or strategic transactions approved by a majority of the disinterested directors of the Company,
provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries,
an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company
additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities
primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $1.2275, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement; provided that the purchase price per Pre-Funded
Warrant shall be the Per Share Purchase Price minus $0.001.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means that certain Placement Agency Agreement by and between the Company and the Placement Agent, dated as
of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means Wellington Shields &amp; Co. LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant</U>&rdquo; means, collectively, the Pre-Funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately upon issuance and shall expire in accordance with
the terms thereof, in the form of <U>Exhibit B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Product</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(hh).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; shall have the meaning ascribed to such term in Section 4.15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in
United States dollars and in immediately available funds (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the Pre-Funded
Warrants, which amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth <U>in the SEC Reports</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Placement Agency Agreement and all exhibits and schedules thereto and hereto
and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company, the current transfer agent of the Company, with an address at 1
State Street, 30th Floor, New York, New York 10004 and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means the Common Warrants and the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.<BR>
</B></FONT>PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1 <U>Closing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the Closing Date, upon
the terms and subject to the conditions set forth herein, the Company agrees to sell, and each Purchaser, severally and not jointly, agrees
to purchase, the number of Shares set forth under the heading &ldquo;Subscription Amount&rdquo; on the Purchaser&rsquo;s signature page
hereto, at the Per Share Purchase Price, and the Warrants representing such Purchaser&rsquo;s Subscription Amount. Notwithstanding anything
herein to the contrary, to the extent that a Purchaser determines, in its sole discretion, that as a result of such Purchaser&rsquo;s
Subscription Amount, such Purchaser (together with such Purchaser&rsquo;s Affiliates and any Person acting as a group together with such
Purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially own Shares in excess of the Beneficial Ownership Limitation,
the Purchaser may elect to purchase Pre-Funded Warrants in lieu of the Shares. The &ldquo;Beneficial Ownership Limitation&rdquo; shall
be 4.99% (or, at the election of the Purchaser, 9.99%) of the number of shares of Common Stock outstanding immediately after giving effect
to the issuance of the Securities on the Closing Date. In each case, the election to receive Pre-Funded Warrants is solely at the option
of the Purchaser; <U>provided</U>, however, the Purchaser shall receive Pre-Funded Warrants at the option of the Company if necessary
to avoid a stockholder vote in connection with the purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Purchaser shall deliver
to the Company, via wire transfer, immediately available funds equal to such Purchaser&rsquo;s Subscription Amount as set forth on the
signature page hereto executed by such Purchaser. The Company shall deliver to each Purchaser its respective Shares and Warrants as determined
in accordance with Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable
at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur remotely
via the exchange of documents and signatures or such other location as the parties shall mutually agree.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.2 <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) On or prior
to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) this Agreement
duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) a legal opinion
of Blank Rome LLP, substantially in form and substance reasonably satisfactory to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) subject to the
last sentence of Section 2.1, the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv) subject to the
last sentence of Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on
an expedited basis a certificate (or book entry statement) evidencing&#8239; a number of Shares equal to the number of Shares set forth
on such Purchaser&rsquo;s signature page hereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v) a Common Warrant
registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 50% of such Purchaser&rsquo;s Shares
and Pre-Funded Warrants, with an exercise price equal to $3.00, subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi) if, applicable,
a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to such Purchaser&rsquo;s
Subscription Amount divided by the Per Share Purchase Price (rounded down to the nearest whole Share), <I>minus</I> the number of Shares
required to be delivered pursuant to Section 2.2(a)(iv), with an exercise price equal to $0.001, subject to adjustment therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii) At the Closing
Date, there shall be furnished to the Placement Agent a certificate, dated the date of its delivery, signed by each of the Chief Executive
Officer and the Chief Financial Officer of the Company, in their capacities as such, and not individually, in form and substance reasonably
satisfactory to the Placement Agent and counsel to the Placement Agent, certifying and confirming the satisfaction of the closing conditions
listed in Section 2.3(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) On or prior
to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; this Agreement duly executed by such Purchaser;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>a completed Accredited Investor Questionnaire in the form included as <U>Exhibit C</U> hereto; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)&#8239;&#8239;&#8239;
</FONT>such Purchaser&rsquo;s Subscription Amount, which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement
with the Company or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3 <U>Closing Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) The obligations
of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the accuracy in
all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) on the Closing Date
of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall
be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) as
of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all obligations,
covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the delivery
by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) The respective
obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the accuracy in
all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all
respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific
date therein in which case they shall be accurate in all material respects or, to the extent representations or warranties are qualified
by materiality or Material Adverse Effect, in all respects) as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all obligations,
covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the delivery
by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv) there shall have
been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v) from the date
hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s principal
Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have
been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service,
or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.<BR>
</B></FONT>REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Representations and
Warranties of the Company</U>. Except as explicitly described in the SEC Reports, which descriptions shall be deemed a part hereof and
shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the applicable SEC Report, the
Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary which it owns, free and clear of any Liens, and all of the issued
and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive
and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries
or any of them in the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to
own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse
effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries,
taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis
its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding
has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Authorization;
Enforcement</U>. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation
by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company
and no further action is required by the Company, the Board of Directors, a committee of the Board of Directors or the Company&rsquo;s
stockholders in connection herewith or therewith, in each case, other than in connection with the Required Approvals and subject to any
stockholder approval that may be requested by the Nasdaq Stock Market LLC,. This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms
hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with
its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, fraudulent conveyance,
fraudulent transfer, moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii)
as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar
as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>No Conflicts</U>.
The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the
issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not
(i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of incorporation,
bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse
of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company
or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation
(with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or
Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset
of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation
of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which
the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset
of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably
be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant
to Section 4.4 of this Agreement, (ii) with respect to applicable federal and state securities laws and the rules and regulations of the
Financial Industry regulatory Authority, Inc., and (iii) application(s) to each applicable Trading Market for the listing of the Shares
and the Warrant Shares for trading thereon in the time and manner required thereby (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
</FONT><U>Issuance of the Shares and Warrants</U>. The Shares and Warrants are duly authorized and, when issued and paid for in accordance
with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens
imposed by the Company. The Warrant Shares when issued in accordance with the terms of this agreement and the Warrants, will be duly authorized
and validly issued and free and clear of all Liens imposed by the Company. The Company has reserved, or will have reserved by the time
of Closing, from its duly authorized capital stock the number of shares of Common Stock currently issuable pursuant to this Agreement
and the Warrants, except as otherwise permitted by the terms of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) <U>Capitalization</U>.
The capitalization of the Company as of September 30, 2025, is as set forth in the SEC Reports. The Company has not issued any capital
stock since its most recently filed periodic report under the Exchange Act, other than pursuant to (i) the exercise of employee stock
options and granting of restricted stock, restricted stock units or similar awards under the Company&rsquo;s equity incentive plans and
(ii) the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock equity incentive plans or purchase
plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed
periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar
right to participate in the transactions contemplated by the Transaction Documents which right has not been waived or satisfied. There
are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities,
rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire,
any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which
the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital
stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common
Stock or other securities to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company
or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon
an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary
that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the
Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any
stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding
shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance
with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar
rights to subscribe for or purchase securities. There are no stockholders agreements, voting agreements or other similar agreements with
respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any
of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h) <U>SEC Reports;
Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by
the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding
the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials,
including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &ldquo;<U>SEC
Reports</U>&rdquo;) As of their respective dates (except to the extent any such SEC Report was subsequently amended), the SEC Reports
complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC
Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The
Company is an issuer subject to Rule 144(i) under the Securities Act, and is not currently a &ldquo;shell company&rdquo; and at least
one year has passed since it filed &ldquo;Form 10 Information&rdquo; with the Commission. The financial statements of the Company included
in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission
with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States
generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except
as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not
contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as set forth in the SEC Reports, (i) there has been no event, occurrence or development that has had or that could
reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise)
other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities
not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of
cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital
stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company
stock option plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except
for the issuance of the Securities contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development
has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective
businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under
applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one Trading
Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j) <U>Litigation</U>.
There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened
against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental
or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;)
which could reasonably be expected to have a Material Adverse Effect on the Company. Neither the Company nor any Subsidiary, nor to the
knowledge of the Company, any director or officer thereof, is or has been the subject of any Action involving a claim of violation of
or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of
the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former
director or officer of the Company. The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k) <U>Labor Relations</U>.
No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could
reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member
of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor any of
its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. To the knowledge of the Company, the Company and its Subsidiaries are in compliance in all material respects
with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions
of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l) <U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m) <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received
all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and
(iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii),
the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n) <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o) <U>Title to
Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each
case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere
with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal,
state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither
delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by
them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, except where such failure
could not reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p) <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have would reasonably be expected to result in a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;).
Other than as set forth in the SEC Reports, none of, and neither the Company nor any Subsidiary has received a notice (written or otherwise)
that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned,
within two (2) years from the date of this Agreement, except as could not have or reasonably be expected to have a Material Adverse Effect.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights, except as could not have or reasonably be expected to have a Material Adverse Effect. The Company and its Subsidiaries
have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except
where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q) <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers it believes to be of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that it
will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r) <U>Transactions
With Affiliates and Employees</U>. None of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company,
none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other
than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing
of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending
of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any
entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder,
member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii)
reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under
any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002, as amended, that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the
Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a
system of internal accounting controls with the goal of providing reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such
disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits
under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules
and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company
and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date,
the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the
conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as
of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such
term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially
affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t) <U>Certain Fees</U>.
Except for fees payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions are or will be payable
by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other
Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect
to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may
be due in connection with the transactions contemplated by the Transaction Documents, other than any obligations incurred directly by
a Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u) <U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v) <U>Registration
Rights</U>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any
securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w) <U>Listing and
Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has
taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock
under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is
or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such
Trading Market. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established
clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing
corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x) <U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of
the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y) <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers
will rely on the foregoing representation in effecting transactions in securities of the Company. The Company acknowledges and agrees
that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z) <U>No Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company,
nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security
or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with
prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market on which any of the
securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa) <U>Private
Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2 and that none of
the &ldquo;bad actor&rdquo; disqualifications described in Rule 506(d)(1)(i) &ndash; (viii) under the Securities Act apply to the offering
of the Securities, no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the
Purchasers as contemplated hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of
the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb) <U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and
franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other
governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations
and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the
taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc) <U>Foreign
Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign
or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)
failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the
Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd) <U>Accountants</U>.
To the knowledge and belief of the Company, the Company&rsquo;s accounting firm (i) is a registered public accounting firm as required
by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&rsquo;s
Annual Report for the fiscal year ending December 31, 2025 (or such other fiscal year end then applicable to the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee) <U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff) <U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except
for Sections 3.2(f) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked
by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company,
or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Securities for any specified term; (ii)
past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo;
transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of
the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which
any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock, and (iv)
each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo;
transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various
times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Warrant
Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of
the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted.
The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg) <U>Regulation
M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action
designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale
or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities,
or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company,
other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh)[INTENTIONALLY
OMITTED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) <U>Stock Option
Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance with the
terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock
on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s
stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice
to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public
announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj) <U>Cybersecurity</U>.
Except as would not reasonably be expected to result in a Material Adverse Event, (i)(x) there has been no security breach or other compromise
of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware,
software, data (including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or
on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) other than as disclosed in
the SEC Reports, the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would
reasonably be expected to result in, any security breach or other compromise to its IT Systems and Data which had or could reasonably
be expected to have a Material Adverse Effect; (ii) to the knowledge of the Company, the Company and the Subsidiaries are presently in
compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental
or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and
to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually
or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially
reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy
and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology
consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk) <U>Office of
Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent,
employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll) <U>U.S. Real
Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of
Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mm) <U>Bank Holding
Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as
amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or
Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to
regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(nn) <U>Money Laundering</U>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance in all material respects with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(oo) <U>Other Covered
Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been
or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(pp) <U>Notice of
Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities
Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company
participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities,
calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with
the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo;) is subject to any of the &ldquo;Bad
Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;),
except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether
any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure
obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Representations and
Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date
hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(a) <U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
</FONT><U>Own Account</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities. Such Purchaser is acquiring the
Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(c) <U>Purchaser Status;
No Disqualifying Event</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as
defined in Rule 144A(a) under the Securities Act. With respect to the Securities to be offered and sold hereunder in reliance on Rule
506 under the Securities Act, none of the Purchaser, any of its predecessors, any affiliated issuer, any director, executive officer,
managing member, general partner, other officer of the Purchaser participating in the offering hereunder, any beneficial owner of 20%
or more of the Purchaser&rsquo;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that
term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Purchaser
Covered Person</U>&rdquo;) is subject to any <U>Disqualification Event</U>, except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Purchaser Covered Person is subject to a Disqualification
Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(d) <U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(e) <U>Access to Information</U>.
Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules
thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary of, and to receive
answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and
risks of investing in the Securities all such questions, if any, have been answered to its satisfaction; (ii) access to information about
the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it
to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire
without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Such
Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser
with any information or advice with respect to the Securities nor is such information or advice necessary or desired. Neither the Placement
Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent
and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided
to it. In connection with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has
acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(f) <U>General Solicitation</U>.
Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result of any advertisement, article, notice
or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or
radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(g) <U>Certain Transactions
and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting
on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short
Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written
or oral) from the Company or any other Person representing the Company setting forth the material pricing terms of the transactions contemplated
hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&rsquo;s
assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that
made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement
or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors,
employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this
transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing
contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares
in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(h) <U>Brokers</U>.
No agent, broker, investment banker, person or firm acting in a similar capacity on behalf of or under the authority of the Purchaser
is or will be entitled to any broker&rsquo;s or finder&rsquo;s fee or any other commission or similar fee, directly or indirectly, for
which the Company or any of its Affiliates after the Closing could have any liabilities in connection with this Agreement, any of the
transactions contemplated by this Agreement, or on account of any action taken by the Purchaser in connection with the transactions contemplated
by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: 51pt">(i) <U>Independent
Advice</U>. Each Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf of the Company
to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the representations
contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in this Agreement (other than the representation and warranty set forth in Section 3.1 (aa), or any representations
and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection
with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt,
nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing
shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE IV.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.1 <U>Transfer Restrictions. </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Securities issuable thereunder may only be disposed of in compliance with state and federal securities laws. In connection with any transfer
of the Securities issuable thereunder other than pursuant to an effective registration statement or Rule 144, to the Company or to an
Affiliate of a Purchaser without payment of consideration therefor or in connection with a pledge as contemplated in Section 4.1(b), the
Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable
to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration of such transferred Shares or Warrant Shares under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities issuable thereunder
in substantially the following form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">NEITHER THIS SECURITY
NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES
ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY
BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT
IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured
Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal
opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall
be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable documentation
as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including,
if the Securities are subject to registration pursuant to Section 4.15 of this Agreement, the preparation and filing of any required prospectus
supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the
list of selling stockholders thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subject
to the remainder of this paragraph, legends (including the legend set forth in Section 4.1(b) hereof) on certificates evidencing the Securities
may be removed: (i) following any sale of such Securities pursuant to a registration statement (including the Registration Statement)
covering the resale of such security that is effective and usable under the Securities Act, (ii) following any sale of such Securities
pursuant to Rule 144, or (iii) if such legend is not required under applicable requirements of the Securities Act (including judicial
interpretations and pronouncements issued by the staff of the Commission). Upon the occurrence of any of the events set forth in clauses
(i) or (ii) in the preceding sentence, the Company shall cause its counsel to issue a legal opinion and an instruction letter to the Transfer
Agent or the Purchaser promptly after request by the Purchaser, if required by the Transfer Agent, to effect the removal of the legend
hereunder, conditioned upon the prior completion and submission by the Purchaser or its broker, as applicable, of customary certificates
or representation letters. The Company agrees that following such time as such legend is no longer required under this Section 4.1(d),
the Company will use its commercially reasonable efforts to, no later than the later of (i) one (1) Trading Day and (ii) the number of
Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the
Transfer Agent of a certificate representing Securities, as the case may be, issued with a restrictive legend together with any customary
certificate or representation letter from the Purchaser or the Purchaser&rsquo;s broker, as applicable (such date when all such conditions
are satisfied, the &ldquo;Legend Removal Date&rdquo;), deliver or cause to be delivered to the Transfer Agent an instruction letter with
respect to the removal of legends, if required by the Transfer Agent. The Company may not make any notation on its records or give instructions
to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Certificates for Securities subject to legend
removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime
broker with the Depository Trust Company System as directed by such Purchaser. As used herein, &ldquo;Standard Settlement Period&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of a certificate representing Shares or Warrant Shares, as the case may be, issued
with a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend
Removal Date until an instruction letter with respect to legend removal (&ldquo;<U>Instruction Letter</U>&rdquo;), if required by the
Transfer Agent, is delivered to the Transfer Agent, and (ii) if the Company (a) fails to issue and deliver (or cause to be delivered)
to the Transfer Agent by the Legend Removal Date the Instruction Letter, if required by the Transfer Agent and (b) fails to issue and
deliver (or cause to be issued and delivered) to the Purchaser by the Legend Removal Date a certificate representing the Securities so
delivered to the Company by such Purchaser that is free from all restrictive and other legends and (c) such Purchaser purchases (in an
open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion
of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of
shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal
to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any)
for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In
Price</U>&rdquo;) over the product of (A) such number of Shares or Warrant Shares that the Company was required to deliver to such Purchaser
by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing
on the date of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares (as the case may be) and ending
on the date of such delivery and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant
to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption
therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution
set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth
in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Furnishing of Information</U>.
Until the earlier of the time that no Purchaser owns Securities, the Company covenants to use its best efforts to timely file (or obtain
extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date
hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Integration</U>. The
Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would be integrated with the
offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder
approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent
transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4 <U>Securities Laws Disclosure;
Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated
hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within
the time required by the Exchange Act. From and after the issuance of such press release. The Company represents to the Purchasers that
it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its
Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement
Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such
press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether
written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or
agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates on the
other hand, shall terminate and be of no further force or effect. The Company understands and confirms that each Purchaser shall be relying
on the foregoing covenant in effecting transactions in securities of the Company. The Company and each Purchaser shall consult with each
other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser
shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect
to any press release of any Purchaser, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required
by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to
the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with
prior notice of such disclosure permitted under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5 <U>Shareholder Rights
Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is
an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6 <U>Non-Public Information</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be
disclosed pursuant to Section 4.4, the Company covenants and agrees that, unless requested by a Purchaser, neither it, nor any other Person
acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably
believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt
of such information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that
the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material,
non-public information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser
shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of
their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade
on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the
Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in
effecting transactions in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7 <U>Use of Proceeds</U>.
The Company shall use the net proceeds from the sale of the Securities hereunder for working capital and general corporate purposes, and
shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment of trade payables
and accrued liabilities in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption of any Common
Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8 <U>Indemnification of
Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers,
shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such
titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section
15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or
employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title
or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses, liabilities,
obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and
reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating
to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other
Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity (including a Purchaser Party&rsquo;s
status as an investor), or any of them or their respective Affiliates, by the Company or any stockholder of the Company who is not an
Affiliate of such Purchaser Party, arising out of or relating to any of the transactions contemplated by the Transaction Documents. For
the avoidance of doubt, the indemnification provided herein is intended to, and shall also cover, direct claims brought by the Company
against the Purchaser Parties; provided, however, that such indemnification shall not cover any loss, claim, damage or liability to the
extent it is finally judicially determined to be attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties,
covenants or agreements made by such Purchaser Party in any Transaction Document or any conduct by a Purchaser Party which is finally
judicially determined to constitute fraud, gross negligence or willful misconduct. If any action shall be brought against any Purchaser
Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in
writing, and, except with respect to direct claims brought by the Company, the Company shall have the right to assume the defense thereof
with counsel of its own choosing reasonably acceptable to the Purchaser Party (Blank Rome LLP is acceptable to the Purchasers). Any Purchaser
Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically
authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ
counsel or (iii) in such action there is, in the reasonable opinion of counsel to the applicable Purchaser Party (which may be internal
counsel), a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which
case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel for all Purchasers.
The Company will not be liable to any Purchaser Party under this Agreement for any settlement by a Purchaser Party effected without the
Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed. In addition, if any Purchaser Party takes
actions to collect amounts due under any Transaction Documents or to enforce the provisions of any Transaction Documents, then the Company
shall pay the costs incurred by such Purchaser Party for such collection, enforcement or action, including, but not limited to, attorneys&rsquo;
fees and disbursements. The indemnification and other payment obligations required by this Section 4.8 shall be made by periodic payments
of the amount thereof during the course of the investigation, defense, collection, enforcement or action, as and when bills are reasonably
incurred and received; provided, that if any Purchaser Party is finally judicially determined not to be entitled to indemnification or
payment under this Section 4.8, such Purchaser Party shall promptly reimburse the Company for any payments that are advanced under this
sentence. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party
against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9 <U>Reservation of Common
Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times,
free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue the Shares pursuant
to this Agreement and Warrant Shares pursuant to any exercise of the Warrants. The Company shall reserve and keep available at all times,
free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue the Warrant
Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10 <U>Listing of Common
Stock</U>. For as long as any Warrants are outstanding and exercisable, the Company hereby agrees to use reasonable best efforts to maintain
the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing,
the Company shall apply to list or quote all of the Shares and the Warrant Shares on such Trading Market and promptly secure the listing
of all of the Shares and the Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common
Stock traded on any other Trading Market, it will then include in such application all of the Shares and the Warrant Shares, and will
take such other action as is necessary to cause all of the Shares and the Warrant Shares to be listed or quoted on such other Trading
Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its
Common Stock on a Trading Market and will comply in all material respects with the Company&rsquo;s reporting, filing and other obligations
under the bylaws or rules of the Trading Market. For so long as the Company maintains a listing or quotation of the Common Stock on a
Trading Market, the Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust
Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust
Company or such other established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 <U>Subsequent Equity
Sales</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) From the date
hereof until 60 days after the date hereof, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce
the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt </FONT>Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12 <U>Equal Treatment of
Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend
or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to
all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each
Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class
and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting
of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13 <U>Certain Transactions
and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor any Affiliate
acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the
Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions
contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4. Each Purchaser,
severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement
are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain
the confidentiality of the existence and terms of this transaction (other than as disclosed to its legal and other representatives). Notwithstanding
the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees
that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities
of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial
press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any
securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by
this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall
have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any
of their respective officers, directors, employees, Affiliates or agent, including, without limitation, the Placement Agent, after the
issuance of the initial press release as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that is a
multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and the
portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such
Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14 <U>Exercise Procedures</U>.
The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers in order to
exercise such Warrants, as applicable. No additional legal opinion, other information or instructions shall be required of the Purchasers
to exercise such Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any
medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise such
Warrants. The Company shall honor exercises of such Warrants and shall deliver the Warrant Shares, as applicable, in accordance with the
terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
</FONT><U>Registration Rights</U>. On or before thirty (30) day following the Closing Date (the &ldquo;<U>Filing Date</U>&rdquo;), the
Company will use commercially reasonable efforts to file a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) with
the Commission registering for resale the Shares and Warrant Shares (the &ldquo;<U>Registrable Securities</U>&rdquo;), and will use commercially
reasonable efforts to have such Registration Statement declared effective by the Commission no later than the sixtieth (60) day following
the Closing Date (or, in the event of a review by the Commission, the later of (i) ninetieth (90) day following the Closing Date and (ii)
the twentieth (20<SUP>th</SUP>) day following the date on which the Company files its Annual Report on Form 10-K for the year ending December
31, 2025) (the &ldquo;<U>Effectiveness Date</U>&rdquo;) and use commercially reasonable efforts to keep such registration statement effective
at all times until the earlier of (i) such time as no Purchaser owns any Shares or Warrant Shares issuable upon exercise thereof and (ii)
such time as all Purchasers are eligible to resell all Shares and Warrant Shares pursuant to Rule 144 without compliance by the Company
with the current public information requirement of Rule 144. The Company&rsquo;s obligations hereunder are conditioned upon each Purchaser
completing and furnishing to the Company a customary selling shareholder questionnaire on a date that is not less than five (5) Trading
Days prior to the filing date of the Registration Statement contemplated by this Section 4.15 and to provide the Company such other customary
information it may reasonably request from time to time in order to file and maintain the effectiveness of the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If:
(i) the Registration Statement is not filed on or prior to its Filing Date, or (ii) the Company fails to file with the Commission a request
for acceleration of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act,
within five (5) Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that
such Registration Statement will not be &ldquo;reviewed&rdquo; or will not be subject to further review (unless such five (5) day period
ends at a time when the Company would be required to include its audited December 31, 2025 financial statements in the registration statement
and has not filed its Annual Report on Form 10-K for the year ended December 31, 2025), or (iii) prior to the effective date of a Registration
Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in
respect of such Registration Statement within twenty(20) calendar days after the receipt of comments by or notice from the Commission
that such amendment is required in order for such Registration Statement to be declared effective, or (iv) a Registration Statement registering
for resale all of the Registrable Securities is not declared effective by the Commission by the Effectiveness Date of the Registration
Statement, or (v) after the effective date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously
effective as to all Registrable Securities included in such Registration Statement, or the Purchasers are otherwise not permitted to utilize
the prospectus therein to resell such Registrable Securities, for more than twenty (20) consecutive calendar days or more than an aggregate
of thirty (30) calendar days (which need not be consecutive calendar days) during any 12-month period (any such failure or breach being
referred to as an &ldquo;<U>Event</U>&rdquo;, and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose
of clause (ii) the date on which such five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such twenty
(20) calendar day period is exceeded, and for purpose of clause (v) the date on which such twenty (20) or thirty (30) calendar day period,
as applicable, is exceeded being referred to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the Purchasers
may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable
Event shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Purchaser an amount in
cash, as partial liquidated damages and not as a penalty, equal to $1,000 per day of such failure (up to a maximum of 2.0% of the Purchaser&rsquo;s
Per Share Purchase Price. If the Company fails to pay any partial liquidated damages pursuant to this Section 4.15 in full within seven
(7) days after the date payable, the Company will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that
is permitted to be paid by applicable law) to the Purchaser, accruing daily from the date such partial liquidated damages are due until
such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply
on a daily pro rata basis for any portion of a month prior to the cure of an Event.</FONT> Notwithstanding anything contained herein,
(i) no liquidated damages shall accrue or be payable with respect to Purchaser if a delay in meeting any deadline is due in whole or in
part to the actions, inactions or directives of any Purchaser and (ii) the Company shall not be obligated to make more than one (1) payment
at any time under this Section 4.15 and the aggregate amount of all payments to a Purchaser under this Section 4.15 shall be 2.0% of such
Purchaser&rsquo;s Per Share Purchase Price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16&#8239;<U>Form
D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and
to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17&#8239;<U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding
shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations
under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant to the
Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, other
than the conditions set forth in this Agreement, regardless of the effect of any such dilution or any claim the Company may have against
any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.<BR>
</B></FONT>MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5</FONT><FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>) Trading Day following
the date hereof; <U>provided</U>, <U>however</U>, that no such termination will affect the right of any party to sue for any breach by
any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2 <U>Fees and Expenses</U>.
Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers,
counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any
fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser),
stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 <U>Entire Agreement</U>.
The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect
to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such
matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing
and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City
time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email
attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30
p.m. (New York City time) on any Trading Day, (c) the second (2</FONT><FONT STYLE="font-size: 10pt"><SUP>nd</SUP></FONT>) Trading Day
following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party
to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages
attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5 <U>Amendments; Waivers</U>.
No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of
an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Pre-Funded Warrant Shares based
on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately
and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 <U>Headings</U>. The headings
herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7 <U>Successors and Assigns</U>.
This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may
not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger).
Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities,
provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction
Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>No Third-Party Beneficiaries</U>.
The Placement Agent shall be a third party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations
and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective
successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except
as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 <U>Governing Law</U>.
All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by
and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 <U>Survival</U>. The
representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11 <U>Execution</U>. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &ldquo;.pdf&rdquo;
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13 <U>Rescission and Withdrawal
Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction
Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not
timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to
its future actions and rights; <U>provided</U>, <U>however</U>, that in the case of a rescission of an exercise of a Warrant, the applicable
Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return
to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser&rsquo;s right
to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement warrant certificate evidencing
such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14 <U>Replacement of Securities</U>.
If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to
be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor,
a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction.
The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including
customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15 <U>Remedies</U>. In addition
to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and
the Company may be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be
adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree
to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16 <U>Payment Set Aside</U>.
To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces
or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are
subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded,
repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any
bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation
or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not
been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17 <U>Independent Nature
of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
Pryor Cashman LLP. Pryor Cashman LLP does not represent any of the Purchasers and only represents the Placement Agent. The Company has
elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it
was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this
Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers
collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18 <U>Saturdays, Sundays,
Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20 <B><U>WAIVER OF JURY
TRIAL</U>. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY
AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES
FOREVER TRIAL BY JURY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&#8239;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&#8239;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
<TD COLSPAN="2" STYLE="padding-bottom: 1.75pt"><B>XCEL BRANDS, INC.</B> <FONT STYLE="text-transform: uppercase"><B>&#8239;</B></FONT></TD>
<TD STYLE="padding-bottom: 1.75pt">&#8239;</TD>
<TD STYLE="padding-bottom: 1.75pt; font-size: 10pt">&#8239;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD COLSPAN="2" STYLE="padding-bottom: 1.75pt">&#8239;</TD>
<TD STYLE="padding-bottom: 1.75pt">&#8239;</TD>
<TD STYLE="padding-bottom: 1.75pt; font-size: 10pt">&#8239;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 45%">&#8239;</TD>
<TD STYLE="width: 2%">&#8239;</TD>
<TD STYLE="width: 48%; font-size: 10pt">&#8239;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
<TD>&#8239;</TD>
<TD>&#8239;</TD>
<TD STYLE="font-size: 10pt">&#8239;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
<TD>&#8239;</TD>
<TD>&#8239;</TD>
<TD STYLE="font-size: 10pt">&#8239;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">550 Seventh Avenue, 11<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">E-Mail:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Blank Rome LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1271 Avenue of the Americas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10020<BR>
E-mail: brad.shiffman@blankrome.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Brad L. Shiffman, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE
AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&#8239;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I></FONT>: _________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory:_________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Principal Place of Business:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Warrants to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded
Warrant Shares: ___________ Beneficial Ownership Blocker </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&#9744;</B></FONT>
4.99% or <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&#9744;</B></FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Warrant Shares: __________________ Beneficial Ownership Blocker </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&#9744;</B></FONT>
4.99% or <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&#9744;</B></FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Form of Common Warrant</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attached as Exhibit 4.2 to the Form 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 29; Options: NewSection; Value: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Form of Pre-Funded Warrant</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attached as Exhibit 4.1 to the Form 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Accredited Investor Questionnaire</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ACCREDITED INVESTOR QUESTIONNAIRE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Purchaser hereby represents
and warrants, pursuant to Section 3.2(c) of the attached Securities Purchase Agreement, that the Purchaser is an &ldquo;accredited investor&rdquo;
as defined in Regulation D under the Securities Act and is correctly and in all respects described by the category or categories selected
below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">A.</TD><TD STYLE="text-align: justify"><B>APPLICABLE TO INDIVIDUALS ONLY.</B> Please answer the following questions concerning your financial
condition as an &ldquo;accredited investor&rdquo; (within the meaning of Rule 501 of Regulation D). If the Purchaser is more than one
individual, each individual must initial an answer where the question indicates a &ldquo;yes&rdquo; or &ldquo;no&rdquo; response, indicating
to which individual it applies. The Purchaser must answer &ldquo;yes&rdquo; in response to question 1, 2 or 3 below to be considered an
 &ldquo;accredited investor.&rdquo; If the Purchaser is purchasing jointly with his or her spouse, one answer may be indicated for the
couple as a whole:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">Does your net worth*, or joint net worth with your spouse, exceed $1,000,000?</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%">&#8239;</TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif">Yes______</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif">No______</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">Did you have an individual income ** in excess of $200,000, or joint income together with your spouse
in excess of $300,000, in each of the two most recent years and do you reasonably expect to reach the same income level in the current
year?</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%">&#8239;</TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif">Yes______</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif">No______</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">Are you an executive officer or director of the issuer?</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%">&#8239;</TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif">Yes______</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif">No______</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">Do you hold in good standing one or more of the following professional certifications or designations
or credentials (check all that apply):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">_____</TD><TD STYLE="text-align: justify">Licensed General Securities Representative (Series 7);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">_____</TD><TD STYLE="text-align: justify">Licensed Investment Adviser Representative (Series 65); or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">_____</TD><TD STYLE="text-align: justify">Licensed Private Securities Offerings Representative (Series 82).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>*</B></FONT></TD><TD STYLE="text-align: justify">For purposes hereof net worth shall be deemed to include ALL of your assets, liquid or illiquid (including
such items as furnishings, automobile and restricted securities, but <U>excluding</U> your principal residence), MINUS any liabilities
(including such items as home mortgages and other debts and liabilities).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">**</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For purposes hereof the term &ldquo;income&rdquo;
is not limited to &ldquo;adjusted gross income&rdquo; as that term is defined for federal income tax purposes, but rather includes certain
items of income which are deducted in computing &ldquo;adjusted gross income.&rdquo; For investors who are salaried employees, the gross
salary of such investor, minus any significant expenses personally incurred by such investor in connection with earning the salary, plus
any income</FONT> from any other source including unearned income, is a fair measure of &ldquo;income&rdquo; for purposes hereof. For
investors who are self-employed, &ldquo;income&rdquo; is generally construed to mean total revenues received during the calendar year
minus significant expenses incurred in connection with earning such revenues.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&#8239;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">B.</TD><TD><B>APPLICABLE TO CORPORATIONS, PARTNERSHIPS AND OTHER ENTITIES ONLY:</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Purchaser is an accredited investor
because the Purchaser falls within at least one of the following categories (Check all appropriate lines):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a bank as defined in Section 3(a)(2) of the Securities Act or a savings and loan association or
other institution as defined in Section 3(a)(5)(A) of the Securities Act whether acting in its individual or fiduciary capacity;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a broker-dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as
amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;an insurance company as defined in Section 2(a)(13) of the Securities Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(iv)&#8239;&#8239;&#8239;&#8239;&#8239; an investment adviser registered pursuant to Section 203 of the
                                                                Investment Advisers Act of 1940 or registered pursuant to the laws of a state;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;an investment adviser relying on the exemption from registering with the Securities and Exchange
Commission under Section 203(l) or (m) of the Investment Advisers Act of 1940;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;an investment company registered under the Investment Company Act of 1940, as amended (the &ldquo;Investment
Company Act&rdquo;) or a business development company as defined in Section 2(a)(48) of the Investment Company Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;a Small Business Investment Company licensed by the U.S. Small Business Administration under
Section 301(c) or (d) of the Small Business Investment Act of 1958, as amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(viii)&#8239;&#8239;&#8239;&#8239;a Rural Business Investment Company as defined in Section 384A of the Consolidated Farm and
Rural Development Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(ix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a plan established and maintained by a state, its political subdivisions, or any agency or instrumentality
of a state or its political subdivisions, for the benefit of its employees, where such plan has total assets in excess of $5,000,000;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;an employee benefit plan within the meaning of Title I of the Employee Retirement Income Security
Act of 1974, as amended (&ldquo;ERISA&rdquo;), where the investment decision is made by a plan fiduciary, as defined in Section 3(21)
of ERISA, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or an employee benefit
plan that has total assets in excess of $5,000,000, or a self-directed plan the investment decisions of which are made solely by persons
that are accredited investors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(xi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;a private business development company, as defined in Section 202(a)(22) of the Investment Advisers
Act of 1940, as amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(xii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;an organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation,
a Massachusetts or similar business trust, a partnership or a limited liability company, not formed for the specific purpose of acquiring
the securities offered, with total assets in excess of $5,000,000;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(xiii)&#8239;&#8239;&#8239;&#8239;&#8239;a trust, with total assets in excess of $5,000,000, not formed for the specific purpose of
acquiring the securities offered, whose purchase is directed by a &ldquo;sophisticated&rdquo; person as described in Rule 506(b)(2)(ii)
under the Securities Act, who has such knowledge and experience in financial and business matters that he is capable of evaluating the
merits and risks of the prospective investment;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(xiv)&#8239;&#8239;&#8239;&#8239;an entity in which all of the equity investors are persons or entities described above (&ldquo;accredited
investors&rdquo;). <B>ALL EQUITY OWNERS MUST COMPLETE PART &ldquo;A&rdquo; ABOVE</B>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1in"><B>&#8239;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(xv)&#8239;&#8239;&#8239;&#8239;&#8239;an entity of a type not listed in clauses (i) through (xiv) above, that is not formed for the
specific purpose of acquiring the Units and owns investments in excess of $5 million. For purposes of this clause, &quot;investments&quot;
means investments as defined in Rule 2a51-1(b) under the Investment Company Act of 1940;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&#8239;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(xvi)&#8239;&#8239;&#8239;&#8239;a family office, as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940,
that (a) has assets under management in excess of $5 million; (b) is not formed for the specific purpose of acquiring the Units and (c)
has a person directing the prospective investment who has such knowledge and experience in financial and business matters so that the
family office is capable of evaluating the merits and risks of the prospective investment;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1in">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1in">______</TD><TD STYLE="text-align: justify">(xvii)&#8239;&#8239;&#8239;a family client, as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940, of a family office meeting
the requirements of clause (xvi) above and whose prospective investment in the Company is directed by that family office pursuant to clause
(xvi)(c) above.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&#8239;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 34; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&#8239;</P>














<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>tm2533803d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: right; text-indent: 0.5in"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>CONFIDENTIAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">December 17, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. James F. Haran</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">550 Seventh Ave, 11th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr. Haran,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This agreement (the &ldquo;<U>Agreement</U>&rdquo;)
constitutes the agreement between Xcel Brands, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and Wellington Shields
 &amp; Co. LLC (&ldquo;<U>WS</U>&rdquo; or the &ldquo;<U>Lead Manager</U>&rdquo;), that WS shall serve as the exclusive lead placement
agent for the Company, on a &ldquo;reasonable best efforts&rdquo; basis (a &ldquo;<U>Placement</U>&rdquo;), in connection with the proposed
offerings of securities (the &ldquo;<U>Securities</U>&rdquo;) of the Company. The terms of such Placement and the Securities shall be
mutually agreed upon by the Company and the Lead Manager and, if a direct placement, the purchasers (each, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively, the &ldquo;<U>Purchasers</U>&rdquo;) and nothing herein grants WS the power or authority to bind the Company or any
Purchaser or creates an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the documents
executed and delivered by the Company and the Purchasers in connection with the Placement shall be collectively referred to herein as
the &ldquo;<U>Transaction Documents</U>.&rdquo; The date of the closing of the Placement shall be referred to herein as the &ldquo;<U>Closing
Date</U>.&rdquo; The Company expressly acknowledges and agrees that WS&rsquo;s obligations hereunder are on a reasonable best efforts
basis only and that the execution of this Agreement does not constitute a commitment by WS to purchase the Securities and does not ensure
the successful placement of the Securities or any portion thereof or the success of WS with respect to securing any other financing on
behalf of the Company. WS may retain other brokers or dealers to act as sub-agents or selected-dealers on its behalf in connection with
the Placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
sale of Securities to any Purchaser will be evidenced by a purchase agreement (&ldquo;<U>Purchase Agreement</U>&rdquo;) between the Company
and such Purchaser, if required by the Purchaser, in a form reasonably satisfactory to the Company and </FONT>WS. Prior to the signing
of any Purchase Agreement, officers of the Company with responsibility for financial affairs will be reasonably available to answer inquiries
from prospective Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notwithstanding
anything herein to the contrary, in the event that </FONT>WS determines that any of the terms provided for hereunder shall not comply
with a FINRA rule, including, but not limited to, FINRA Rule 5110, then the Company shall agree to amend this Agreement in writing upon
the request of WS to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable
to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
1.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Compensation and other Fees.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">As compensation for the services
provided by WS hereunder, the Company agrees to pay to WS the fees set forth below with respect to the Placement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt"></TD><TD STYLE="width: 27pt">i)</TD><TD STYLE="text-align: justify">A cash fee (&ldquo;<U>Cash Fee</U>&rdquo;) payable immediately upon the closing of the Placement: (i) equal to 8.0% of the gross proceeds
to us from the sale of the Securities in the offering with respect to gross proceeds of the offering up to $5,000,000, (ii) equal to 7.0%
of the gross proceeds to us from the sale of the Securities in the offering with respect to gross proceeds of the offering in excess of
$5,000,000 but less than $10,000,000, (iii) equal to six percent (6.0%) of the gross proceeds to us from the sale of the Securities in
the offering with respect to gross proceeds of the offering equal to or greater than $10,000,000. Notwithstanding the foregoing, the Cash
Fee with respect to certain investors identified by the Company as listed on <U>Schedule I</U> attached hereto (the &ldquo;<U>Company
Identified Investors</U>&rdquo;), any member of management or a director of the Company (&ldquo;<U>Insiders</U>&rdquo;), or Hilco Global
or UTG Capital, Inc (&ldquo;<U>UTG</U>&rdquo;) shall be five percent (5.0%).</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt"></TD><TD STYLE="width: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)</FONT></TD><TD STYLE="text-align: justify">Subject to compliance with FINRA Rule 5110(f)(2)(D), the Company also agrees, in case of a Closing of
the Placement, to reimburse the Lead Manager for all reasonable and documented out-of-pocket expenses incurred, including the reasonable
fees, costs and disbursements of its legal counsel, in an amount not to exceed an aggregate of $50,000; <U>provided</U>, however, that
if the Placement is terminated, then such reimbursement shall not exceed an aggregate of $35,000. The Company will reimburse Lead Manager
directly upon the Closing of the Placement from the gross proceeds raised in the Placement.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Xcel Brands, Inc.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">December 17, 2025</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Page 2</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 54pt"></TD><TD STYLE="width: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)</FONT></TD><TD STYLE="text-align: justify">Warrants (&ldquo;<U>Placement Agent Warrants</U>&rdquo;) to purchase: (i) 4.0% of the aggregate number
of shares of common stock and/or Pre-Funded Warrants sold in this offering with respect to gross proceeds of the offering up to $5,000,000;
(ii) 3.0% of the aggregate number of shares of common stock and/or Pre-Funded Warrants sold in this offering with respect to gross proceeds
of the offering in excess of $5,000,000 but less than $10,000,000 and (iii) 0% with respect to gross proceeds equal to or in excess of
$10,000,000. Such placement agent warrants will be non-exercisable for six (6) months after the Closing Date and will expire five years
after the commencement of sales of the offering. Notwithstanding the foregoing, the number of Placement Agent Warrants issued with respect
to Company Identified Investors shall be two and one-half percent (2.5%), and no Placement Agent Warrants shall be issued in respect to
any participation from Insiders of the Company and UTG.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
2.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>RESERVED.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
3.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>REPRESENTATIONS AND WARRANTIES</U>. The Company makes to WS all of the representations and warranties which the Company
makes to the Purchasers in the Purchase Agreement, and in addition makes the following representation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>FINRA
Affiliations</U></FONT>. There are no affiliations with any FINRA member firm among the Company&rsquo;s officers, directors or, to the
knowledge of the Company, any five percent (5%) or greater stockholder of the Company, except as set forth in the Company&rsquo;s public
filings under the Securities Exchange Act of 1934, as amended, with the Securities and Exchange Commission (the &ldquo;<U>SEC Filings</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
4.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>REPRESENTATIONS OF WS</U>. WS represents and warrants that it is (i) a member in good standing of FINRA, (ii) registered
as a broker/dealer under the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;), and (iii) licensed as a broker/dealer under
the laws of the States applicable to the offers and sales of Securities by WS. WS will immediately notify the Company in writing of any
change in its status as such. WS covenants that it will use its reasonable best efforts to conduct the Transaction hereunder in compliance
with the provisions of this Agreement and the requirements of applicable law. Except as required by law or as contemplated by this agreement,
WS will keep confidential all material nonpublic information, including information regarding the Transaction contemplated hereunder,
provided to it by the Company or its affiliates or advisors and use such information only for the purposes contemplated herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
5.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>INDEMNIFICATION</U>. The Company agrees to the indemnification and other agreements set forth in the Indemnification
Provisions (the &ldquo;<U>Indemnification</U>&rdquo;) attached hereto as Addendum A, the provisions of which are incorporated herein by
reference and shall survive the termination or expiration of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
6.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>ENGAGEMENT TERM</U>. WS&rsquo;s engagement hereunder shall become effective on the date hereof and shall continue
until the earlier of December 31, 2025 and the Closing Date (such date, the &ldquo;Termination Date&rdquo;). Notwithstanding anything
to the contrary contained herein, the provisions concerning confidentiality, indemnification, contribution and the Company&rsquo;s obligations
to pay fees and reimburse expenses earned or due prior to the termination of the Agreement contained herein and the Company&rsquo;s obligations
contained in the Indemnification Provisions will survive any expiration or termination of this Agreement. WS agrees not to use any confidential
information concerning the Company provided to WS by the Company for any purposes other than those contemplated under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
7.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>TAIL FEE</U>. Upon a Closing, or if the Engagement Period ends prior to Closing (other than a termination for &ldquo;Cause&rdquo;),
then if within twelve (12) months following such time, the Company completes any financing of equity, equity-linked, convertible or debt
or other capital raising activity with, or receives any proceeds from, any of the investors contacted or introduced by WS during the Engagement
Period (the &ldquo;Tail List&rdquo;), then the Company will pay WS upon the closing of such financing or receipt of such proceeds the
compensation equivalent to that set forth in Section 1 herein. Upon written request from the Company following the Closing of an Offering
or termination of the Engagement Period, WS will provide the Tail List to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Xcel Brands, Inc.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">December 17, 2025</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Page 3</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
8.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>LEAD MANAGER INFORMATION.</U> The Company agrees that any information or advice rendered by WS in connection with
this engagement is for the confidential use of the Company only in their evaluation of the Placement and, except as otherwise required
by law, the Company will not disclose or otherwise refer to the advice or information in any manner without WS&rsquo;s prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
9.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>NO FIDUCIARY RELATIONSHIP.</U> This Agreement does not create, and shall not be construed as creating, rights enforceable
by any person or entity not a party hereto, except those entitled hereto by virtue of the Indemnification Provisions hereof. The Company
acknowledges and agrees that WS is and shall not be construed to be a fiduciary of the Company and shall have no duties or liabilities
to the equity holders or the creditors of the Company or any other person by virtue of this Agreement or the retention of WS hereunder,
all of which are hereby expressly waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
10.</U></FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>CLOSING.</U> The obligations of WS and the closing of the sale
of the Securities hereunder are subject to the accuracy, when made and on the Closing Date, of the representations and warranties on
the part of the Company and its Subsidiaries contained herein, to the accuracy of the statements of the Company and its Subsidiaries
made in any certificates pursuant to the provisions hereof, to the performance by the Company and its Subsidiaries of their obligations
hereunder, and to each of the following additional terms and conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">(A)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;All
corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement,
the Securities, and all other legal matters relating to this Agreement and the transactions contemplated hereby shall be reasonably satisfactory
in all material respects to WS, and the Company shall have furnished to such counsel all documents and information that they may reasonably
request to enable them to pass upon such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">(B)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;WS
shall have received from outside counsel to the Company such counsel&rsquo;s written opinion, addressed to WS and dated as of the Closing
Date, in form and substance reasonably satisfactory to WS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">(C)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
the Company nor any of its Subsidiaries (i) shall have sustained since the date of the latest audited financial statements of the Company
included in the SEC Filings, any loss or interference with its business from fire, explosion, flood, terrorist act or other calamity,
whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set
forth in or contemplated by the SEC Filings, and (ii) since such date there shall not have been any change in the capital stock or long-term
debt of the Company or any of its subsidiaries or any change, or any development involving a prospective change, in or affecting the business,
general affairs, management, financial position, stockholders&rsquo; equity, results of operations or prospects of the Company and its
subsidiaries, otherwise than as set forth in or contemplated by the SEC Filings, the effect of which, in any such case described in clause
(i) or (ii), is, in the judgment of WS, so material and adverse as to make it impracticable or inadvisable to proceed with the sale or
delivery of the Securities on the terms and in the manner contemplated by the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">(D)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
common stock of the Company is registered under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">(E)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect
or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other
nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance
or sale of the Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">(F)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall have prepared and filed with the Commission a Current Report on Form 8-K with respect to the Placement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">(G)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall have entered into Purchase Agreements with each of the Purchasers and such agreements shall be in full force and effect
and shall contain representations and warranties of the Company as agreed between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">(H)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Prior
to the Closing Date, the Company shall have furnished to WS such further information, certificates and documents as WS may reasonably
request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Xcel Brands, Inc.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">December 17, 2025</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Page 4</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
11</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>GOVERNING LAW.</U> This Agreement will be governed by, and construed in accordance with, the laws of the State of
New York applicable to agreements made and to be performed entirely in such State. This Agreement may not be assigned by either party
without the prior written consent of the other party. This Agreement shall be binding upon and inure to the benefit of the parties hereto,
and their respective successors and permitted assigns. Any right to trial by jury with respect to any dispute arising under this Agreement
or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement may be brought into the courts
of the State of New York or into the Federal Court located in New York, New York and, by execution and delivery of this Agreement, the
Company hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid courts.
Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such suit, action
or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the address in effect for
notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. If either party
shall commence an action or proceeding to enforce any provisions of a Transaction Document, then the prevailing party in such action or
proceeding shall be reimbursed by the other party for its attorney&rsquo;s fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
12</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>ENTIRE AGREEMENT/MISCELLANEOUS</U>. This Agreement (including the attached
Indemnification Provisions) embodies the entire agreement and understanding between the parties hereto and supersedes all prior agreements
and understandings relating to the subject matter hereof. If any provision of this Agreement is determined to be invalid or unenforceable
in any respect, such determination will not affect such provision in any other respect or any other provision of this Agreement, which
will remain in full force and effect. This Agreement may not be amended or otherwise modified or waived except by an instrument in writing
signed by WS and the Company. The representations, warranties, agreements and covenants contained herein shall survive the closing of
the Placement and delivery and/or exercise of the Securities, as applicable. This Agreement may be executed in two or more counterparts,
all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been
signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the
event that any signature is delivered by facsimile transmission or a &ldquo;.pdf&rdquo; format file, such signature shall create a valid
and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such
facsimile signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
13</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>CONFIDENTIALITY</U>. WS (i) will keep the Confidential Information (as such term is defined below) confidential and
will not (except as required by applicable law or stock exchange requirement, regulation or legal process), without the Company&rsquo;s
prior written consent, disclose to any person any Confidential Information, and (ii) will not use any Confidential Information other than
in connection with its evaluation of the Transaction. WS further agrees to disclose the Confidential Information only to its Representatives
who need to know the Confidential Information for the purpose of evaluating the Transaction, and who are informed by WS of the confidential
nature of the Confidential Information. The term &ldquo;<U>Confidential Information</U>&rdquo; shall mean, all confidential, proprietary
and non-public information (whether written, oral or electronic communications) furnished by the Company to WS or its Representatives
in connection with WS&rsquo;s evaluation of the Transaction. The term &ldquo;<U>Confidential Information</U>&rdquo; will not, however,
include information which (i) is or becomes publicly available other than as a result of a disclosure by WS or its Representatives in
violation of this Agreement, (ii) is or becomes available to WS or any of its Representatives on a nonconfidential basis from a third-party,
(iii) is known to WS or any of its Representatives prior to disclosure by the Company or any of its Representatives, (iv) is or has been
independently developed by WS and/or the Representatives without use of any Confidential Information furnished to it by the Company, or
(v) is required to be disclosed pursuant to applicable legal or regulatory authority.. The term &ldquo;Representatives&rdquo; shall mean
a party's directors, board committees, officers, employees, financial advisors, attorneys and accountants. This provision shall be in
full force until the earlier of (a) the date that the Confidential Information ceases to be confidential and (b) two years from the date
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>SECTION
14</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>NOTICES.</U> Any and all notices or other communications or deliveries
required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the
date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified on the signature pages
attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b) the next business day after the date of transmission,
if such notice or communication is delivered via facsimile at the facsimile number on the signature pages attached hereto on a day that
is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the business day following the date of mailing,
if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>[Signature page follows]</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Xcel Brands, Inc.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">December 17, 2025</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Page 5</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are excited about this equity offering and look forward to working
with you. Please confirm that the foregoing correctly sets forth our agreement by signing and returning the enclosed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Very truly yours,</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase">WELLINGTON sHIELDS &amp; CO. LLC</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Stephen Portas</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name: Stephen Portas</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title: Chief Compliance Officer</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><U>Address for notice:</U></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">60 Broad Street, 39<SUP>th</SUP> Floor</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">New York, NY 10004</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Attention: Steve Portas</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accepted and Agreed to as of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the date first written above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>XCEL BRANDS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="width: 3%; font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid; width: 47%">/s/ James Haran</TD>
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name: James Haran</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title: Chief Financial Officer</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Address for notice:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">550 Seventh Ave, 11th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Xcel Brands, Inc.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">December 17, 2025</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Page 6</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ADDENDUM</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>INDEMNIFICATION PROVISIONS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with the engagement of Wellington
Shields &amp; Co. LLC (&ldquo;<U>WS</U>&rdquo;) by Xcel Brands, Inc. (the &ldquo;<U>Company</U>&rdquo;) pursuant to this Agreement, the
Company hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">To the extent permitted by law, the Company will indemnify WS and each of its affiliates, directors, officers,
employees and controlling persons (within the meaning of Section 15 of the Securities Act of 1933, as amended, or Section 20 of the Securities
Exchange Act of 1934, as amended) against all losses, claims, damages, expenses and liabilities, as the same are incurred (including the
reasonable fees and expenses of counsel), relating to or arising out of its activities hereunder or pursuant to the Agreement, except,
with regard to WS, to the extent that any losses, claims, damages, expenses or liabilities (or actions in respect thereof) are found in
a final judgment (not subject to appeal) by a court of law to have resulted primarily and directly from WS&rsquo;s willful misconduct,
gross negligence, bad faith or intentional misconduct in performing the services described herein, as the case may be.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promptly after receipt by WS
of notice of any claim or the commencement of any action or proceeding with respect to which WS is entitled to indemnity hereunder, WS
will notify the Company in writing of such claim or of the commencement of such action or proceeding, and the Company will assume the
defense of such action or proceeding and will employ counsel reasonably satisfactory to WS and will pay the fees and expenses of such
counsel. Notwithstanding the preceding sentence, WS will be entitled to employ counsel separate from counsel for the Company and from
any other party in such action if counsel for WS reasonably determines that it would be inappropriate under the applicable rules of professional
responsibility for the same counsel to represent both the Company and WS. In such event, the reasonable fees and disbursements of no more
than one such separate counsel for all indemnified parties will be paid by the Company. The Company will have the exclusive right to settle
the claim or proceeding provided that the Company will not settle any such claim, action or proceeding without the prior written consent
of WS, which will not be unreasonably withheld, </FONT>unless such settlement (x) includes an unconditional release of <FONT STYLE="font-size: 10pt">WS</FONT>
from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement as to or any admission
of fault, culpability or a failure to act by or on behalf of <FONT STYLE="font-size: 10pt">WS.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">The Company agrees to notify WS promptly of the assertion against it or any other person of any claim
or the commencement of any action or proceeding relating to a transaction contemplated by the Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: justify">If for any reason the foregoing indemnity is unavailable to WS or insufficient to hold WS harmless, then
the Company shall contribute to the amount paid or payable by WS, as the case may be, as a result of such losses, claims, damages or liabilities
in such proportion as is appropriate to reflect not only the relative benefits received by the Company on the one hand, and WS on the
other, but also the relative fault of the Company on the one hand and WS on the other that resulted in such losses, claims, damages or
liabilities, as well as any relevant equitable considerations. The amounts paid or payable by a party in respect of losses, claims, damages
and liabilities referred to above shall be deemed to include any legal or other fees and expenses incurred in defending any litigation,
proceeding or other action or claim. Notwithstanding the provisions hereof, WS&rsquo;s share of the liability hereunder shall not be in
excess of the amount of fees actually received, or to be received, by WS under the Agreement (excluding any amounts received as reimbursement
of expenses incurred by WS).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Xcel Brands, Inc.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">December 17, 2025</P>

<P STYLE="margin-top: 0; margin-bottom: 0">Page 7</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">5.</TD><TD STYLE="text-align: justify">These Indemnification Provisions shall remain in full force and effect whether or not the transaction
contemplated by the Agreement is completed and shall survive the termination of the Agreement, and shall be in addition to any liability
that the Company might otherwise have to any indemnified party under the Agreement or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Very truly yours,</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-transform: uppercase">WELLINGTON sHIELDS &amp; CO. LLC</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Stephen Portas</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name: Stephen Portas</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title: Chief Compliance Officer</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><U>Address for notice:</U></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">60 Broad Street, 39<SUP>th</SUP> Floor</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">New York, NY 10004</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Attention: Steve Portas</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accepted and Agreed to as of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the date first written above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>XCEL BRANDS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; width: 47%">/s/ James Haran</TD>
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name: James Haran</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title: Chief Financial Officer</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Address for notice:</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Xcel Brands, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">550 Seventh Ave, 11th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Company Identified Investors</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>tm2533803d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><FONT STYLE="font-size: 10pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B>Xcel Brands Announces
$2.05 Million Private Placement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>NEW YORK / GLOBE
NEWSWIRE / December&nbsp;17, 2025</B> / Xcel Brands,&nbsp;Inc.&nbsp;(NASDAQ: XELB) (&ldquo;Xcel&rdquo; or the &ldquo;Company&rdquo;),
announces today that it has entered into a securities purchase agreement for a private investment in public equity (&ldquo;PIPE&rdquo;)
financing that is expected to result in gross proceeds to the Company of approximately&nbsp;$2.05 million, before deducting placement
agent fees and offering expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">The Company intends
to use the net proceeds from the offering for general corporate purposes and working capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Pursuant to the
terms of the securities purchase agreement, the Company is selling an aggregate of 1,670,055 shares of common stock (or pre-funded warrants
in lieu thereof) and common stock purchase warrants to purchase up to 835,023 shares of common stock at a purchase price of&nbsp;$1.2275&nbsp;per
share (or pre-funded warrants in lieu thereof) and one-half common stock purchase warrant, subject to certain beneficial ownership limitations
set by each holder. The warrants issued in the offering are exercisable at an exercise price of&nbsp;$3.00&nbsp;per share, subject to
adjustment as provided therein, and will expire five years from the date of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Wellington Shields&nbsp;&amp;
Co. LLC acted as the sole placement agent for the PIPE financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">The unregistered
shares of common stock, pre-funded warrants and warrants sold in the PIPE financing described above were offered under Section&nbsp;4(a)(2)&nbsp;of
the Securities Act of 1933, as amended (the &ldquo;Act&rdquo;) and Regulation D promulgated thereunder and, along with the shares of
common stock underlying the pre-funded warrants and warrants, have not been registered under the Act or applicable state securities laws.
Accordingly, the shares of common stock, the pre-funded warrants, the warrants and the shares of common stock underlying the pre-funded
warrants and warrants may not be offered or sold in&nbsp;the United States&nbsp;absent registration with the Securities and Exchange
Commission (&ldquo;SEC&rdquo;) or an applicable exemption from such registration requirements. The securities were offered only to accredited
investors. Pursuant to the terms of the securities purchase agreement with the investors, the Company has agreed to file one or more
registration statements with the SEC covering the resale of the unregistered shares of common stock and the shares issuable upon exercise
of the unregistered pre-funded warrants and warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">This press release
shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>About Xcel Brands</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Xcel Brands,&nbsp;Inc.
(NASDAQ: XELB) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce
sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic
consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as social commerce.
Xcel owns the Halston, Judith Ripka, and C. Wonder brands, as well as the co-branded collaboration brands TowerHill by Christie Brinkley,
Trust. Respect. Love by Cesar Millan, and GemmaMade by Gemma Stafford, and also holds noncontrolling interests or long-term license agreements
in Orme Live, and Mesa Mia Live by Jenny Martinez. Xcel also owns and manages the Longaberger brand through its controlling interest
in Longaberger Licensing, LLC. Xcel is pioneering a modern consumer products sales strategy which includes the promotion and sale of
products under its brands through interactive television, digital live-stream shopping, social commerce, brick-and-mortar retailers,
and e-commerce channels to be everywhere its customers shop. The company&rsquo;s previously owned and current brands have generated in
excess of $5 billion in retail sales via livestreaming in interactive television and digital channels alone, and over 20,000 hours of
content production time in live-stream and social commerce. The brand portfolio reaches in excess of 46 million social media followers
with broadcast reach into 200 million households. Headquartered in New York City, Xcel Brands is led by an executive team with significant
live streaming, production, merchandising, design, marketing, retailing, and licensing experience, and a proven track record of success
in elevating branded consumer products companies. For more information, visit <U>www.xcelbrands.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>For further information please contact:</B><BR>
Seth Burroughs<BR>
Xcel Brands,&nbsp;Inc.<BR>
<U>sburroughs@xcelbrands.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>xelb-20251217.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaOF+bOdzZR+6YkxtmB4bQkqHyMnfpIr1yWoTgzGoR8A -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:xelb="http://xcelbrands.com/20251217" elementFormDefault="qualified" targetNamespace="http://xcelbrands.com/20251217">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://xcelbrands.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="xelb-20251217_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="xelb-20251217_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>xelb-20251217_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>xelb-20251217_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="xelb-20251217.xsd#Cover" roleURI="http://xcelbrands.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xcelbrands.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 17, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 17,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">XCEL BRANDS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001083220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">76-0307819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">550 Seventh Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">11th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">727-2474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XELB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2533803d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xcelbrands.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2533803d1_8k.htm">tm2533803d1_8k.htm</File>
    <File>xelb-20251217.xsd</File>
    <File>xelb-20251217_lab.xml</File>
    <File>xelb-20251217_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2533803d1_8k.htm": {
   "nsprefix": "xelb",
   "nsuri": "http://xcelbrands.com/20251217",
   "dts": {
    "inline": {
     "local": [
      "tm2533803d1_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "xelb-20251217.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "xelb-20251217_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xelb-20251217_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://xcelbrands.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-12-17",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2533803d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-12-17",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2533803d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xcelbrands.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001104659-25-122806-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-122806-xbrl.zip
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M^,?_$3S6SA9)DG1U-X<@Y6L8]&\N8G]W^U 1E7#LE?5UR+_0+XKAK\,^EBI
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M3:Y-MI"BOYPSF;H FZ<@*_DG-RK T\D=-&!QXVVK-B]''DEEHG:"IT>OWZI
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M4NN42D)T2I6_^3'7C6QW(J9I%YG0R\'^@F%W6%RKX/=Q$@E7>.,*7T2D[#[
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MNT39 )8U@JPD_=+E#ZB=[)Z. DRU)5$*77DF&4@$%B<X..PX--;,BXYR)-,
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MM8\E^%C"5_M8PA]SI\]*3BIQ4D95Q#L9?YR8S*2.RO7!BCK+I.">G@EW%[.
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MIF'Z!@=U>R%KG".1(T4&X%ZJUV#O8BO" -CK4V $P"M3O:)DKNFJ2FW[H&J
M$*%@ &8%@(Y9UNU@)S]W$T%)(E%3PYD[\>D=@O*)5K%/^5)PU!Y3IDBWVB!(
M9EN)D[/)KPKH_;@[SY;/(V+2RV*N>ZM=7.9+!,>0?ZK)N_K 9X#XI+0P-Y87
M'UW&,TFCB;J4P5:C?4 8:@Y\M#H,H6#R/D3-6Z.Q4+5//!?M-1Y$3"%*^]R(
M(10%MCAHII4>RYOJE]U0BD>'[4_>=.*.'F]HH^#:'R*@/!BM+X[H7:D\HMR1
M92#Q0;OBQ9(TMLQMDB ': ZJ[S#OOA=<;J2I3]9=&>R8+[.8*@B?]&4#<I7L
M),%]M5MB?!:O:LZJ7-&1LULEE3CY]:AK0E$QO"GJ.25!,7_1DGL;I3OU:J]N
M:J+35^;H2GP7.9-XHKM]6QE5,\>-R6R S);M4+E^MU%"UON<Y2"'/JQ =/R3
M0\"I6/9:E_N-E*VV^E5,;Z&6R%&<31,_&-2\"QT'0FK*QH:?3VR9"4F'1F.V
M,/:A:%5V#S5@CBM7>VHPT_[UT+BFD[&!V8H07$<.OX_JV65M''847F-2_[L!
M&A1W=*,9X^LU[(+GF%M(-8CAVGV#,Z8=,C4-(CY&W&E<K)A@5;):=&H*V#0G
MP^@H4P)SP+<0!P/NLIGJN* :EZC.& =Z!T;=WGM_TXM\QARBWXEKXLS@SX8O
MT4+8B7K#&$IY,Y29?8^O+5\J#+\H/%N:=;BXT/E1$DDG,T/8;.@U"+_%$/^"
M>05M/<):B)N@RJ_;3;;!E5YG%]F_"U:%-6:&(8B,D*%-G2T71(])*0MYF2N5
M/#(+9\NB9L(&.EL"_Z7T;:S8W8R"//LA,75)JV<HA/_YSX.I^>P5/V;4>LY%
M'0*8,\NEYR;IUP7U#2#4A:J=7G-CQ4QQLD5"R=%T!1RRMO9!Q(-04V5!%$?.
MG13$*4Q!;K-'AI&C/M)*=[GGLY("C+9V,!&OPC'FST4.CE<?[)-74C(V"#1F
M#-< N&-@C.9E5<"(?''YC!%Y< SS+IE=PSL[0<C6L+$/.)-] /T<%*IU]U@,
MRV[SCNL(4)$^TC$59X_\//2X)?P976B&['@T@<"UBS4)A0[)8I5V1F!ABBZ0
MHJC)ZX@$&9]RE65[U%U93-E-?*YKD(;%/=8<EVA-.^7I*K]$89A<"Q"IQ?Q;
M8KJ%D:] :M2B<!)C*?XC?$0U]1&1G7'*K][V_49A?I@:0\-O/?3Z@*;7!A5$
MQGI*-@,'YF[M* *:L*?*VQ.H-[Y:(RCV5[G H>JJW$FAQ"'%0]Y):\*3(-,_
MVFWQ9=/01@8>T+Q%MY+Q_X94VR%FO0Y.0"M\*SV^=CI)XU=QSZ=S"\<LA5VE
M5%/JPANMAZ"D#*\P. 31<5J3P=ZF2K"/C]G2LP,RU+ ^T $)9;>R+%@T),]\
M+3"-OM97M $G<,R#0R"L7.M-&O$ \VI^=G#KD=:J(-E572Q5R5S6VSE="D2H
MSA3W/#HA3^==&;#'1ONX=A6>=ZGH&52M)/&\C6W:V\Q8W*T3;O)YW31$AB7Y
MJ.28(]<TF9P$#HD)N54+BNM<TZ")7?NSUSLN.5F[J=\KG)3"T4S@@%KC>[RQ
MC3Q @ ]^),DD9 9@P9N%^CNR7A6-)-89?%PL*+46A/)@?;DPN(:9$9,H19XH
M-DA=LQQ4*QR:_V0EM!/NXL4['VPGV8[:R15RYH\F2J-R[*H[]>[SGMGDV9P5
M&,N418X^7 %N13Z2_&(%H>7Q##GD!^!YX0]1%_%($S5&I'@A,JGJ51#@U(:L
MS1O4B[ZX_\Q/TYW"<G_?A^5,6.[OGW=8[H^YSV?,AGKBR^),)T?D^1M*2 AJ
M%4CMIAM*LWB!K79/:]P2G!T[5GW1<8[=*M;&"Q09/:9ES3"EDK&<1ZO7(#LZ
M_RQX @O-N-$UW3=16JL/ZH+:NO*^H@;1M6$R(&9G"R44:FUCBC[">#G.XTLQ
MQ5EXO<Z8'!99S*AO?K/91-@!V\NTM#.&&+3CAW>8S+*,,6A]Y_0MO?$;?1">
M'AR%I?D4 6L-_V5<)E2KQ^/0@VTO#O_^61/K1#Q'PR6MAHO<?[P=,9WH\?]M
M[8CI1(AM?E]VQ&\B"%@+@&OQV;='I^<GSU\=)R?_@#$]^_97?N&;\^^/3Y.C
M[TZ/CW\X?GU^EKQYF<!'R5OLQO'9K_SV7VE2H^2^QR EL% [;IX5)E'F",+F
M770_P1OS5^[ [R-S/3N0?MS]/^<1V(0B7X0I\9Y-#-&1/VQ.\/8-,>52#-XR
MEK ?VE6-ET+RUF6,^2"#(3?B!Y:U(VA2I"X,=<I<+*%_7 0,9XY@$5E)=W/5
M7%'<*,XX)F!T!90-257L>%4/F"G(KESK&C6'7JXX@#>@&V7)1FKE1H+?7'NP
MH6?S@Y3-4NT;KH/0N/@K!*:,+P)"G*,'D6.<O531RE6]I0YOJS;'U2D9(RNV
MJFF2R5E\/?H%@E0Y'R9L.M6;B?.,L/I\I_<1&_;Z8I=I:MIUL(NZV26]AL5M
MSE>&CQOXS;*L\U:HO'EB@C57C[ ^C]>VE+>"$0K67C\9A9O_N7*F/TZTS#]2
MM-A$=52+'')CC9D['6DR;2W5$(GS1HLZ.Y^+.1,IGT4P&7+.J3#L!S?+"_)E
MRM;LB"!8=BUF3TLL:/V)TYS_D"O]^OB$%(;S[T_.$''V[O3D_)_3R>LWIZ0U
MR">@."0GK\_?)#]^?_+\^_#A!/Y]_'^.3Y^?G!T] S7G^Z-_'"?/CH]?)Z?'
MWYV<G1^?'K](?H2WQ T>O7X!/WS^_='K[XZ3YV]^^.'D[.SDS>ND]VH0B>;;
ME_##?\)4'9V#2H4O>75R]/KY<?+N+7Q[]!K[\L-;K+F2O#Q]\X-TXO2(/GGW
M^L5Q;V!'S\^QU<.O'CU*DR/X&_2F%]#G&3XGV0"V,_"\H[G 0<#_/7_^YO3%
MR>OO7OTS37XX^F?R^LTY3 &T^I)&#R,Z>_.*1GO\]CQY^^[T[-W1Z_,$)A0[
M#$\]/S^!60OZ2B-$%6ZPU]0-;#AJ[.@?1R>O:!W">4CQ69BNHP3:?WT&/\9O
ML)]G[Y[]/_!^^'U*[P@Z<7K\/^].3D--,IPZZ BL([9,DT!+0:M]]/;MJY/G
MU!5>+/.[5T<_(D]PL(VPF7C+G<'0L %:6]EDQ]P/^U.8\ND$YOOMJ^,7WQU3
M;YZ_>?WZF ?)O4F>O7E]E+P\>7$,CY]^)QU^!Q,GWYO=^NSTS?\^/KWWXOCH
M%4P\3!PKU:_>'+G67IZ\AJ&>'+V"EYV=GYR_HU>=?W\$$W*">UMW#KP%FCPY
MIV[]X_CL_,VI)D/!7GMQ# UQCT_?P4 Y;>N&?1KTA;[$_L)Y> ?GTC_\*UYB
MOT<I-N9M$02:<;=8S0X5+$86$$RAYO^*MA9HF6#C5@C96N;266Z3]$%1\E@1
MX: M!5+N+7.P=KF8 %?:S#PMO!:Q1"6PK=<<5RG+@<N-7N_!8B:WSD,"/BQ'
MD.Y&DR0XGN-'4/1BY>]H_Z2+B#*>U*?6]L*W.,NJD,GD+KDT,KP+>Q,.EER)
M])1X"OBQ1 KC"NC>*=5UXQOWA5[F>9"\A%4.KK(R!K$(9R!Y),$.\>HR1Z]5
M:=:L NY4&O2(RQ+A-W5C]5V9K] <(/4$M\O]Y"47G<40L"#7^-=4?\/]7*>7
M7^TR5WW5AJ%$/8'>AN1U%/,3WY:ENN#V#817W6)*$="ZJ<[CU2!5S"P>VRM.
MTQ<&[QM-(KMZO:UO<0BP9_NHTR98Y< 2L*?7*)1/7 S?1/8DT8)P,.JE1%N0
M4>KLA)0%47PV5O&EXC<L @R5T^.'CT%YGMV2.2N@"$_RX+@)!B3 D=G%O.IH
MGY''E^S%$FN/XU;A6N-![5RC$O^)KH2/82S^8A\D-$'"+_9!PM^]4C-;?+@1
M?L;RT/ELFAR14TL5KP5!Q$!WR3:7J=C5;0Q]$G-[,#[#CBJ!,V(U=*GC@#!K
MI'='5Q2#0$,AADBX'5^-Z_HJ7S*Y@3?'":8I'*41A4:DB8TX^:(QG-JGSO2I
M XRL7>4.NNIKR7)A1=7.5+'RKD6\$[8MB>IQS@!*(KK3F*83.RCOG:RUFFPA
M/Y&U* *GE^IAEF!Y@.XY9G#T,_03_ >U2=0$00S!Y6?X\? N\@4-V;OB/88P
MXRL;(Q;\S\']Y-U& HKU@DO-^#*_\C@50&O#C275::<3W _**2&!( Q%,8,S
MA:J1*2C$]7)PB^H1(VQ(%39$_6&GV76$>I^H=IR.(N$^WM!EWG6Y ^R>.T<C
MIW-(S,V0+8"YL$%8$^.25,>)H3^AUFS)OE#347+AVGLZY6!X'947W@".4Y]C
MAAM )YOQQI(%JF,$K4AQ63U0DM#F* XMIOY:2:D_(ITQ1UMJH 6A0YZ[-N0A
ML,:6/POLED7S2M.%[<XF?Z!,9V!GA.[ V1)93'IJK5]^7PXLZ66EM50+%-^5
M=39$S7_"N&D#5GDR.SS I5HR">-.D^HXIZ[:(DD'L02;9Y@1M"E\"HL4UX+>
M=YTHB6\9)S\S9"WS'*;'B@S\K2.A0U8J"P ?2LJB;IA=Q0Y3LW A*MXJU\2W
M(5AS%LZIGG5GTDI8[<I="F%"."5_ZG8!V6I>.[9;/)0_V)+!!\Z4&=RDR<P1
M53)5G,O_].FF8+B@<4"Q!N9IO71\N:]X)*=RWI!GT[OSU"RB=,=M*[G<!@40
M"0J9]6&APBS!$93<G'.Y?^\@+,(CAJM%Z _.HZ0_) !229(^DM*1^7S!2?"N
M;ZU3#:(AT('-JQ+4EEPO1Q=4):R(/A_([^B,)L^M.H!!,7,+&6--Q9O.A@_T
M.2.:WK?&3)"12>F1X^)C[/_0LV3@FL,[# [M&@X1;S2/97J1;^JVH!C5>0,;
MW$V]U""B(J*-"Z7%#(E'+0HE!6&X@J7C4D$V(&A)><:%$5Q]/LI>D8<YU089
M9/!DM0)Z\4+)RJTV'0/XX)@S&AD__ .7H+80#QOS<Z6HF61/[RQ;EAJ1*(8Z
M\R8!-!*-NTD<:7+M@#SZ$]FT=[((EA]N$9R@%V>I]69'<T#$(\%LC89K<4CC
MVF3,,A#H.Q4NW66J;)?DKH.#718@UY:,;EYFZTPA<%1*@9Q+>965'2/#B3,M
M^<MA^N#! W(NC<5N9_.L]113__CQZ*U52=V&M7NTIX&+^T@DS*!0/#""?T4W
M6J"C#=R/HGVIF+/*RP*NE[\</L!#;,\I:K[5 M458<W\R\/>,UQ>;/8D4$P4
M&R^W(4^M\!U<;&FMT1V\S0_\U 9ZC4/6OQ)A;*]$4,&ZHKSA8@O08#QXG1Y3
MZ_'$_/@5_3A@B1^X^6*-)F4JL!OOW]0K:47HXD7W]@KV=&N, N/]G(W=\P=C
MUZ3<1 -*!'W>'^\=;G?N_7RHI\B6-]Q54=7,:*#7@U?B6']O$-.1^=C6KA]^
M"72*^_R\:CZO$ ! ^AY*#7M:#$&M^"!H"A8'<5,^:75&^$YTTX/*M^8KR^9O
MJ5<5*:$/3(6]0" 0#1K/)P9># 6(L*BCN=X?D*27*64=)P,ZY)*_?H??REA6
M7X+EUA\@L5Y&9FS_K4G\4@>Z[(UU(.T6P1!$%4@4<9A\2UB(.+M6(4_L^XZ%
M'%T)5(L\R=:D7E%_W8E!?KOVICQ2KE?H\.*8@YM;]P1K8^CO\PE&AO0;J0CO
MU:M[&QAEWFF\PY&^P-%5K.S(S+0^[W+Y"=_;JX&YW=W#V_=M(S!^1QGH:AQN
MFAIK@Y'Y>22;W^^.T>NOQ]."O*5.QIA-WKOO)<5H6"!08C$5ML S,'O&)B^8
MINCB6$CZ%6UC7K*1*Q<[9"^:FW+%*?O=ZI&Q!1R+EL@(7FE 3(W#<96AKV >
MF"3N7D?X6M6>D%], (#&.<'>*[IY_D2JZ,>$5[[<AU=,>.7+?7CE]V],Y1]N
M3!UG >D48@&NF!'?&34_U04567>^A*A*#*6]DXNTQU,[=&.3AQ,CNTE8NLU%
M19@1S#,2!?&1V\,"E@.$W+=!3%J"W5X.V@93K6WR<[[>L$9$T6;FC&.6"%0$
M Y  65W(SAQ&=8;C-:1I[%S",OUN (7.Z(R,="/+QPZJD7-5=>J+H1A C^)O
MP ,_8-V1HA0$O$:\J^3EUG<3WB;V95.Y1_15+4@9<_[\?C:6C%2>*-J0#^9/
MAE;^@%<_Y@I/+[E6EJ U^NR.[\B.);TT:T"W\<59'#=-55M='VM^6S^Y/:$8
M/:RHEA/L6HT[S%$]\D$&:KA$FQU]U6B6$/$>%D3K0&'43"=G/ILJ4/03W-(2
M #.'\:+)%JH_'8@]Q=205N^;Y]2&LS-=4,;9^D'E*7L&\<OCGV$2*K@(,%Z(
MT;K8G)8X).K_<:'MFTO/VI8_YRW[B+-\N_RB\9L4G?L^[<-G=Z+83YDRD\M^
MD@7IRG_R-TR3N]T%!G!2Y1=U1P QL]4D&NO"W#84Y6/\T\G#X:M""I@RR@X]
M$#(,2[G.G75][4/UT5\-,UJIF^"FUM#"OKFY%=-E88J2VVK#M89E[)'/F\.2
MPO'*7='$$K(=&45%-8\901C0.ZE)I-:"Y"@9IX04:3-M>3 BDG',)5M3:A,/
M-8I)#*0_=@%AQ:^<'OD[/#J/\>B8M:>BR2\<X\]3U,OF=#!V[E1%CFOT!HID
M]#^D#J8.,4"1%;QV<S04A5'(,4XK;]B'\(7-=ZGW\*&$SZ02=R?TOF@TO\1\
MJB_O_6^KCSE/8;\$6>MIA#OF#4X#?5+#_WR9<-"<+KS8$QD(YN0E.>M00W(7
MAN7&9#"JG:!PEDWAPW[A2B;$@G/&:T&>:N;]+%T=2W1HFC+HZ1@Y:.",-(X
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M4$T;"0VG#*4W7LXV5P<MO_YKSA10W' ,#._CKV.<SC*?A_3'ABZ21 Y^@")
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MLK5 #/@O/%J!$U<B)F)Q=H+92[N/:S)PW_*@L@OO094[T7&LQ?:.>BNLW*P
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M[Q8LY).X,!6C'E+QV=8T>X9;?%1-6QI1@'D9'8\AD>XNP:;3P%PH<G%F&/.
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M33=0H[#R ] P89Q><S11I*#4.F?<L>G<3>^^_OA:^,BN/YVL.R#S!AP5 !6
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M5T*_VF7V7U]C,LQ54]QJZ,]RBQW.OR>:SORSE=3#6$(>WL0YB;DPU3#F_.#
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M+B7+S>D&IF06R1BC4A.TW:3QD&AMV&5P'"7$<L7500P\B<#:^1-:I8F:Y>R
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MBJ:._4MY)E5):^&!C^UZ?J.M8^ /*5QJD5@T-P--T(DWVQ#!K9B!JS**L7N
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MNN%%8PL 6H%3#;9@&K1"AZ"Q.4;6Y@"*,7\2@:@.MVR+R*#7@&2BMXE3N"?
M*O."2?::Y:UP23@.KZ6 HBV@018E3UK$PTF<L-#-3531-%?1H%A G,JPL$PU
M@.IV(I).1 ;@BZ.A&S>[1ICE1N,T6YAI.@CS:[/7!$='IUM!Z4>V8N#F2=<W
M_$B><E3V@ZPAXO>Y^*U@YKL;#4S21YY*8$$CTJ_&DZ8!W*\ZEI:MU9M0'Z<E
M,?5E1+Y(/ /<I<^$PC3&-+"A6=6I;'>EAY?ZHR.O4W +"\[C7BX"<-C.E$*"
MH SLBQ.-ZZ@\Q>)Z>L=0GU)0=!DO6NKQZSDAM?;+(!V/R>+&B]*7\2[&S[LJ
M3LKC<VRP_^L,G!F0/#%7-&8 ?]AHO(%H'G\6S09;X+R($,L82!E2U-"!TPP%
M,)Q[8(Y9Q:X76G =.<K36"D:6G"E-F+)TODP3=Y]PV!_;C9WDA9;Z#H>WTA8
M3/&LERV5;N)05!A #85;!(EML(>+=F)]AT=H$=A"<J Z0E0'8$5V4F5))["P
M?J97[;7(^9N^2#-2!C$<(M!H"@0!\R0FL@+X",$]JC=,=.U:MB#!>)<$7-!Q
MD('X)75[.&9'3[[0@<'"R65\->>F>6H?)@<X'6.0Q7T4F(#,PM',(5C1+*DI
M&(R*FB!LRO1C.F78C;!$ 9:7S4M]\]F*WA&FJCE<YQHP5A.IA&E5[ZN*J['E
M+2KOR=9+TQ78(=@+_IJ4 Y'P(& AL5MHM<FI:CL=FY,>^2[AK\,8ZSS#O,6_
M-P?\)7/4:E"O !(\1],=?6[@^,HP BWJ,I4Y11_=HMW9#G[??VG6[;M.[X]N
M/SAY%?R_B_Z?9M'V>YTC+J,<!YWC/X/.P7GOY-C<\Z)WW@I.^L%I_^2@VSWL
M';^6CYBO]LX.>_C!8+]_<O'ZS7FP_R?^[K33/S=_>MWI'9^=XT].SM^8.^+/
MS0.]Z>(?>]VSH-LY>!/\X_CDG;GTD1E+Y_C0W.&\>PS7[1P=P<=/\!NO^]W.
M>==<K_LO^'5PVNV_[9V?=P_QKJ>G1[V#SOY1-SCJO&L%YFY=^/'^V<G1Q7D7
M+G-Q?'!R?-ASU^WU^]T_3N!+,.I#<]W3?O?LS/P-)^ALH_'JQ'S"C!LG"&X#
M\[5%Y./?F_%8XO;>R\TS"_0\Q5K2*Z06:_[^<^]S/;BZNWW,+W$S[R[+RB*_
MK,LBJBSRR[HL\I5L=^D.8;;F=[WS8[.)!>]@!SQYU=(H4&*0,><UA=40(;HV
M?X&D6.TSC_X#LEOS\<)!1BFSXSMPX7QVG6;((TA0\31C 201U8"3>!1G(,(!
M&/<!85DOTYN'48L]QP,$Y"3.3CL'YD3Z^P_;/^#?3SN'A_+WCQ[>;3R<7<-'
MMW^T.P"$GN$T-PM _O0#Z%J<]^7R-X!*&81C>1!:"?2AP^#@!(9X_/<?=NQX
MIN $)E=NR6P]VV/]C'^91S!GM#GDSLRQ=WR 1UC@[0LX/<2E8ASD%\%\.C41
M4 C#,A>P$[7O%OCY(8_ECOO;[Z[VA0I:6'T%\X_^9YJHCQSHUWXR_A ;U]Z/
M5=(I]\;,N[]X4?OBEY]IUOQW]WY<,F7\H9T5/K/[O.I9[V$J/^/\X0E:FL'R
MH]8__#?VP.>0P?\"3_PS[MGW<W+<OXO]P\N.(K<E6NL7]WCUO;WMX Q;UZZ#
M#G:CMX)VVU.5"5Z-TS2[QWLZ8@-+>6Q.MO;S>[Q%]\G;,![?YT3=_XM]AZP+
MW%*?BKZ]RT.J$B"!T)L/^WG,MIV\AT]&4!^YQPNW=YZUV3C%#^Q,S">-<_'9
MK7)GF_3"NMBT:7;!+!QNY=?Q:&2N^'\OX9$S\\1;@W1RGVM^QEU8YC T-PR.
MMH(SOF<KZ.;_OC]?]TLE!?ZSWWW;Z1T?4M;HM/.ZZR=I@J/NJ_-@_ZAS_(_/
M/)*SWNOCSOE%OTNC> 6YJ8O^P9O.F1G;JY.CHY-W9__UF<?PA1(QJZ0EGJW3
M$BHM\6R=EOA:UOJ?;A7Z2_0,\K=GW8.+?@\3OO*YC4;G=;_;?6LVD6][O7Y2
M1H;JZ$A^L-'X^NF8P&9C-AH/)QWS66Y-L9C')/\B^.]/_,_G'NJ73"G>JV9K
M[Z6M(2#6K^-L\8QM<>&] WH^W*17>!V?>R:^L"56S<Y'&^5W,B>8.+BW2?E>
M9J6+I#.23*B;G2\_*Y\C$CTE.DZ@TP2,'3RMH&T>=@A=SO7 6>V.F6]F\(>*
MW(C[RG/O48+->$3$2D@#E0O''[(>?1OYC@IMGQ?!W[ZME4+B116;XH,>]?VY
M&4[/::/A"SIY<^*XZL?!R2T#[TV0FP[>&U.NU5];:51<'OOUV>ZN+H\!1^*O
MO_X(L*W[O7#P*USWD;Q?PG8M?;?K5_PU7G'7Q+7'<^!VKO7(OA/':Z4LW/-U
M%DYEX9ZOLW!?W%YMTGC_9?=?;WK[O?.@\QEQBE\X$W[Q\A60>3F8,A\(@%G]
M+IZP(T*EQI7NDJATL+NU(X!T?/KG3SYW;>4_DLM\^B#*&K_^%IR@9VX.>W,S
M)IZVN^S.KU]FF_4W$CL[CV7ONG,-5&9V/]UO_&);X_[WN#66Q6V_\^VQ_5BW
MQZ?;CV3[J[[E>O?[:[O?P?>T^W4&@RP:QE #[:&J@PG'_\D25@D02'\WF^!*
M.\,7BC_7.\,7?._8L]<Y..AW#WO0[M8[_J-[=G[2#_YY8?[=.SD^[O3Z7;+S
M>US87Q4W<:Y;[H5!T#$P>+*>0%6N6+F4F.?FH&FI?,6%6(JM:%7PIK#P$^LA
MA&Z_B7F_L8H/(4A%C(3SH!]=S9E7]5#1.JK[=YC() ;6E QDU9B& /IO@:22
ML!QP52A57#I"%8!J7&$)/9,_PP5SIIP UJ9Q>OLY<8:N54:WQA1;9][U#L_?
M_/T'Z'SYA+Z9U1)8]9AW\\7J9@D\;@%$7OX-F5]GJ_C[ZN3@_DO5>'I^8I:F
MV8UZAQ>=H[/@Y/B(>D6#TW$48CMT?LM&,,*&2N@3KY1;7*3S#,0)P@02VJCE
MQE)-X6JV2")=W&8.,@9,MM"'KO>][3;^6=EG<TMH&SRS1^$85)5.DXA:MF[B
MX1RHW[#/W/T@F,P1110#,1R2V=##WL+2Q0O+@UJH4>YT4Q91+@,W!LT_3%+Y
M&5--12WY+JD4I"Q?HT81DX0SL.(&_A:"X^-!E>\:)_8FL(78L;9;P0X,Z6F
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M-I6@=D^YAL].A78(@*3BPJ$CRYYPGDZOC3=)_!Z"+21/C<YHM1,SH\LOFY<
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MMI%LMZ956<'O5TP<D:AF,-S1E=NZ:<#=#OP09CF&I8OB'*9I%[K#,ZWR<!+
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MFT-7U) ,,Y8LE^<900;B0T"5[1:0Y=P( +F23A:G%R#H,[0<X-&/QW&#F:$
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M_ _H/^+M:>]H_PST\J.][CV:AOXBBID!@#?'<== Q47S68@=ZXCPGP%V_#X
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M8>5F. 4ZP)"#M.F$FELB5(ZW1@M48*HIU[M>#((C^/FR"ZDOV,#@;A8)JL"
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M.1Q,!>^44UQ" 1=JGD; ,>!^$#W(IT)!:N"OPWTIN\\:83*%FT4'V<"K@BT
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M-L87@D>/E*7ZH/?>#>]X5.5S>.3Q7 >1/!KE597/G@>_X'>CO(!SU]^]3B/
MJCU889FGR>2'5PWA(C90T%\"<S9,/P)4^/1H%*-@\1P.$M=L+^F7AA7A,F\[
MI068GQ R#(SO%B_N7*K83_.2&.D@@HMXG7A1LK:U1,*"I,"1.-((R "2;\5L
M-&/1KREB7"39.)F#1.VR,&"D_BMA.TL^3+(H([F<WRZ1@(;((ECE;)D$" ?
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MJ#AA%I!RC%.:3LEQS&8%UM>GH/^F";!R8<BV_JGC@X[SB@PO$N!8(_";&U8
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M*$T=Q/.\3"B2W E#"[;,@@Z&^^XBI"@:SB3O!Q]@P$D178$XTX%!8*1\DD2
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M.2<S#.*1=KP4#,K.<4I&US5HXBRG *Z<2>-=3LJ>#VO6G:"3+6V:2F9N.V"
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M--B=NSWXQ'262)=\9@!2C]IO[P2=,ECH^D+ C&KV(RO0P,@\(K+5F]QS-)@
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M',L<2SE-# OW*E %Q%X:,A1@^,L<6P+Z7<C\I:\N5V_U)W-*+BM0\&E.8M+
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M1>>+',T#@+E7$6@ <T35 A1^6<B97NG9J_7)?,63403NIN?RE<B&MI_>D]7
MV)#NTS1Q$\OHD[4]U%+D_G3&Q<\Q:GUKYC5M<'S\D UKMX$(&AEY31A6U/VU
MV]_O#;H2BKL&TK^&.3<<Y]@#2K)JJ1W4TFM#I0SJK/1_/T1HWM"4>!1-5._<
M-P!_JI/_S1G_5O&?#[V#X=N__T LX'.7R?1^MX'>WX!%H06QSI)PS\V^L=V=
MQS>(S]G:<XP7UC"?<<@8>$U8S_9=YDLW_2^Q"\#9A02.\QT^N/_Y'Z=SG_RN
MF_69-H._CN,T> T_3DH5ZI*-=\+;K2<*#N(TNJ(">E;A%GL%NMVR:E^\SY7V
M*#2),^XHL$G%H%.]BNIVRS!9II-X:N7JF1:!5@;V+(XRBGJO-2ZO)2W[TLOZ
M GZE"_CX6[F XIU1I5)*BK73U1,UM_L?_,^O\N&W.EJCV[>*;D_N&-U4887;
M8!KWXI'N(O-H.;,2T=WR+R;K819-J$#YUO@BQK;T6;S]_-O&KF_,E0CXT8P>
MGVNU:1_I _ @RKX"(/W7WB]_,T#Z>@Z;?6P*HY"K+=KO#Z^J?>=?8<M*2H&=
MIYC;HW8O\@HOA[442I>RNTGMH@;HE7X-KHDC_#J:Q9K(UXG\TSLD\CV[0,@M
M)0J@UW'*S7NCP+F!8;VNA6KD5"YFB'C_5R0-$&#M\G31992DF&UVNZ5,%\1P
MW'[$*)./0;B?F+)07A'#M23S[2+YSW>(Y*=&?KT=7E'\F-<MJJEFG73"\4IK
M>U*T;J,ZH393MUG'C?&8VL!X\UH]K%2?I;68M1:S/F>U@M^FP]7!A\Y^T 'L
MI&*DN!@)1&'RWO[?GT-&P_3G//_T"#2@8LF!J)=)Q*N(@DE"O5&YTXP8H,IE
M6<6S;QHZ]TT21LN;$<?YQ;+$U>D^9%PNT2[27.77(N)U^'FJP/(5*.&=S-N8
M0K%Z*9\',AMF7S_JX/LBK%0 D#LPHY%;TPQ>!Q?[=4I?ZG *;@*CNE7=MPZW
MEF1O+\G^<H>2[&O.D584[Y;.AND*@=8R+&,-$L!&JJ6,7@UIXE93L+B_9H;U
M6JG QVW6(AW5=?T269')+!![M25..TU553]@7*%RV("43+U4;NV;RB[A[N6%
M6$[0#JF\,;"[OJ[U$AP$=F-ZXP$>F!+#V- >X+SW[,F3VWJD2EW=E(J6Z_ZB
M5#,^HZ)$JK<Y:,K8X"[)J(APJ=4 4Z?;]UK?;BWLXMZ*/*6EIH>X5J4G6":6
M_I3E6'#I_LZ]U&^W#@/-IZ$%H&TLCSK#2J>J7"KVWINT6;OVMJ)M-'C9:[O=
M.JRR!5:U\XQ;-14Q]I(MUS:$;X[R_O6.O2&J>_EM4*?A+LKUTJT1+-*+%9W.
MN94473 D]IW*M(8\C:1T$I"_\I;T)9O\1,WD7"+")/Y"&K1IAV TIM0ZW<;$
MH=*P$UAQ<AFA6_IVJ["[<%%6&?7P4OU65$%_ZMUIII/";@56J-JFNK;Q#%WV
MU&0QI8K>EA'Q=@NR&F*,D*1PDP2?1WZ+5A)[7CW:#]^!$>6.T]Y61-OK(,VO
ME??V1XI3W$G.A56WXHX6H[=Y 9+6HW(>81!QEE\5$9SP/:M)F.%HNO=\K1R9
M!WRH]WQ^MZR2\X#.[*LO_0N=\!_-05Z?\;=_QBL*%GW+A_RUK6!?(\Y]2^?!
M!3/0<S8WL+RM6!.Y1BM%EY)I)W.8*[7&@]^2:4+]5MCQ$XUCS^7X9ZZ@<9OZ
M4T]?!"?<M.QY<!25U3KIZK9)5U\H ^H/!2;]]/KDX".2F)_>#M\=O?K_4$L#
M!!0    ( !-(DUMN9-%-N%,  -/4 0 5    =&TR-3,S.# S9#%?97@T+3(N
M:'1M[7UK4]M8UNYW5_D_Z/29Z3)U%!IRF^YT)E4.F(YG"##8))V:FGI+MF50
MQY8\D@SQ^^O/NNVK) -I2-*TIZ::@"WMV]KKOI[U\LWP[>&K=NOEFUYW'WX&
M^+^7P_[PL/?JY0_\$S[]03Y^^?IX_T,P&'XX[/W]NVF6EB^"W9U%&0R3>5P$
M1_%5<)K-HS3D/X3!(,Z3Z7?P(#QZHIXKXT_EHVB6G*<O@CPYORA_#N91?I[
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MC10&QZ>!][;#[GM:6_<(B:L[E-G#LH[Z0W@K_6VP79D%39HFW-W[UUD?IWL
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MRN-@R4VFM6V9L*%RS GZ8)$9Z Q?\)09XW-?^@IZ:,5=#$XAV:$CH*QY;.6
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MQD79:2;JL?>8A?0164VA+!/I6N[&#<,RACO1D*,ZIJ;/&@E%J <],1;Y=.P
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M[UF82_8,) '*-%O98Y@^RFOB<CW*BE()[ 0U4]YN&J9$=1)/K4(_TV'< D_
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MO#[>_X",XX<WP[>'K_X_4$L#!!0    ( !-(DUMQQ#TEWE(   NV 0 5
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M'&LEZV5!)KE6DF0_6#NQINUU%ZDP2SCQE G1I#/8@7KW3CAYTW6WCQITM%O
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MI6M/.AO8UIJ^$_[PXQWSAR+.+PRR14/RMI,0@_[Y5&# ,.VE),\&MR,'2N&
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M0(VIMBR:&YHQ^<H.8C>SGGL<OKA>-N)/#]F(7S<;\:>';,3[<F-N*^ WOH.
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M"<6?9BEA3@<EY7K!&2JG+2AB!,),:MD%D'F6J_:"47&S>2CW+:QNH MH@_W
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M.II"'H> 2+Z1PA$4I00%;Q6=) DNR"5"CNN6XBOYHGY%C/>W.[2;KG@7#AW
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MJI>A>@5H)9\1*ZM O\M*4%&+[??+ZYNNQ2>Q66\2?ZUP1L26_P)02P,$%
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M7U!>PZC'DK.8&29FG^T=HF*$5W.NLH-"1DGV_,(:)GRGJ(LTM;?=^3HNM]=
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M#3V&;XH Q:'Q07VC$!A#19@N.D>Z;NP!]X[:XAOWR[V'U1[Y'U!+ 0(4 Q0
M   ( !-(DULC?OMH*!L  &F:   2              "  0    !T;3(U,S,X
M,#-D,5\X:RYH=&U02P$"% ,4    "  32)-;KZ%R)I2H  !#B@, %@
M        @ %8&P  =&TR-3,S.# S9#%?97@Q,"TQ+FAT;5!+ 0(4 Q0    (
M !-(DUO,Q-<ZG"<  -C8   6              "  2#$  !T;3(U,S,X,#-D
M,5]E>#$P+3(N:'1M4$L! A0#%     @ $TB36W5-]W&M3@  )[T! !4
M         ( !\.L  '1M,C4S,S@P,V0Q7V5X-"TQ+FAT;5!+ 0(4 Q0    (
M !-(DUMN9-%-N%,  -/4 0 5              "  = Z 0!T;3(U,S,X,#-D
M,5]E>#0M,BYH=&U02P$"% ,4    "  32)-;<<0])=Y2   +M@$ %0
M        @ &[C@$ =&TR-3,S.# S9#%?97@T+3,N:'1M4$L! A0#%     @
M$TB36R5+B@@X"@  QR   !8              ( !S.$! '1M,C4S,S@P,V0Q
M7V5X.3DM,2YH=&U02P$"% ,4    "  32)-;0\XE)2D#  #H"P  $0
M        @ $X[ $ >&5L8BTR,#(U,3(Q-RYX<V102P$"% ,4    "  32)-;
M(/O6)/T*  !_A@  %0              @ &0[P$ >&5L8BTR,#(U,3(Q-U]L
M86(N>&UL4$L! A0#%     @ $TB36X0 O/Q;!P  V%<  !4
M ( !P/H! 'AE;&(M,C R-3$R,3=?<')E+GAM;%!+!08     "@ * )H"  !.
% @(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>tm2533803d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="xelb-20251217.xsd" xlink:type="simple"/>
    <context id="AsOf2025-12-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083220</identifier>
        </entity>
        <period>
            <startDate>2025-12-17</startDate>
            <endDate>2025-12-17</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-12-17" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-12-17" id="Fact000004">0001083220</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-12-17" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-12-17" id="Fact000010">2025-12-17</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-12-17" id="Fact000011">XCEL BRANDS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-12-17" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-12-17" id="Fact000013">001-37527</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-12-17" id="Fact000014">76-0307819</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-12-17" id="Fact000015">550 Seventh Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-12-17" id="Fact000016">11th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-12-17" id="Fact000017">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-12-17" id="Fact000018">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-12-17" id="Fact000019">10018</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-12-17" id="Fact000020">347</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-12-17" id="Fact000021">727-2474</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-12-17" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-12-17" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-12-17" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-12-17" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-12-17" id="Fact000026">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="AsOf2025-12-17" id="Fact000027">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-12-17" id="Fact000028">XELB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-12-17" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
